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 I 
Zusammenfassung 
 
Der  L-Carnitin/γ-Butyrobetain  Antiporter  CaiT  ist  ein  Mitglied  der 
Betain/Carnitin/Cholin Transporter (BCCT) Familie. Sekundärtransporter der BCCT 
Familie  transportieren  Substrate,  die  eine  positiv-geladene  quartäre  Ammonium-
gruppe besitzen.  
CaiT besteht aus 504 Amiosäuren und besitzt ein moleculares Gewicht von 
etwa  56  kDa.  In  Enterobakterien  wie  Escherichia  coli,  Proteus  mirabilis  und 
Salmonella  typhimurium  wird  die  Expression  des  caiTABCDE  Operons  unter 
anaeroben  Bedingungen  induziert.  Unter  diesen  Bedinungen  ist  CaiT  der 
Haupttransporter des Betain-Derivates L-Carnitin. In Enterobakterien wird L-Carnitin 
unter anaeroben Bedingungen aufgenommen und dehydratisiert wobei Crotonobetain 
ensteht. Crotonobetain wird anschließend zum Endprodukt γ-Butyrobetain reduziert. 
γ-Butyrobetain ist das Gegensubstrat, das aus der Zelle hinaustransportiert wird, wenn 
L-Carnitin  in  die  Zelle  aufgenommen  wird.  Der  Austauschmechanismus  von  L-
Carnitin  gegen  γ-Butyrobetain  geschieht  ohne  das  Vorhandensein  eines 
elektrochemischen Gradients, d.h. CaiT ist sowohl H
+- als auch Na
+-unabhängig.  
 
Ein Ziel dieser Arbeit war es die drei-dimensionale (3D) Struktur von CaiT 
mittels Röntgenstrukturanalyse zu lösen. Weiterhin sollten mit Hilfe der 3D-Struktur 
und funktionellen Studien detailiertere Erkenntnisse über den kationenunabhängigen 
Antiportmechanismus von CaiT ermittelt werden.   
 
Im Rahmen dieser Arbeit wurden die 3D-Röntgenkristallstrukturen von drei 
CaiT-Homologen der Enterobakterien P. mirabilis (PmCaiT), E. coli (EcCaiT) und S. 
typhimurium  (StCaiT)  mittels  molekularem  Ersatz  (engl.:  molecular  replacement, 
MR) mit einem Alanin-Model des CaiT verwandten Na
+/Glycinbetain Symporters 
BetP  gelöst.  PmCaiT  konnte  mit  einer  Auflösung  von  2.3  Å  gelöst  werden.  Das 
Protein  kristallisierte  in  der  Kristallraumgruppe  H3,  mit  drei  Molekülen  in  der 
asymmetrischen Einheit (engl.: asymmetric unit, AU). Die drei PmCaiT-Moleküle 
ordneten sich innerhalb der AU um eine kristallographische dreifach Symmetrieachse II 
an.  EcCaiT  wurde  mittels  MR  mit  einem  Alanin-Model  von  PmCaiT  bei  einer 
Auflösung von 3.5 Å gelöst. EcCaiT kristallisierte in der Kristallraumgruppe P32, 
ebenfalls mit drei Molekülen in der AU, jedoch ohne kristallographische Symmetry. 
Während der Verfeinerung des EcCaiT-Models wurde eine strenge dreifache nicht-
kristallographische  Symmetry  (engl.:  non-crystallographic  symmetry,  NCS) 
angewandt. StCaiT, das ebenfalls mittels MR mit einem Alanin-Model von PmCaiT, 
aber  bei  einer  Auflösung  von  4.0  Å  gelöst  wurde,  kristallisierte  in  der 
Kristallraumgruppe  P65,  ebenfalls  mit  drei  StCaiT-Molekülen  in  der  AU,  ohne 
kristallographische Symmetry. Bei der Verfeinerung des StCaiT-Modells wurde wie 
bei EcCaiT eine strenge NCS angewandt.  
Da  die  Auflösung  von  4.0  Å  bei  StCaiT  zu  niedrig  ist  um  detailierte 
moleculare Erkenntnisse zu gewinnen, wurden Protein- sowie Substratinteraktionen 
nur an den Strukturen von PmCaiT und EcCaiT analysiert. Alle drei CaiT-Homologe 
weisen jedoch einen ähnlichen strukturellen Aufbau auf.  
 
In der Röntgenkristallstruktur bildet CaiT ein symmetrisches Trimer, das über 
ionische und polare Wechselwirkungen zwischen den Protomeren stabilisiert wird. 
Der trimere Oligomerisierungszustand von CaiT in Detergenzlösung sowie in zwei-
dimensionalen Lipidmembrankristallen wurde bereits in früheren Arbeiten gezeigt. 
Jedes der drei CaiT-Protomere besteht aus zwölf Transmembranhelices (TMH), die 
N- und C-terminalen Domänen des Proteins befinden sich auf der cytoplasmatischen 
Seite. Zehn der TMH bilden zwei invertierte Wiederholungseinheiten aus jeweils fünf 
TMH. Die erste Einheit besteht aus den TMH 3 – 7, die invertierte zweite Einheit 
besteht aus den TMH 8 – 12. Beide Wiederholungseinheiten sind strukturell nahezu 
identisch  und  lassen  sich  fast  vollständig  übereinanderlegen,  jedoch  weisen  die 
Aminosäuren der beiden Einheiten keine signifikante Sequenzidentität auf. Die ersten 
beiden Helices der Wiederholungseinheiten, die TMH 3 – 4 und die TMH 8 – 9, 
bilden ein antiparalleles vier-Helix-Bündel, in dem in CaiT zwei Substratbindestellen 
lokalisiert sind. Eine derartige Transporterarchitektur wurde erstmals in der Struktur 
des Na
+/Alanin Symporters LeuTAa des thermophilen Bakteriums Aquifex aeolicus 
gezeigt. Bislang wurden, inklusive CaiT, sieben Sekundärtransporterstrukturen gelöst, 
die diese LeuT-Transporterarchitektur aufweisen. Ungewöhnlich dabei ist, dass diese 
sieben  Sekundärtransporter  fünf  verschiedenen  Transporterfamilien  angehören  und III 
eine Verwandschaft auf Basis der Aminosäuren nicht zu finden ist. Da jedoch die 
tertiäre Struktur dieser Tansporter konserviert ist, kann davon ausgegangen werden, 
dass sie alle von einem Urprotein entstanden sind, welches zunächst aus fünf TMH 
bestanden haben muss. Im Laufe der Evolution hat sich das Urgen des Urproteins 
zunächst  dupliziert  und  die  weitere  Evolution  hat  zwar  die  Aminosäuresequenz 
verändert  und  den  Umweltbedingungen  angepasst,  jedoch  ist  die  tertiäre  Struktur 
erhalten geblieben. Da sich die tertiäre Struktur der sieben Sekundärtransporter so 
stark ähnelt, ist zu vermuten, dass auch der Transportmechanismus ähnlich, jedoch 
nicht  identisch  ist.  Nach  dem  strukturellen  Aufbau  der  Transporter,  der  Lage  der 
Substratbindestellen in den jeweiligen Transportern und der Tatsache, dass es sich bei 
diesen  Proteinen  um  Membranproteine  handelt,  wurde  ein  Transportmechanismus 
aufgestellt, in dem die Bindestelle des zu transportierende Substrats alternierend zu 
beiden  Seiten  der  Membran  zugänglich  ist,  ohne  jedoch  jemals  den  Substratweg 
innerhalb  des  Proteins  vollständig  zu  öffnen.  Dieser  Mechanismus  wurde  als 
“alternating access mechanism” beschrieben. Anhand der unterschiedlichen Zustände, 
in  denen  einige  der  Transporter  kristallisierten,  kann  abgeleitet  werden,  welche 
Konformationsänderungen  erforderlich  sind  um  das  Substrat  von  einer  Seiter  der 
Membran auf die andere zu transportieren. Bisher kristallisierten einzelne der sechs 
Transporter in der nach außen gerichteten offenen Form, der nach außen gerichteten 
Form, in der die Substratbindestelle jedoch nicht mehr zugänglich ist, in einer Form, 
die keine Öffnungspräferenz der Substratbindestelle zu einer Seite der Membran hat 
und in der nach innen gerichteten Form, in der die Substratbindestelle jedoch nicht 
geöffnet ist. CaiT kristallisierte in der noch fehlenden Konformation, der nach innen 
gerichteten  Form,  in  der  die  Substratbindestelle  zugänglich  ist.  Mit  dieser  noch 
fehlenend  Konformation  kann  der  Transportzyklus  des  “alternating  access 
mechanism” vollständig beschrieben werden.    
 
Alle  drei  CaiT-Homologe  kristallisierten  in  der  nach  innen  gerichteten, 
offenen Konformation. Im Gegensatz zur EcCaiT-Struktur kristallisierte PmCaiT in 
der  substratungebundenen  Form.  In  der  StCaiT-Struktur  konnte  aufgrund  der 
niedrigen  Auflösung  kein  Substrat  nachgewiesen  werden.  In  der  EcCaiT-Struktur 
sind  zwei  γ-Butyrobetain-Moleküle  gebunden.  Das  erste  Molekül  wurde  in  der 
zentralen Substratbindestelle, der sogenannten Tryptophan-Box bestehend aus vier IV 
Tryptophanen,  im  Zentrum  des  Protein  lokalisiert.  Das  zweite  γ-Butyrobetain-
Molekül  wurde  in  einer  Vertiefung  an  der  extrazellulären  Proteinoberfläche 
gefunden.  Beide  Substrate  werden  hauptsächlich  über  Kation-π-Interaktionen 
zwischen der positiv geladenen quatären Ammoniumgruppe des Substrats und des π-
Elektronensystems der Tryptophane in den jeweiligen Bindestellen gebunden.  
 
Eine  besondere  Eigenschaft  von  CaiT  ist  der  H
+-  bzw.  Na
+-unabhängige 
Substrattransport. Die CaiT-Struktur erklärt warum kein zusätzliches Kation benötigt 
wird um Substrat zu binden oder zu transportieren. In der EcCaiT-Struktur ist eine 
wichtige  polare  nicht-bindende  Interaktion  zwischen  der  Carboxylgruppe  des  γ-
Butyrobetains und dem Schwefelatom eines Methionins in der zentrale Bindestelle zu 
erkennen. Dieses Methionin ist konserviert in den prokaryotischen CaiTs und in den 
Na
+-unabhängigen  eukaryotischen  L-Carnitin  Transportern  (OCTN),  jedoch  ist  es 
nicht konserviert im Na
+-abhängigen verwandten Glycinbetain Transporter BetP. In 
BetP ist diese Position des Methionins durch ein Valin ersetzt. Die Mutation des 
Methionins  in  CaiT  zu  Valin  ermöglicht  zwar  immernoch  die  H
+-  bzw.  Na
+-
unabhängige  Bindung  des  Substrates  durch  die  Tryptophan-Box,  jedoch  ist  der 
Substrattransport  nahezu  vollständig  zerstört.  Eine  derart  wichtige  Substrat-
koordinierende  Funktion  des  Schwefelatoms  eines  Methionins  wurde  bisher  nicht 
beschrieben.  
Eine weitere Stelle, die in H
+- bzw. Na
+-abhängigen Transporter mit H
+ bzw. 
Na
+ besetzt ist, ist in CaiT von einem positiv geladenen Arginin eingenommen. Eine 
positive Ladung an dieser Stelle stabilisiert den Bereich im Protein in der Nähe der 
zentralen Substratbindestelle. Die Mutation des Arginins zu Glutamat in CaiT erzielt 
eine  vollständige  Inaktivierung  des  Substrattansports.  Durch  Zugabe  von  Na
+  im 
Transportansatz  kann  die  Substrattransportaktivität  der  Glutamat-Mutante  jedoch 
teilweise zurückerlangt werden. 
Diese eben beschriebenen Aminosäurereste in den beiden Stellen des Proteins 
erklären die Kationenunabhängigkeit von CaiT.  
 
Die  Aktivierung  des  Antiportmechanismus  in  CaiT  wurde  mit  Hilfe  von 
Bindungsstudien an rekonstituiertem Protein ermittelt. Diese Messungen ergaben für 
das Wildtypprotein ein sigmoidales Substratbindungsverhalten, was auf ein positiv-V 
kooperatives  Bindungsverhalten  hindeutet.  Die  beiden  Substratbindestellen  im 
Protein sowie die beiden unterschiedlichen Substrate, L-Carnitin und γ-Butyrobetain, 
lassen auf einen heterotropen positiv-kooperativen Bindungs- und einen allosterisch 
regulierten  Transportmechanismus  schließen.  Bei  diesem  Mechanismus  erhöht  die 
Bindung  eines  Substrats  in  der  regulatorischen  Bindestelle  durch  induzierte 
Konformationsänderungen  die  Affinität  eines  anderen  Substrats  in  einer  weiteren 
Substratbindestelle.  Die  regulatorische  Bindestelle  in  CaiT  befindet  sich  an  der 
extrazellulären  Proteinoberfläche.  Eine  Schwächung  der  Substrataffinität  in  dieser 
Bindestelle  durch  Einführung  einer  Mutation,  verstärkt  das  sigmoidale  Substrat-
bindungsverhalten und hat einen negativen Einfluss auf den Substrattransport.  
 
Durch  die  in  dieser  Arbeit  gelösten  3D-Röntgenkristallstrukturen  der  zwei 
CaiT-Homologen,  PmCaiT  und  EcCaiT,  sowie  den  durchgeführten  funktionellen 
Studien sowohl an Wildtypprotein wie auch an Mutanten konnte ein L-Carnitin/γ-
Butyrobetain Antiport-Mechanismus für CaiT vorzuschlagen werden.  VI 
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1   Introduction 
 
1.1   Carnitine 
 
L-carnitine (R-(-)-3-hydroxy-4-trimethylaminobutyrate) is biosynthesized from 
the amido acids lysine and methionine (Horne and Broquist, 1973; Kleber, 1997; 
Tanphaichitr and Broquist, 1973). It is an essential metabolite in animals, plants, and 
prokaryotes. L-carnitine is used both as carbon and nitrogen source in prokaryotes 
grown under aerobic, as well as in some bacteria grown under anaerobic conditions. 
In some bacteria it is required as electron acceptor, osmoprotectant or cryoprotectant. 
In eukaryotic cells, L-carnitine is needed as a carrier of acyl groups. In mammalian 
cells, the main use of L-carnitine is in mitochondrial β-oxidation of long-chain fatty 
acids.  
 
 
1.1.1   Carnitine metabolism in eukaryotes 
 
Carnitine homeostasis in mammals is maintained by endogenous synthesis, 
absorption  from  dietary  sources  and  highly  efficient  tubular  reabsorption  in  the 
kidney  (Rebouche  and  Seim,  1998).  Carnitine  is  an  essential  metabolite  with 
numerous roles in the metabolism of liver, skeleton muscle and heart, kidney, and 
brain (Bremer, 1983). Carnitine has a crucial function in the mitochondrial shuttle 
system  for  activated  long-chain  fatty  acids.  Fatty  acyl  carnitine  diffuses  from  the 
mitochondrial  intermembrane  space  across  the  inner  membrane  into  the 
mitochondrial matrix, where β-oxidation takes place (Ramsay et al., 2001; Vaz and 
Wanders, 2002).  
Although  animals  obtain  carnitine  primarily  from  the  diet,  additional 
endogenous synthesis of carnitine contributes to carnitine homeostasis. Carnitine is 
synthesized  in  mammals  from  amino  acids.  The  carbon  backbone  of  carnitine  is Introduction 
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provided  by  lysine  while  the  4-N-methyl  groups  originate  from  methionine 
(Rebouche and Seim, 1998; Vaz and Wanders, 2002).  
In humans, approximately 70 – 80 % of carnitine is absorbed from the food 
supply. The carnitine concentration in tissues such as heart, muscle, liver and kidney 
is generally 20 to 50-fold higher than in the plasma (Tein, 2003). Most of the tissues 
depend on carnitine uptake from the blood by active transport (Vaz and Wanders, 
2002).  A  subfamily  of  the  organic  cation  transporter  family,  the  carnitine/cation 
OCTN  transporters  OCTN1,  OCTN2  and  OCTN3  have  been  isolated  and 
characterized in mice (Tamai et al., 2000). The three carntitine transporters of the 
OCT subfamily exhibit a sequence identity of 75 %. Carnitine transport by OCTN1 
was  shown  to  be  H
+-  dependent  (Tamai  et  al.,  1997),  OCTN2  showed  Na
+-
dependence  (Tamai  et  al.,  2001)  whereas  the  carnitine  transport  by  OCTN3  was 
shown  to  be  H
+-  and  Na
+-independent  (Durán  et  al.,  2005).  However,  the 
electrochemical gradient dependence of carnitine/cation transporters described in the 
literature is inconsistent, which may be attributable to interspecies variation, tissue-
specific  kinetic  differences  and  differences  in  tissue  preparation  or  methodology 
(Tein, 2003).  
Studies  support  that  mutations  in  the  OCTN  gens  (SLC22A4  encoding 
OCTN1 and SLC22A5 encoding OCTN2) confer risk for Crohn’s disease (Noble et 
al., 2005; Peltekova et al., 2004). Crohn’s disease is a chronic, inflammatory disorder 
of the gastrointestinal tract. SLC22A4 and SLC22A5 are widely expressed (Elimrani 
et al., 2003; Wu et al., 2000; Wu et al., 1999) but they are specifically expressed in 
intestinal cell types that are infected by Crohn’s disease (Peltekova et al., 2004). 
Defects  in  the  organic  carnitine/cation  transporters  may  diminish  uptake  of 
physiologic compounds while increasing uptake of potential toxins and may impair 
fatty acid β-oxidation in intestinal epithelium (Peltekova et al., 2004). 
 
 
1.1.2   L-carnitine used as osmo- and cryoprotectant 
 
L-carnitine  is  involved  in  osmoprotection  in  E.  coli  (Jung  et  al.,  1990a; 
Verheul et al., 1998) and other microorganisms (Kleber, 1997), both under aerobic Introduction 
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and anaerobic growth conditions. When E. coli is exposed to increased osmolarity, it 
responds by accumulating osmoregulatory solutes to increase the osmotic pressure 
inside the cell to avoid dehydration (Le Rudulier et al., 1984). These solutes include 
ions like K
+, amino acids such as proline or glutamate and other zwitterionic organic 
compounds like glycine betaine (one of the most widely used osmoprotectants), γ-
butyrobetaine, crotonobetaine or carnitine (Kappes et al., 1996). The molecular basis 
for their action as osmoprotectants arises from the fact that they can be accumulated 
to high concentrations inside the cell in response to increased external osmolarity and 
thus  are  able  to  restore  cellular  hydration  and  volume  without  disrupting  cellular 
functions (Yancey et al., 1982). In E. coli the major osmoregulated transporters are 
ProU, ProP, and BetT. ProU is a glycine betaine and proline betaine ABC transporter 
(Haardt  and  Bremer,  1996),  which  shares  sequence  homology  with  the  carnitine 
transporter OpuC from Bacillus subtilis and Listeria monocytogenes. The H
+/proline 
betaine  symporter  ProP  (MacMillan  et  al.,  1999)  belongs  to  the  major  facilitator 
superfamily (MFS). BetT is a proton-dependent choline transporter (Lamark et al., 
1991) belonging to the betaine/carnitine/choline transporter (BCCT) family.  
Some  bacteria  such  as  L.  monocytogenes  use  osmoprotectants  as 
cryoprotectants  (Ko  et  al.,  1994).  It  has  been  shown  that  in  L.  monocytogenes 
carnitine is accumulated very efficiently under both osmotic and chill stress (Smith, 
1996). The major carnitine transporter in L. monocytogenes is the ABC transporter 
OpuC (Angelidis et al., 2002). 
 
 
1.1.3   Carnitine metabolism in microorganisms 
 
1.1.3.1  Degradation of carnitine 
 
Some  bacteria  (e.g.  Pseudomonas)  are  able  to  use  L-carnitine  as  the  sole 
source of carbon and nitrogen (Kleber, 1997). When these organisms grow under 
aerobic  conditions,  supplementation  of  L-carnitine  induces  the  expression  of  the 
enzyme carnitine dehydrogenase (L-carnitine : NAD
+ oxidoreductase), which reduces Introduction 
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carnitine  to  3-dehydrocarnitine  while  oxidizing  one  molecule  NAD
+  to  NADH 
(Figure  1-1;  (Kleber,  1997;  Rebouche  and  Seim,  1998)).  3-Dehydrocarnitine 
subsequently  is  degraded  to  glycine  betaine,  which  is  metabolized  by  step 
demethylation to glycine (Eichler et al., 1994; Kleber, 1997).  
 
 
Figure 1-1 | Degradation of L-carnitine 
Under aerobic conditions some microorganism use L-carnitine as a sole carbon or nitrogen source. The 
oxidation of L-carnitine to 3-dehydrocarnitine is catalyzed by the enzyme L-carnitine dehydrogenase. 
3-dehydrocarnitine is subsequently cleaved to glycine betaine, which is further degraded to glycine and 
other biomass precursors (Kleber, 1997; Rebouche and Seim, 1998). 
 
 
1.1.3.2  Reduction of carnitine to γ-butyrobetaine 
 
Enterobacteria such as Escherichia coli, Proteus mirabilis, and Salmonella 
typhimurium,  do  not  assimilate  the  carbon  and  nitrogen  skeleton  of 
trimethylammonium  compounds  but  are  able  to  metabolize  carnitine  via 
crotonobetaine  to  γ-butyrobetaine  (Figure  1-2;  (Kleber,  1997).  The  carnitine 
metabolic pathway involves the products of the caiTABCDE operon. Transcription of 
caiTABCDE is induced under anaerobic conditions by carnitine or crotonobetaine 
(Jung et al., 1990b; Jung et al., 1987; Kleber, 1997). The presence of γ-butyrobetaine Introduction 
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and electron acceptors like nitrate and fumarate (Kleber, 1997; Obon et al., 1999) 
represses caiTABCDE transcription (Walt and Kahn, 2002). Expression of the cai 
operon  produces  six  proteins.  CaiT  has  been  characterized  as  a  carnitine/γ-
butyrobetaine  exchanger  (Jung  et  al.,  2002).  CaiA  is  a  crotonobetainyl-CoA 
reductase, CaiB is a CoA-transferase, CaiC is a betaine-CoA ligase and CaiD is an 
enoyl-CoA  hydratase.  The  function  of  CaiE  is  still  unknown  although  over-
production of CaiE was shown to stimulate the carnitine racemase activity and to 
increase the level of carnitine dehydratase, suggesting a possible role as a cofactor for 
carnitine  pathway  enzymes  (Eichler  et  al.,  1994;  Rebouche  and  Seim,  1998).  A 
seventh open reading frame in the cai operon has been identified (Engemann et al., 
2005) at the 3’ region adjacent to the caiTABCDE operon. The caiF gene encodes for 
a  transcription  factor  (CaiF)  that  is  transcribed  in  the  opposite  direction  to  the 
caiTABCDE operon. In the presence of L-carnitine, CaiF is activated and induces the 
expression of the cai genes.  
At the 5’ region adjacent to the E. coli cai operon, another operon has been 
identified with four additional open reading frames, the genes fixABCX (Eichler et al., 
1995).  The  two  promoters  of  the  cai  and  fix  operons  are  arranged  back-to-back, 
separated by a 289-bp region which contains binding sites for regulatory proteins 
(Buchet et al., 1998).  
The proteins FixA and FixB of E. coli resemble the β- and α-subunit of the 
electron transfer flavoproteins (Tsai and Saier, 1995) that transfer electrons from a 
dehydrogenase to ubiquinone oxidoreductase. FixC has regions that resembles the 
ubiquinone oxidoreductase family (Walt and Kahn, 2002). FixX is predicted to be a 
novel type of ferredoxin (Bruschi and Guerlesquin, 1988). It has been hypothesized 
that the FixA and FixB proteins accept electrons from acyl-CoA dehydrogenases and 
pass them to FixC, which donates electrons via FixX to acyl-CoA reductases (Walt 
and Kahn, 2002). 
 
Under anaerobic growth conditions and in the presence of carbon and nitrogen 
sources, enterobacteria metabolize carnitine to γ-butyrobetaine in a multi-step process 
if no other electron acceptors are present (Figure 1-2; (Bernal et al., 2008; Kleber, 
1997; Rebouche and Seim, 1998)). The degradation of L-carnitine starts with the 
transfer of CoA to carnitine. This step is catalyzed by the enzyme betaine:CoA ligase Introduction 
6 
(CaiC), which has been demonstrated to be ATP dependent (Bernal et al., 2008). The 
activated  L-carnitinyl-CoA  is  further  dehydrated  by  the  enzyme  enoyl-CoA 
dehydratase  (CaiD;  (Jung  et  al.,  1989))  to  crotonobetainyl-CoA.  The  dehydration 
reaction of L-carnitinyl-CoA to crotonobetainyl-CoA is reversible and the production 
of L-carnitine from crotonobetaine is possible. The subsequent reduction reaction of 
crotonobetainyl-CoA  to  γ-butyrobetainyl-CoA  catalyzed  by  crotonobetainyl-CoA 
reductase (CaiA) is an irreversible reaction. This reaction step involves the proteins 
FixA,  FixB,  FixC  and  FixX.  In  the  last  reaction  step  where  the  final  product  γ-
butyrobetaine is produced (Jung et al., 1990b; Kleber, 1997; Seim and Kleber, 1988), 
CoA is regenerated. The CoA-transferase CaiB catalyzes this last reaction. Under 
physiological  conditions  CaiT  (Section  1.2)  enables  the  exchange  of  L-carnitine 
against γ-butyrobetaine. 
 
Some strains of the genera Escherichia and Proteus are able to reverse the L-
carnitine to γ-butyrobetaine pathway, and are used for commercial production of L-
carnitine. During the L-carnitine biotransformation process, waste products of the 
chemical industry such as D-carnitine or the achiral substrate crotonobetaine are used 
as inducer in the growth media. Although the L-carnitine metabolism is related to 
anaerobic growth conditions, the production of L-carnitine is favoured in the presence 
of oxygen which inhibits the irreversible crotonobetaine reductase reaction (Obon et 
al., 1999). 
 Introduction 
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Figure 1-2 | Reduction of L-carnitine to γ-butyrobetaine 
Under  anaerobic  conditions  enterobacteria  metabolize  L-carnitine  via  crotonobetaine  to  γ-
butyrobetaine. The biotransformation occurs at the level of CoA derivatives. L-carnitine is activated by 
the addition of CoA which is catalyzed by the betaine:CoA ligase (CaiC). L-carnitine-CoA is then 
dehydrated to crotonobetainyl-CoA, catalyzed by the enzyme enoyl-CoA-dehydratase (CaiD), which is 
a  reversible  reaction.  The  next  step  is  the  non-reversible  reduction  of  crotonobetainyl-CoA  to  γ-
butyrobetainyl-CoA  by  the  enzyme  crotonobetainyl-CoA  reductase  (CaiA).  The  FixABCX  system 
supplies the electrons to CaiA, which are required in the synthesis of γ-butyrobetaine. After CoA 
activation, crotonobetaine, supplied in the external media, can directly be used as an electron acceptor 
in the biotransformation of γ-butyrobetaine. The last reaction step is catalyzed by the enzyme CoA 
transferase  (CaiB),  which  regenerates  CoA  from  γ-butyrobetaine-CoA  and  γ-butyrobetaine  is 
produced.  (Bernal et al., 2008; Rebouche and Seim, 1998; Walt and Kahn, 2002) Introduction 
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1.2   The  prokaryotic  carnitine/γ-butyrobetaine  antiporter 
CaiT 
 
In enterobacteria such as E. coli, P. mirabilis and S. typhimurium, carnitine is 
taken  up  by  the  secondary  transporter  CaiT  that  belongs  to  the  glycine 
betaine/carnitine/choline transporter (BCCT) family. CaiT is the main transporter of 
betaine  derivatives  when,  under  anaerobic  conditions,  the  transcription  of  the 
caiTABCDE operon is induced (Canovas et al., 2003; Jung et al., 1990b; Jung et al., 
1987; Kleber, 1997). It has been shown that CaiT functions as a specific antiporter 
(Jung  et  al.,  2002).  CaiT  exchanges  D-/L-carnitine,  crotonobetaine  and  γ-
butyrobetaine  in  both  directions  across  the  membrane  (Figure  1-3).  Unlike  its 
relatives, the Na
+/glycine betaine symporter BetP from C. glutamicum (Farwick et al., 
1995) and the proton-dependent choline transporter BetT from E. coli (Lamark et al., 
1991), which are activated by osmotic stress, CaiT is constitutively active and, in 
contrast to many other secondary transporters, no proton or sodium dependence of 
substrate binding or transport has been found (Jung et al., 2002).  Introduction 
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Figure 1-3 | Model of the CaiT exchange mechanism 
CaiT  is  a  highly  specific  exchanger  for  products  involved  in  the  reduction  of  L-carnitine  to  γ-
butyrobetaine  (Figure  1-2).  Under  native  conditions  CaiT  exchanges  L-carnitine  against  γ-
butyrobetaine and, when supplied in the medium, crotonobetaine against γ-butyrobetaine.  
 
The caiT gene encodes a protein of 504 – 514 amino acids, depending on the 
species. Hydropathy analysis of the amino acid sequence predicts 12 putative TM 
helices, with the amino and carboxy termini on the cytoplasmic side of the membrane 
(Figure 1-4; (Jung et al., 2002)). The highly conserved amino acids of TM 8 (Figure 
1-4,  Figure  1-8)  are  predicted  to  play  an  important  role  in  substrate  binding  and 
translocation across the membrane (Kappes et al., 1996). 
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Figure 1-4 | Secondary structure prediction of the E. coli CaiT 
The carnitine/γ-butyrobetaine antiporter from E. coli consists of 504 amino acids. Hydropathy analysis 
of the CaiT amino acid sequence predicts 12 putative TM helices with the amino and carboxy termini 
facing the cytoplamic side. The predicted TM helices are represented as rectangles and are numbered I 
– XII. The predicted loop regions are numbered L1 – L12, starting from the N-terminus (Jung et al., 
2002). 
 
Previous structural studies of the L-carnitine/γ-butyrobetaine antiporter from 
E.  coli  showed  CaiT  to  be  a  trimer  both  in  detergent  solution  and  in  the  lipid 
membrane of two-dimensional crystals (Figure 1-5, Figure 1-6; (Vinothkumar et al., 
2006)). Introduction 
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Figure 1-5 | 2D averages of CaiT single particles 
The 2D averages of single particles of CaiT solubilized in DDM showing a trimeric structure. No 
symmetry was applied in (A), whereas three-fold symmetry was applied in (B) (Vinothkumar et al., 
2006). 
 
 
Figure 1-6 | 2D crystal lattic, power spectrum and projection map of negatively 
stained 2D CaiT crystals  
2D crystal lattices of single membranes (A) and the corresponding power spectrum (B) of negatively 
stained 2D CaiT crystals. The projection map (C) of single membrane 2D crystals was calculated to a 
resolution of 25 Å with P3 symmetry applied (Vinothkumar et al., 2006). Introduction 
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1.3   The  betaine/carnitine/choline  transporter  (BCCT) 
family 
 
The BCCT family comprises a large group of secondary transporters (Table 
1-1),  which  share  the  common  feature  of  transporting  substrates  containing  a 
quaternary ammonium group [R – N
+(CH3)3].  
 
So far, the best-characterized member of the BCCT family is the Na
+/glycine 
betaine symporter BetP from Corynebacterium glutamicum (Farwick et al., 1995; 
Morbach and Krämer, 2005; Peter et al., 1996; Ressl et al., 2009; Ziegler et al., 
2004). The 3.35 Å X-ray structure of BetP (Ressl et al., 2009) shows a homotrimeric 
arrangement of the protein. Each protomer has 12 transmembrane (TM) α–helices, 
with the amino and carboxy termini on the cytoplasmic side (Figure 1-7). In addition, 
one α–helix (h7) runs almost parallel to the membrane and two small helices, the 
intracellular helix IH1 and the extracellular helix EH2, connect the helix pairs TM4 to 
TM5 and TM9 to TM10, respectively (Figure 1-7). The C-terminal domain of the 
protomer forms a long α–helix that contains two positively charged clusters, termed 
+1 and +2 (Ressl et al., 2009). 
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Table 1-1 | BCCT family members 
Protein  Main 
substrates 
Organism  Transport 
Mechanism 
Function  Reference 
CaiT  carnitine/γ-
butyrobetaine 
E. coli  Antiport  Redoxprotectant 
transporter 
(Jung et al., 1989); 
(Eichler et al., 1994); 
(Jung et al., 2002) 
BetT  choline  E. coli  Symport  Osmoprotectant 
transporter 
(Lamark et al., 1991) 
BetU  glycine 
betaine 
E. coli  Symport  Osmoprotectant 
transporter 
(Ly et al., 2004) 
BetP  glycine 
betaine 
C. glutamicum  Symport  Osmoprotectant 
transporter 
(Farwick et al., 1995); 
(Peter et al., 1996) 
EctP  ectoine  C. glutamicum    Osmoprotectant 
transporter 
(Steger et al., 2004) 
LcoP  proline  C. glutamicum    Osmoprotectant 
transporter 
(Steger et al., 2004) 
OpuD  glycine 
betaine 
B. subtilis  Symport  Osmoprotectant 
transporter 
(Kappes et al., 1996) 
BetM  glycine 
betaine 
M. halophilus  Symport  Osmoprotectant 
transporter 
(Vermeulen and Kunte, 
2004) 
EctM  ectoine  M. halophilus    Osmoprotectant 
transporter 
(Vermeulen and Kunte, 
2004) 
ButA  glycine 
betaine 
T. halophila  Symport  Osmoprotectant 
transporter 
(Baliarda et al., 2003) 
BetS  glycine 
betaine 
S. melitoli  Symport  Osmoprotectant 
transporter 
(Boscari et al., 2002) 
CudT  choline  S. xylosus  Symport  Osmoprotectant 
transporter 
(Rosenstein et al., 
1999) 
BetL  glycine 
betaine 
L. monocytogenes  Symport  Osmoprotectant 
transporter 
(Sleator et al., 1999) 
BetT  choline  P. syringae  Symport  Osmoprotectant 
transporter 
(Chen and Beattie, 
2008) 
BetT  choline  H. influenzae  Symport  Osmoprotectant 
transporter 
(Fan et al., 2003) 
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Figure 1-7 | Side view of BetP monomer A 
The BetP monomer is built up of 12 TM helices (numbered 1 – 12). The N- and C-termini are located 
on the cytoplasmic side of the membrane. The long loop regions connecting TM4 with TM5 on the 
cytoplasmic side and TM9 with TM10 on the periplasmic side form the short helices, which are termed 
IH1 and EH2. The C-terminal domain  forms a long α−helix that contains two positively charged 
patches (+1 and +2) (Ressl et al., 2009).  
 
Most  BCCT  members  respond  to  hyperosmotic  shock  by  transporting  compatible 
solutes, which serve as osmoprotectants, into or out of the cell. The most effective 
and  widely  used  osmoprotectant  is  glycine  betaine.  BCCTs  involved  in  glycine 
betaine transport are listed in Table 1-1. Other BCCTs transport ectoine (EctP in C. 
glutamicum or EctM in M. halophilus), proline (LcoP in C. glutamicum), carnitine 
(CaiT in E. coli) or choline (BetT in E. coli, P. syringae and H. influenzae) (Table 
1-1). In E. coli, also choline transport is osmotically activated. However, choline is 
not directly used as a compatible solute (Styrvold et al., 1986), but is oxidized to the 
osmoprotectant glycine betaine by the Bet enzymes BetI, BetB and BetA (Tondervik 
and Strom, 2007).  
 
A sequence alignment of the BCCTs CaiT and BetT from E. coli, BetP from 
C. glutamicum and OpuD from B. subtilis (Figure 1-8) indicates long C-terminal ends Introduction 
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for BetP and BetT. For BetT it was shown that the C-terminal domain is involved in 
regulation of osmotic activation (Peter et al., 1996; Tondervik and Strom, 2007). The 
hydrophilic C-terminal domain in BetP (Figure 1-7) is involved in membrane lipid 
mediated  osmosensing  and  regulation  of  the  BetP  transport  activity  (Krämer  and 
Morbach, 2004; Krämer and Ziegler, 2009). CaiT and OpuD do not have such long 
C-termini and a regulation by the C-terminus could not be demonstrated. CaiT is 
exceptional within the BCCT family in that it is the only transporter not involved in 
the regulation of osmotic stress (Verheul et al., 1998). 
 
With the exception of CaiT, all BCCT family transporters show a Na
+- or H
+-
dependent substrate transport that allows high accumulation of osmoprotectant within 
the cell. In the BetP X-ray structure the substrate glycine betaine was co-crystallized 
within the binding pocket of the transporter (Ressl et al., 2009). The substrate-binding 
pocket in BetP is defined by three tryptophans (Trp) and one tyrosine (Tyr). These 
residues are highly conserved within the BCCT family (Figure 1-8; red boxes). In 
addition, the positions of two Na
+ ions in BetP were modeled by homology to the 
structurally  related  LeuT  transporter  (Section  1.4.1.1).  One  of  these  ions  is 
coordinated by the substrate while the other ion is stabilizing the environment of the 
substrate-binding site (Ressl et al., 2009).  
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Figure 1-8 | Sequence alignment of selected BCCT family members 
The amino acid sequence of the carnitine/γ-butyrobetaine antiporter CaiT from E. coli (EcCaiT) is 
aligned with the choline transporter BetT form E. coli (EcBetT), the Na
+/ glycine betaine symporter 
BetP  from  C.  glutamicum  (CgBetP)  and  the  glycine  betaine  transporter  OpuD  from  B.  subtilis 
(BsOpuD). Residues 604 – 677 of BetT were removed from the sequence alignment. 
The red-boxed residues are highly conserved within the BCCT family and have been shown to be 
involved in substrate binding in BetP. 
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1.4   3D X-ray structures  
 
1.4.1   Atomic  resolution  structure  of  BetP  and  structurally 
homologous secondary transporters 
 
The 3D X-ray structure of the CaiT relative BetP has been solved recently 
(Ressl  et  al.,  2009).  In  the  crystal,  BetP  forms  symmetric  trimers.  Each  BetP 
monomer (Figure 1-7) consists of 12 TM helices. Ten of these form two inverted 
structural repeats of five TM helices, which build up the transporter core (Figure 1-9).  
 
 
Figure 1-9 | BetP topology 
BetP  consists  of  12  TM  helices,  with  the  N-  and  C-terminus  facing  the  cytoplasmic  side  of  the 
membrane. The transporter core is formed by two inverted repeats of five TM helices. Repeat 1 (TM4 
– TM7) is coloured in orange, with colour intensity decreasing from the N- to the C-terminus. The 
structurally related repeat 2 (TM8 – TM12) is coloured in blue, again with decreasing colour intensity 
from the N- to the C-terminus. Protein segments not belonging to the inverted repeats are coloured in 
grey. The substrate molecule is represented as a black triangle, sodium ions are represented by green 
spheres (Ressl et al., 2009).   
 
The core architecture of BetP resembles that of several secondary transporters 
from  other  families.  The  first  reported  crystal  structure  of  a  sodium-coupled Introduction 
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secondary transporter with two 5-TM inverted repeats was the Na
+/alanine transporter 
LeuTAa in complex with leucine from Aquifex aeolicus (LeuT-Leu; (Yamashita et al., 
2005)),  a  member  of  the  neurotransmitter/sodium  symporter  (NSS)  family.  Since 
then, five other secondary transporters have revealed the same 5-TM inverted repeat; 
they are therefore referred as the LeuT-type transporters.  
The Na
+/galactose transporter vSGLT from Vibrio parahaemolyticus (solute 
sodium  symporter  (SSS)  family;  (Faham  et  al.,  2008))  and  the  benzyl-hydantoin 
symporter Mhp1 from Microbacterium liquefaciens (nucleobase cation symporter-1 
(NCS-1) family; (Weyand et al., 2008)) are sodium-coupled transporters like BetP. 
The recently solved crystal structures of two proton-coupled transporters of the amino 
acid, polyamine, organocation (APC) transporter family, AdiC (Fang et al., 2009; 
Gao et al., 2009; Gao et al., 2010) and ApcT (Shaffer et al., 2009), also show the 
LeuT-type core architecture.  
Comparisons of the various structures revealed four different conformations 
(Figure  1-10)  that  provide  insights  into  the  substrate  transport  mechanism  with 
alternating  access  of  the  substrate-binding  site  to  either  side  of  the  membrane 
(Jardetzky, 1966). The “outward-facing open” conformation is represented by Mhp1 
(Weyand et al., 2008), LeuT-Trp (Singh et al., 2008), and AdiC (Fang et al., 2009; 
Gao et al., 2009; Gao et al., 2010). LeuT-Leu (Yamashita et al., 2005) and Mhp1 in 
complex with its substrate benzyl-hydantoin (Mhp1-5FH; (Weyand et al., 2008)) are 
crystallized in the “outward-facing occluded” conformation, whereas BetP complexed 
with glycine betaine (BetP-Bet; (Ressl et al., 2009) and ApcT (Shaffer et al., 2009) 
are trapped in the “occluded” conformation in which the substrate is inaccessible 
from either side of the membrane. The “inward-facing occluded” conformation is 
represented by vSGLT with bound galactose (vSGLT-Gal; (Faham et al., 2008).  
 Introduction 
20 
 
Figure 1-10 | Conformations of LeuT-type transporters 
The four different conformations of six LeuT-type transporters give insights into the alternating access 
substrate transport mechanism. The proteins were superimposed on their inverted repeat motif and are 
shown parallel to the membrane. The structure of Mhp1 (PDB accession code 2JLN) represents the 
outward-facing open conformation. The structures of LeuT-Trp (PDB accession code 3F3A) and the 
substrate-free transporter AdiC (PDB accession code 3H6B and 3HOK) are also in the outward-facing 
open  conformation.  The  outward-facing  occluded  conformation  is  represented  by  LeuT-Leu (PDB 
accession code 2A65) and Mhp1-5FH (PDB accession code 2JLO). In the BetP-Bet, the substrate Introduction 
21 
glycine betaine (PDB accession code 2WIT) is occluded. The ApcT structure (PDB accession code 
3GIA) without substrate shows the same occluded conformation as BetP. The inward-facing occluded 
conformation  is  represented  by  vSGLT-Gal  (PDB  accession  code  3DH4).  The  substrate  molecule 
(yellow stick representation) is bound in the center of the transporter core domain (yellow arrow). 
 
The substrate-binding sites of the transporters are located approximately half 
way  across  the  lipid  membrane  in  the  center  of  the  protomer  core  (Figure  1-10; 
yellow arrows). The core center consists of four TM helices, the four-helix bundle, 
comprising the first two TM helices of each repeat. In BetP, the four-helix bundle 
consists of TM3 and TM4 of repeat 1 and TM8 and TM9 of repeat 2. The substrate-
binding  site  for  glycine  betaine  is  a  so-called  tryptophan  box  consisting  of  three 
tryptophans  and  one  tyrosine  (Figure 1-11). Two of the tryptophans (Trp189 and 
Trp194) and the tyrosine (Tyr197) are located in TM4; the third tryptophan (Trp374) 
is  located  in  TM8.  The  tryptophan  box  provides  an  environment  in  which  the 
quaternary ammonium derivative can be bound via cation-π interaction and van der 
Waals  interactions  (Ressl  et  al.,  2009).  The  residues  that  are  involved  in  glycine 
betaine binding in BetP are highly conserved within the BCCT family (Figure 1-8).  
 
 
Figure 1-11 | Substrate-binding site of BetP 
The residues Trp189, Trp194 and Tyr197 in TM4 and Trp374 in TM8 define the tryptophan box and 
provide the glycine betaine-binding site in BetP. The substrate glycine betaine is bound via cation-π 
interaction and van der Waals interaction.  (Ressl et al., 2009) 
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1.4.1.1  Cation binding in LeuT-type transporters 
 
In  the  LeuT-Leu  structure  two  sodium  sites  were  clearly  resolved  (Figure 
1-12; (Yamashita et al., 2005)). The two bound Na
+ ions have key roles in stabilizing 
the central core of the protein (Yamashita et al., 2005). The carboxyl oxygen of the 
substrate leucine, residues in TM1 and residues in TM6 coordinate Na1. Interestingly, 
the coordination of Na1 by residues in TM1 stabilizes the unwound structure of this 
helix, which contains residues that are directly involved in substrate binding. In fact, 
all LeuT-type transporter structures reported so far show this unwound region of the 
first TM of repeat 1. Na2 in LeuT is located between TM1 and TM8 (Figure 1-12) 
and coordinated by residues in the unwound region of TM1 and in TM8. 
 
 
Figure 1-12 | Cation positions in LeuT-type transporters 
In the LeuT-Leu structure two Na
+ ions have been localized. Na1 coordinates the leucine substrate and 
stabilizes the unwound region of TM1. In addition, Na2 stabilizes the unwound region of TM1 from Introduction 
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the opposite direction. In vSGLT-Gal, one Na
+ ion was identified which superimposes on the Na2 
position in LeuT-Leu. In the structure of Mhp1-5FH one Na
+ ion was modeled between TM1 and 
TM8, which again corresponds to the Na2 position in LeuT-Leu. The corresponding Na2 position of 
LeuT-Leu is occupied by a lysine (K158, TM5) in ApcT. The four proteins were superimposed on 
their inverted repeat motif and are shown from the periplasmic site. 
 
Functional studies of the Na
+-dependent symporter BetP have shown that two 
Na
+  ions  are  necessary  to  transport  one  glycine  betaine  molecule  across  the 
membrane  (Farwick  et  al.,  1995).  The  limited  resolution  of  the  BetP  structure 
prevents the definite assignment of Na
+ ions. Nevertheless, the authors propose two 
potential Na
+ binding sites (Figure 1-13; (Ressl et al., 2009)), which were structurally 
modeled from the Na
+ binding sites of LeuT-Leu (Yamashita et al., 2005). In BetP, 
the carboxyl group of the substrate and residues in TM3 coordinate the first Na
+ ion 
(Na1), while residues in TM3 and TM7 coordinate the second Na
+ ion (Na2). 
 
 
Figure 1-13 | Proposed sodium binding in BetP 
The  two  Na
+  ions  were  modeled  on  the  basis  of  structural  alignment  of  BetP  on  the  LeuT-Leu 
structure.  The  first  Na
+  ion  (Na1)  is  coordinated  by  the  substrate  glycine  betaine,  together  with 
residues in TM3. The second Na
+ ion (Na2) is coordinated by residues in TM3 and TM7.  (Ressl et al., 
2009) 
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In the sodium dependent galactose transporter vSGLT the one bound Na
+ ion 
is located at the Na2 position in the LeuT-Leu structure (Figure 1-12; (Faham et al., 
2008)). This Na
+ ion is coordinated by residues in the unwound region of TM2 (TM1 
in LeuT, TM3 in BetP), which also provides one residue for binding the substrate 
galactose. As in vSGLT, the electron density from the Na
+-coupled benzyl-hydantoin 
transporter Mhp1 indicates only one possible Na
+ binding site. The authors modeled 
this Na
+ ion between TM1 and TM8 (Figure 1-12; (Weyand et al., 2008)) which 
again corresponds to the Na2 position in LeuT. In Mhp1, the unwound region of TM1 
provides one residue for substrate binding. 
 
In the proton coupled amino acid transporter ApcT, the ε-amino group of a 
lysine (K158 in TM5), which superimposes on the LeuT-Leu Na2 position (Figure 
1-12), forms a hydrogen bond to the main chain carbonyl oxygen of a glycine that is 
located in the unwound region of TM1 (Shaffer et al., 2009).  
 
In some LeuT-type transporters, Na1 is required for coordinating the substrate as 
seen  in  LeuT-Leu  and  as  proposed  for  BetP-Bet.  In  addition,  Na1  stabilizes  the 
binding environment in these transporters (unwound region of TM1 in LeuT-Leu) 
when the substrate is present. A positive charge at the position of Na2 probably has a 
regulatory function as demonstrated for ApcT, where substrate transport is strongly 
enhanced when lysine (K158) is protonated (Shaffer et al., 2009).  Introduction 
25 
1.5   Aims of this work 
 
Most members of the BCCT family are either Na
+ or H
+-dependent substrate 
transporters  that  are  activated  under  osmotic  stress  condition.  The  L-carnitine/γ-
butyrobetaine  antiporter  CaiT  is  an  exception,  as  it  is  independent  of  an 
electrochemical gradient and becomes active under redoxstress.  
 
The  recently  solved  structure  of  the  Na
+/glycine  betaine  permease  BetP,  a 
member of the BCCT family and close relative to CaiT, gave insights into the Na
+-
dependent substrate transport mechanism. The BetP structure revealed an internal 5-
TM  helix  motif  in  the  transporter  core.  This  structural  feature  has  been  reported 
previously  for  secondary  transporters  of  different  gene  families.  This  structural 
homology suggests that the different gene families have a common ancestor, even 
though there is no significant sequence similarity. From the different conformational 
states shown by these transporter structures a general transport mechanism, though 
not yet complete, is beginning to emerge.   
 
The 3D structure and the mechanism of Na
+-independent substrate transport in 
CaiT are unknown. The aims of this work are to solve the 3D X-ray structure of CaiT 
and to understand the substrate/product exchange mechanism.  
The  X-ray  structure  should  reveal  why  CaiT  is  Na
+-independent  whereas  its 
close relative BetP is Na
+-dependent. In combination with functional studies, this 
should help to explain the substrate antiport mechanism in CaiT.  
In addition, the CaiT structure should give further information to the general 
substrate transport mechanism of secondary transporters.  
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2   Materials and Methods 
 
2.1   Materials 
 
2.1.1   Instruments 
 
Minifors Tischbioreaktor (Fermenter, INFORS AG) 
Cary 50 UV-Vis Sprectrometer (Varian) 
Ettan LC system (GE Healthcare) 
F-4500 Flourescence Spectrophotometer (Hitachi) 
TRI-CARB 1500 scintillation counter (Canberra-Packard) 
Mosquito
TM pipetting robot (TTPLabtech) 
MacroMax
TM-007HF diffractometer  
R-AXIS IV
++ detector (RIGAKU Americas) 
FR-E
+ SuperBright diffractometer  
Saturn 944
+ detector (RIGAKU Americas) 
 
 
2.1.2   Chemicals 
 
Chemicals used in this work were purchased from Anatrace, Avanti, Biomol, 
Bio-Rad,  Fermentas,  Gerbu,  Glycon,  Merck,  New  England  Biolabs,  Roth,  Pierce, 
Roche and Sigma. γ-butyrobetaine was a kind gift from Lonza Group Ltd.. 
 
 
2.1.3   Reagent kits 
 
THROMBIN CleanCleave
TM Kit (Sigma) Materials and Methods 
28 
PCR Purification Kit (Qiagen) 
QIAquick Gel Extraction Kit (Qiagen) 
QIAprep Spin Miniprep Kit (Qiagen) 
QuikChange® Site-Directed Mutagenesis Kit (Stratagene)  
 
 
2.1.4   Column materials 
 
Chelating Sepharose
TM (GE Healthcare) 
PD-10 Sehadex G-25M (GE Healthcare) 
Superose
TM 6 3.2/30 (GE Healthcare) 
 
 
2.1.5   Media and antibiotics 
 
2.1.5.1  LB-Medium 
Bacto-tryptone    10 g/l 
Bacto-yeast extract  5 g/l 
NaCl      10 g/l 
 
2.1.5.2  2 × YT Medium (with 5 M NaOH to pH 7 adjusted) 
Bacto-tryptone    16 g/l 
Bacto-yeast extract  10 g/l 
NaCl  5 g/l 
 
2.1.5.3  TB-Medium 
Bacto-tryptone  12 g/l 
Bacto-yeast extract  24 g/l 
Glycerol  4 ml/l Materials and Methods 
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Phosphate buffer  100 mM/l 
 
2.1.5.4  SelenoMet Medium (Molecular Dimensions) 
SelenoMet
TM Medium Base  21.6 g/l 
SelenoMet
TM Nutrient Mix  5.1 g/l 
 
2.1.5.5  Antibiotics  
 
Ampicillin     100 mg/ml 
Carbenicillin     100 mg/ml 
Chloramphenicol  50 mg/ml (in ethanol) 
 
 
2.1.6   E. coli strains 
 
BL21(DE3) pLysS (Novagene) 
Genotype: E. coli B F
– ompT hsdSB(rB
– mB
–) gal dcm (DE3) pLysS (Cam
R) 
 
B834(DE3) (Novagene) 
Genotype: E. coli B F
– ompT hsdSB(rB
– mB
–) gal dcm met (DE3) 
 
BL21(DE3)-RIL-X (Stratagene) 
Genotype: E. coli B F
– ompT hsdS(rB
– mB
–) dcm
+ Tetr gal λ(DE3) endA 
metA::Tn5(kan
R)Hte [argU ileY leuW Cam
R] 
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2.1.7   Oligonucleotide primers 
 
Table 2-1 | Primer for the PmcaiT construct 
Label  Sequence  Description 
CaiTProtsNdeI  5ƹ′-GGCGGCCATATGAGCAAAGATAATAAA 
AAGGCAGG-3ƹ′ 
Sense primer with NdeI 
restriction site 
CaiTProtasXhoI  5ƹ′-CCGCCGCTCGAGTCAATCTTTCCAGTG 
ACTTTGGC-3ƹ′ 
Anti-sense with XhoI 
restriction site 
PmCaiT_E111A_s  5ƹ′-GCTGTTTTGGGGCTCAATTGCAATATAC 
TACTACATTTCAAG-3ƹ′ 
Sense primer to mutate the 
glutamate at position 111 to 
alanine 
PmCaiT_E111A_as  5ƹ′-CTTGAAATGTAGTAGTATATTGCAATTGA 
GCCCCAAAACAGC-3ƹ′ 
Anti-sense primer to mutate 
the glutamate at position 111 
to alanine 
PmCaiT_H141A_s  5ƹ′-GCTTACAGCTTATTCGCCTGGGGCCCGCT 
ACCTTGG-3ƹ′ 
Sense primer to mutate the 
histidine at position 111 to 
alanine 
PmCaiT_H141A_as  5ƹ′-CCAAGGTAGCGGGCCCCAGGCGAATAAG 
CTGTAAGC-3ƹ′ 
Anti-sense primer to mutate 
the histidine at position 111 
to alanine 
ProCai_W142As  5ƹ′-GCTTACAGCTTATTCCACGCGGGCCCG 
CTACCTTGGGC-3ƹ′ 
Sense primer to mutate the 
tryptophan at position 142 to 
alanine 
ProCai_W142Aas  5ƹ′-GCCCAAGGTAGCGGGCCCGCGTGGAA 
TAAGCTGTAAGC-3ƹ′ 
Anti-sense primer to mutate 
the tryptophan at position 142 
to alanine 
ProCai_W147As  5ƹ′-CTGGGGCCCGCTACCTGCGGCAACC 
TATAGTTTCCT-3ƹ′ 
Sense primer to mutate the 
tryptophan at position 147 to 
alanine 
ProCai_W147Aas  5ƹ′-AGGAAACTATAGGTTGCCGCAGGTAG 
CGGGCCCCAG-3ƹ′ 
Anti-sense primer to mutate 
the tryptophan at position 147 
to alanine 
ProCaiY150As  5ƹ′-CGCTACCTTGGGCAACCGCTAGTTTC 
CTGTCTGTCGCC-3ƹ′ 
Sense primer to mutate the 
tyrosine at position 150 to 
alanine Materials and Methods 
31 
ProCaiY150Aas  5ƹ′-GGCGACAGACAGGAAACTAGCGGTTGC 
CCAAGGTAGCG-3ƹ′ 
Anti-sense primer to mutate 
the tyrosine at position 150 to 
alanine 
PCaiTR262Es  5ƹ′-GGGTAAAAATCGCCAGTGATGTGGAAACT 
TACCTGAGCTTC-3ƹ′ 
Sense primer to mutate the 
arginine at position 262 to 
glutamate 
PCaiTR262Eas  5ƹ′-GAAGCTCAGGTAAGTTTCCACATCACT 
GGGGATTTTTACCC-3ƹ′ 
Anti-sense primer to mutate 
the arginine at position 262 to 
glutamate 
PCaiT_W316As  5ƹ′-GGGGGTTTTCCTCAGGCTGCGACTGTC 
TTCTATTGGGC-3ƹ′ 
Sense primer to mutate the 
tryptophan at position 316 to 
alanine 
PCaiT_W316Aas  5ƹ′-GCCCAATAGAAGACAGTCGCAGCCTG 
AGGAAAACCCCC-3ƹ′ 
Anti-sense primer to mutate 
the tryptophan at position 316 
to alanine 
ProtCai_W323As  5ƹ′-CTGTCTTCTATTGGGCTGCGTGGGTT 
ATTTACGCC-3ƹ′ 
Sense primer to mutate the 
tryptophan at position 323 to 
alanine 
ProtCai_W323Aas  5’-GGCGTAAATAACCCACGCAGCCCA 
ATAGAAGACAG-3ƹ′ 
Anti-sense primer to mutate 
the tryptophan at position 323 
to alanine 
ProCai_W324As  5ƹ′-GTCTTCTATTGGGCTTGGGCGGTTATT 
TACGCCATTC-3ƹ′ 
Sense primer to mutate the 
tryptophan at position 324 to 
alanine 
ProCai_W324Aas  5ƹ′-GAATGGCGTAAATAACCGCCCAAGC 
CCAATAGAAGAC-3ƹ′ 
Anti-sense primer to mutate 
the tryptophan at position 324 
to alanine 
ProCaiW323324As  5ƹ′-GGACTGTCTTCTATTGGGCTGCGGCGGTT 
ATTTACGCCATTCAAA-3ƹ′ 
Sense primer to mutate both 
the tryptophan at position 323 
and the tryptophan at position 
324 to alanine 
ProCaiW323324Aas  5ƹ′-CTCATTTGAATGGCGTAAATAACCGCCGC 
AGCCCAATAGAAGACA-3ƹ′ 
Anti-sense primer to mutate 
both the tryptophan at 
position 323 and the 
tryptophan at position 324 to 
alanine Materials and Methods 
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ProCaiW324323As2  5ƹ′-CTGTCTTCTATTGGGCTGCGGCGGTT 
ATTTACGCC-3ƹ′ 
Sense primer to mutate both 
the tryptophan at position 323 
and the tryptophan at position 
324 to alanine 
ProCaiW324323Aas  5ƹ′-GGCGTAAATAACCGCCGCAGCCCA 
ATAGAAGACAG-3ƹ′ 
Anti-sense primer to mutate 
both the tryptophan at 
position 323 and the 
tryptophan at position 324 to 
alanine 
PCaiT_Y327As  5ƹ′-GGGCTTGGTGGGTTATTGCCGCCATT 
CAAATGAGTATC-3ƹ′ 
Sense primer to mutate the 
tyrosine at position 327 to 
alanine 
PCaiT_Y327Aas  5ƹ′-GATACTCATTTGAATGGCGGCAATAAC 
CCACCAAGCCC-3ƹ′ 
Anti-sense primer to mutate 
the tyrosine at position 327 to 
alanine 
ProCaiT_M331As  5ƹ′-GGTTATTTACGCCATTCAAGCGAGTATC 
TTCTTAGCGCG-3ƹ′ 
Sense primer to mutate the 
methionine at position 331 to 
alanine 
ProCaiT_M331Aas  5ƹ′-CGCGCTAAGAAGATACTCGCTTGAATGGC 
GTAAATAACC-3ƹ′ 
Anti-sense primer to mutate 
the methionine at position 
331 to alanine 
ProCaiT_M331Vs  5ƹ′-GGTTATTTACGCCATTCAAGTCAGTATC 
TTCTTAGCGCG-3ƹ′ 
Sense primer to mutate the 
methionine at position 331 to 
valine 
ProCaiT_M331Vas  5ƹ′-CGCGCTAAGAAGATACTGACTTGAATGGC 
GTAAATAACC-3ƹ′ 
Anti-sense primer to mutate 
the methionine at position 
331 to valine 
 
 
Table 2-2 | Primer for the EccaiT construct 
Label  Sequence  Description 
caiT_5BamHI  5ƹ′-GCGGGATCCATGAAGAATGAAAAG 
AGAAAAACGGG-3ƹ′ 
Sense  primer  with  BamHI 
restriction site 
caiT_3HindIII  5ƹ′-GCGTTCGAATTAATCTTTCCAGTT 
CTGTTTCGC-3ƹ′ 
Anti-sense  primer  with 
HindIII restriction site 
caiT_5NdeI  5ƹ′-GCGCATATGATGAAGAATGAAAAG 
AGAAAAACGGG-3ƹ′ 
Sense  primer  with  NdeI 
restriction site 
caiT_3XhoI  5ƹ′-GCGCTCGAGTTAATCTTTCCAGTT 
CTGTTTCGC-3ƹ′ 
Anti-sense primer with XhoI 
restriction site 
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Table 2-3 | Primer for the StcaiT construct 
Label  Sequence  Description 
StCaiT5Nd  5ƹ′-GGCGGCCATATGAAAAATGAAAAG 
AAAAAATCGGG-3ƹ′ 
Sense  primer  with  NdeI 
restriction site 
StCaiT3Xh  5ƹ′-GGCGGCCTCGAGTTATCACTTGTC 
TTTCCAGTGCACTTTGGCG-3ƹ′ 
Anti-sense primer with XhoI 
restriction site 
 
 
2.1.8   Mutants 
 
Table 2-4 | Mutants of PmCaiT 
Number  Mutant 
M1  W323A 
M2  W142A 
M3  W324A 
M4  W147A 
M5  Y150A 
---  --- 
M7  W142A/W323A 
M8  W323A/W324A 
M9  W142A/W323A/W324A 
M10  W316A 
M11  Y327A 
M12  M331A 
M13  M331V 
M14  H141A 
M15  E111A 
M16  E111A/H141A 
M17  R262E 
All mutants were produced in this work. 
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2.1.9   Crystallization screens 
 
Index
TM (Hampton) 
Crystal Screen
TM (Hampton) 
Crystal Screen II
TM (Hampton) 
Detergent Screening Kits
TM 1 – 3 (Hampton) 
Additive Screen
TM (Hampton) 
Heavy Atom Screen Pt
TM (Hampton) 
Aeavy Atom Screen Au
TM (Hampton) 
Heavy Atom Screen Hg
TM (Hampton) 
Heavy Atom Screen M1
TM (Hampton) 
Heavy Atom Screen TM2
TM (Hampton) 
MbClass
TM (Qiagen) 
MbClass II
TM (Qiagen) 
MemStart
TM (Jena Bioscience) 
MemSyst
TM (Jena Bioscience) 
Tantalum Cluster Derivatization Kit
TM (Jena Bioscience) 
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2.2   Molecular biological methods 
 
2.2.1   Polymerase chain reaction 
 
The polymerase chain reaction (PCR) is a method for in vitro amplification of 
template DNA (Mullis and Faloona, 1987) with known sequences at both ends of the 
DNA fragment (Saiki et al., 1988). The known sequences at the ends of the DNA 
fragment  are  used  to  design  two  synthetic  DNA  oligonucleotides,  which  are 
complementary to the sequences of the DNA fragment. These oligonucleotides serve 
as  primers  for  the  in  vitro  DNA  synthesis.  PCR  is  a  cyclic  repetitive  three-step 
reaction  consisting  of  denaturation,  hybridization  and  elongation.  During  the 
denaturation step both strands of the DNA are separated which allows the primers in 
the second step to hybridize to complementary sequences in the DNA strands. During 
the last step a thermo-stable DNA polymerase elongates the DNA primers at the 3’-
OH end. 
The thermo-stable Taq-Polymerase (Fermentas) was used for analytical PCR 
to  create  mutants  of  the  wild-type  caiT  gene  while  for  preparative  PCR  Pfu-
Polymerase  (Fermentas)  was  used.  The  Pfu-Polymerase  possesses  a  3’  –  5’ 
exonuclease  activity,  which  corrects  mutations  that  were  produced  during 
amplification.  
 
Table 2-5 | PCR mixture 
Component   Volume (µl) 
Pfu-Polymerase buffer (10×) (Fermentas)   5 
DNA template (100 – 150 ng/µl)  3 
sense primer (10 mM)  5 
anti-sense primer (10 mM)  3 
dNTP mix (each 2 mM)  3 
Pfu-Polymerase (Fermentas)  1 
H2O (autoclaved)  28 
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Table 2-6 | Standard PCR temperature program 
Step  Temperature (˚C)  Time (sec)  Cycle 
Denaturation  96  180  1 
Denaturation  96  60  25 – 30 
Hybridization  Thybr  30  25 – 30 
Elongation  72  x  25 – 30 
End elongation  72  300  1 
  4  ∞  1 
 
The hybridization temperature depends on the nucleotide composition of the 
primers  used  in  the  reaction.  For  primers  with  a  length  of  25  nucleotides  the 
hybridization temperature can be calculated with the following equation: 
 
  Thybr = 4 × (number of G or C) + 2 × (number of A or T) 
  G = guanine   A = adenine 
  C = cytosine  T = thymine 
 
The elongation time x depends on the polymerase activity and on the DNA 
fragment length to be amplified. The Pfu-polymerase exhibits an elongation activity 
of 500 base pairs per minute.  
 
 
2.2.2   Site-directed mutagenesis 
 
Site-directed mutagenesis was performed with the QuikChange Site Directed 
Mutagenesis  Kit  (Stratagene)  according  to  the  manufacturer’s  instructions.  All 
constructs were verified by nucleotide sequencing. 
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2.2.3   DNA cleavage using restriction endonucleases 
 
Hydrolytic cleavage of double-stranded DNA was performed using restriction 
endonucleases  from  New  England  Biolabs  according  to  the  manufacturer’s 
instructions. Hydrolysis with two different enzymes was set up in the same test tube 
as long as the reaction conditions for both enzymes were similar. The reactions were 
performed in succession when the reaction conditions for both endonuclease enzymes 
were distinctly different.  
Cleaved DNA fragments were purified either with the PCR Purification Kit 
(Qiagen) or by agarose gel electrophoresis. DNA fragments were extracted with the 
QIAquick Gel Extraction Kit (Qiagen) according to the manufacturer’s instructions. 
 
 
2.2.4   Agarose gel electrophoresis 
 
Depending on the length of the DNA fragments a separation was achieved by 
a 1 – 1.5 % (w/v) agarose gel in 1× TAE buffer (Table 2-7). The DNA samples were 
mixed with 6× DNA sample buffer (Table 2-8) before they were loaded onto the gel. 
The electrophoresis was performed at 100 V (distance of electrodes 10 cm). 
For visualization of the DNA fragments ethidium bromide (0.5 µg/ml) was 
added  to  the  agarose  gels.  Ethidium  bromide  is  an  organic  fluorescent  dye  with 
aromatic rings that intercalates with the nucleotides of the DNA. The fluorescent dye 
can be illuminated at the excitation wavelength λ = 312 nm.  
 
Table 2-7 | TEA buffer 
TAE buffer (1×) 
Tris-acetate (pH 8.3)  40 mM 
EDTA    1 mM 
 
 
 Materials and Methods 
38 
Table 2-8 | DNA sample buffer 
DNA sample buffer (6×) 
bromophenol blue  0.25 % (w/v) 
sucrose  40 % (w/v) 
 
 
2.2.5   DNA concentration and purity 
 
The  concentration  and  purity  of  DNA  is  determined  photometrically.  The 
concentration  of  double-stranded  DNA  can  be  calculated  with  the  optical  density 
(OD) at the absorption maximum at 260 nm (OD260). The reference value is OD260 = 
1 for a pure 50 µg/ml DNA solution.  
The purity of a DNA solution can be estimated by the OD260 to OD280 ratio 
(Glasel, 1995; Warburg and Christian, 1942). An absorption at wavelength λ = 280 
indicates the presence of proteins, which were co-purified during DNA purification. 
A pure DNA solution shows an OD260 to OD280 ratio of 1.8 – 2.0. 
 
 
2.2.6   Ligation of DNA fragments 
 
For a ligation reaction, 50 – 100 ng of purified vector DNA and a 3 – 5 fold 
molar excess of purified insert DNA was mixed with T4-ligase buffer (10×) and T4-
DNA-ligase (200 U). Both the vector and the insert DNA have been cleaved by the 
same  restriction  enzymes  before  being  added  to  the  ligation  reaction.  The  total 
volume of the reaction solution was 20 µl. The ligation was incubated overnight at  
8 ˚C. 
The caiT constructs used in this work were cloned into a pET-15b (Novagen) 
vector using the restriction nucleases NdeI (NEB) and XhoI (NEB). 
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2.2.7   Preparation and transformation of chemically competent cells 
 
Chemically  competent  E.  coli  cells  were  produced  by  the  Chung  method 
(Chung et al., 1989). This method uses TSS medium (Table 2-9), which is based on 
LB medium. 
An E. coli strain to be made competent was grown in 100 ml LB medium overnight 
(37 ˚C, 125 rpm). The next morning, the culture was adjusted to an OD600 of 0.1 and 
cultured (20 ˚C, 125 rpm) again to an early exponential phase (OD600 = 0.4). To cool 
down the culture slowly it was incubated for 30 minutes at 4 ˚C before the cells were 
pelleted (4 ˚C, 2500 g, 10 min). The supernatant was removed and the cells were 
resuspended  in  TSS  medium  with  1/10  of  the  original  culture  volume.  The  cell 
suspension was aliquoted (100 – 200 µl) and shock frozen in liquid nitrogen. The 
aliquots were stored at -80 ˚C. 
 
Table 2-9 | TSS medium 
TSS medium   
LB-medium (without NaOH)   
  + PEG 8000 (w/v)  10 % 
  + DMSO (v/v)    5 % 
  + MgCl2 × 6 H2O (w/v)  50 mM 
  + Glycerol (v/v)  15 % 
Sterilized by filtration (exclusion size ∅ 0.45 µm) 
 
The  transformation  reaction  was  set  up  with  100  –  200  µl  of  chemically 
competent E. coli cells and either 10 µl of ligation reaction solution or 25 – 50 ng of 
circular vector DNA. After addition of DNA, the competent cells were incubated for 
30 minutes at 4 ˚C. To increase the transformation rate a heat shock at 42 ˚C for 90 
sec was administered. The cells were again incubated at 4 ˚C for 5 min before 1 ml of 
LB medium was added and the culture incubated at 37 ˚C for 45 minutes (125 rpm). 
This incubation step is necessary to allow the expression of the antibiotic resistance 
gene located on the inserted vector. After incubation, the cells were plated on LB-Materials and Methods 
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agar-plates with the corresponding selection marker (e.g. ampicillin) and incubated at  
37 ˚C overnight.  
 
 
2.2.8   Isolation of vector DNA 
 
Transformed cells were grown overnight at 37 ˚C in 5 ml LB medium with the 
appropriate  selection  marker.  The  next  morning,  cells  were  harvested  by 
centrifugation  (20  ˚C,  2500  g,  5  min)  and  vector  DNA  was  isolated  using  the 
QIAprep Spin Miniprep Kit (Qiagen) according to the manufacturer’s instructions. 
 
 
2.2.9   Preparation of bacteria glycerol stocks 
 
A  single  isolated  E.  coli  colony,  grown  on  a  LB-agar-plate  under  selection 
conditions, was transferred into 2 ml LB medium containing the selection marker. 
The culture was grown overnight (37 ˚C, 125 rpm) and 30 % (v/v) glycerol was 
added  to  the  culture  before  it  was  shock  frozen  in  liquid  nitrogen.  The  bacteria 
glycerol stocks were stored at -80 ˚C. 
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2.3   Biochemical methods 
 
2.3.1   Protein production of native CaiT 
 
The  genes  encoding  EcCaiT,  PmCaiT  and  StCaiT  were  cloned  into  the 
expression vector pET-15b (Novagen) using the restriction enzymes NdeI (NEB) and 
XhoI  (NEB).  In  the  pET-15b  vector  the  target  gene  is  under  control  of  a  strong 
bacteriophage  T7  transcription  promoter.  The  plasmids  were  transferred  into  the 
expression host E. coli BL21(DE3) pLysS.  
BL21(DE3) cells are lysogens of bacteriophage DE3, a lambda derivative that 
has the immunity region of phage 21 and carries a chromosomal copy of the T7 RNA 
polymerase under control of the lacUV5 promotor. The lacUV5 promotor is inducible 
by  IPTG.  ITPG  induction  activates  the  lacUV5  promotor,  which  induces  the 
transcription  of  T7  RNA  polymerase,  which  in  turn  leads  to  expression  of  the 
recombinant protein.  
BL21(DE3)  pLysS  cells  contain  an  additional  compatible  plasmid  with  a 
selectivity marker that provides a small amount of T7 lysozyme, a natural inhibitor of 
the T7 RNA polymerase (Moffatt and Studier, 1987; Studier, 1991). T7 lysozyme 
inhibits expression of the target genes before ITPG induction and is also able to cut a 
specific bond in the peptidoglycan layer of the E. coli cell wall. This allows the cells 
to be lysed simply by freezing and thawing. 
 
For  protein  production  50  µl  of  a  thawed  glycerol  stock  containing 
transformed BL21(DE3) pLysS cells were used to inoculate 100 ml of LB medium 
containing  100  µg/ml  ampicillin  and  50  µg/ml  chloramphenicol.  After  overnight 
growth at 37 ˚C with shaking (150 rpm), 10 ml of the culture were used to inoculate 2 
l of 2×YT medium supplemented with the appropriate antibiotics. This culture was 
grown at 37 ˚C with shaking (120 rpm) until an OD600 of 0.6 – 0.9 was reached. To 
start over-production of recombinant CaiT, IPTG was added to a final concentration 
of 0.5 mM. After over-production for 4 h at 30 ˚C with shaking (120 rpm), cells were 
harvested by centrifugation (4 ˚C, 4000 g, 20 min), with a potter homogenized in Materials and Methods 
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buffer containing 25 mM HEPES (pH 7.5), 100 mM NaCl and 0.1 mM PefaBloc 
(Biomol), and frozen overnight at -20 ˚C. 
 
 
2.3.2   Protein production of selenomethionine-labeled protein 
 
The pET-15b vector containing the genes encoding either EcCaiT or PmCaiT 
was  transferred  into  the  expression  hosts  B834(DE3)  (Novagene)  or  BL21(DE3)-
RIL-X (Stratagene). Both cell strains are auxotrophic for methionine and useful for 
selenomethionine  (SeMet)-labeling  of  proteins  used  for  protein  crystallography. 
BL21(DE3)-RIL-X  cells  contain  an  additional  compatible  plasmid  with  a  second 
selectivity marker (chloramphenicol) and extra copies of argU, ileY and leuW tRNA 
genes. These genes encode tRNAs that recognize certain condons for arginine (R), 
isoleucin (I) and leucin (L), which are rarely used in E. coli. However, these genes 
were not used for expression of SeMet-labeled CaiT.  
 
CaiT was SeMet-labeled by different methods. The first, flask based method, 
was very similar to the method used for unlabeled recombinant protein production, 
while the second approach was a fed-batch fermentation strategy to achieve a higher 
yield of SeMet-labeled protein. 
 
 
2.3.2.1  Flask based production of SeMet-labeled protein  
 
For flask based SeMet-labeled protein production, 50 µl of a thawed glycerol 
stock  containing  either  transformed  B834(DE3)  cells  or  BL21(DE3)-RIL-X  cells 
were used to inoculate 100 ml of LB medium containing 100 µg/ml ampicillin. After 
overnight  growth  at  37  ˚C  with  shaking  (150  rpm),  the  cells  were  pelleted  by 
centrifugation (20 ˚C, 4000 g, 20 min). The supernatant was removed and the cells 
were washed and resuspended in 40 ml SelenoMet medium (Molecular Dimensions) 
supplemented with the appropriate antibiotic and 80 mg/l methionine. The complete Materials and Methods 
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40 ml cell suspension was used to inoculate 1 l of SelenoMet medium supplemented 
with the appropriate selection marker and 80 mg/l methionine. This culture was again 
grown  overnight  at  37  ˚C  with  shaking  (125  rpm)  before  100  ml  were  used  to 
inoculate 2 l of SelenoMet medium supplemented with 100 mg/l ampicillin and 40 
mg/l SeMet. The culture was grown at 37 ˚C with shaking (120 rpm) until an OD600 
of 0.6 – 0.9 was reached. Over-production of recombinant SeMet-labeled CaiT was 
induced with IPTG. The final concentration of ITPG in each culture was 0.5 mM. 
After over-production for 6 – 8 h at 30 ˚C, cells were harvested by centrifugation  
(4 ˚C, 4000 g, 20 min), homogenized in buffer containing 25 mM HEPES (pH 7.5), 
100 mM NaCl, 2 mM TCEP and 0.1 mM PefaBloc (Biomol), and frozen overnight at  
-20 ˚C. 
 
 
2.3.2.2  Fed-batch fermentation 
 
For fed-batch fermentation, 50 µl of a thawed glycerol stock containing either 
transformed  B834(DE3)  cells  or  BL21(DE3)-RIL-X  cells  were  used  to  inoculate  
100 ml of TB medium with 100 µg/ml ampicillin. The cells were cultured overnight 
at 37 ˚C with shaking (150 rpm), pelleted by centrifugation (20 ˚C, 4000 g, 20 min), 
washed  and  resuspended  in  40  ml  SelenoMet  medium  supplemented  with  the 
appropriate antibiotic and 80 µg/ml methionine. The complete 40 ml cell suspension 
was used to inoculate 3 l of SelenoMet medium supplemented with the 100 mg/l 
ampicillin and 80 mg/l methionine. The cells were grown at 37 ˚C and 200 rpm until 
the  concentration  of  dissolved  O2  in  the  medium  decreased  (Figure  2-1).  This 
signaled a depletion of methionine. At this point the culture showed an OD600 of 1.3 – 
1.7  and  the  feeding  with  SeMet  was  started  to  a  final  concentration  of  80  mg/l. 
SeMet-labeled  protein  production  was  induced  15  –  30  minutes  after  starting  the 
SeMet  feed  by  adding  IPTG  to  a  final  concentration  of  0.5  mM.  The  culture 
continued  to  grow  to  a  final  OD600  of  2.4  –  2.6.  The  cells  were  harvested  by 
centrifugation (4 ˚C, 4000 g, 20 min), homogenized with a potter in buffer containing 
25  mM  HEPES  (pH  7.5),  100  mM  NaCl,  2  mM  TCEP  and  0.1  mM  PefaBloc 
(Biomol), and frozen overnight at -20 ˚C. Materials and Methods 
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Figure 2-1 | Fed-batch fermentation diagram 
The blue line indicates the concentration of dissolved O2, the red line shows the temperature (cell 
growth at 37 ˚C, protein over-expression at 30 ˚C) and the black line shows the agitation rate (constant 
at 200 rpm). The starting phase indicated by 1 was used to calibrate the O2 electrode. At time point 2 
the culture was supplemented with SeMet, at time point 3 over-expression was induced by IPTG, at 
time point 4 a mix of nutrients, SeMet (final concentration 80 mg/l) and ampicillin (final concentration 
100 mg/l) was added. At time point 5 the cells were harvested (usually 10 – 12 hours after induction). 
 
 
2.3.3   Cell disruption 
 
2.3.3.1  Enzymatic cell disruption 
 
Cell were disrupted enzymatically simply by thawing BL21(DE3) pLysS cells 
which  contain  T7  lysozyme.  Freezing  and  thawing  of  the  cells  lead  to  cell  wall 
breakage of a few cells and the release of T7 lysozyme into the solution. This in turn 
caused the lysis of more cells in a chain reaction manner. Materials and Methods 
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Release  of  chromosomal  E.  coli  DNA  during  cell  lysis  causes  the  cell 
suspension  to  become  viscous.  The  cell  suspension  became  fluid  again  after  the 
addition of small amounts of DNAse I (Roche).  
 
 
2.3.3.2  Cell disruption using a microflidizer 
 
Cells were in addition, or as an alternative to enzymatic disruption, disrupted 
using a microfluidizer (Model M-110L, Microfluidics Corp., Newton, MA) with 3 
passes  at  60,000  psi  (8.7  MPa).  The  microfluidizer  pushes  cells  at  high  pressure 
through a narrow nozzle (∅ < 0.5 mm). After leaving the nozzle the cells expand due 
to the release of high pressure. The disruption of the cells is caused by cell expansion 
together with the shearing force, which occurs when the cells leave the nozzle. To 
avoid a temperature increase of the cell lysate, all containers and the microfluidizer 
were precooled with ice. 
 
 
2.3.4   Protein purification 
 
2.3.4.1  Membrane preparation 
 
To isolate E. coli membranes, two centrifugation steps were needed after cell 
disruption. Cell debris was removed by low-speed centrifugation (4˚C, 10,000 g, 30 
min), after which membranes were isolated by ultracentrifugation (4˚C, 125,000 g, 90 
min). The membrane pellet was resuspended in membrane buffer. Aliquots of 20 – 40 
ml  volume  with  a  total  protein  concentration  of  10  mg/ml  were  frozen  in  liquid 
nitrogen and kept at -80 ˚C. 
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Table 2-10 | Membrane buffer 
Component  Concentration 
HEPES or Tris-HCl, pH 7.5  50 mM 
NaCl or KCl  200 mM 
TCEP  2 – 4 mM 
Glycerol  20 % (v/v) 
 
 
2.3.4.2  Protein solubilization 
 
For CaiT solubilization, membranes were thawed and incubated with constant 
stirring either with 1.5 – 2 % DDM for 2 hours at 4 ˚C or with 1.5 – 2% Cymal-5 
overnight at 4 ˚C. 
 
Table 2-11 | Solubilization buffer 
Component  Concentration 
HEPES or Tris-HCl, pH 7.5  25 mM 
NaCl or KCl  100 mM 
TCEP  1 – 2 mM 
Glycerol  10 % (v/v) 
DDM or Cymal-5  1.5 – 2 % (w/v) 
 
After  solubilization  an  ultracentrifugation  step  (4  ˚C,  125,000  g,  40  min) 
removed  the  unsolubilized  fraction.  The  supernatant,  which  contained  solubilized 
CaiT,  was  supplemented  with  50  mM  imidazole  (final  concentration)  to  prevent 
unspecific binding of contaminating proteins in the next purification step.  
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2.3.4.3  Immobilized Metal Ion Affinity Chromatography (IMAC) 
 
The recombinantly expressed protein contains an N-terminal hexa-histidine 
tag (His6-tag) and a thrombine cleavage site included in the linker region between the 
His6-tag  and  CaiT.  The  first  purification  step  involved  a  Ni
2+  loaded  Chelating 
Sepharose
TM  (GE  Healthcare)  column  (Ni
2+-Sepharose  column).  For  40  ml  of 
solubilized fraction, 2 ml of wet column material was used. The column material was 
equilibrated with the appropriate buffer (Table 2-12) before the solubilized fraction 
was loaded. The binding of the target protein to the column results from the formation 
of  a  chelate  complex  between  Ni
2+  ions,  the  column  material,  and  two  histidine 
residues of the His6-tag. Before the protein was eluted, the column was washed twice 
with at least 5 column volumes. The first washing step was performed with Wash 1 
buffer (Table 2-12) and the second with Wash 2 buffer (Table 2-12). Aliquots of 500 
– 1000 µl were collected and fractions containing the highest concentration of protein 
were pooled. 
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Table 2-12 | Buffers used for affinity chromatography purification 
Buffer  Component  Concentration 
Equilibration / Wash 1  HEPES or Tris-HCl, pH 7.5  25 mM 
  NaCl or KCl  50 – 100 mM 
  TCEP  1 – 2 mM 
  DDM or Cymal-5  0.02 – 0.2 % (w/v) 
  Imidazole  50 mM 
  Glycerol  10 % (v/v) 
Wash 2  HEPES or Tris-HCl, pH 7.5  25 mM 
  NaCl or KCl  50 – 100 mM 
  TCEP  1 – 2 mM 
  DDM or Cymal-5  0.02 – 0.2 % (w/v) 
  Imidazole  50 mM 
Elution  HEPES or Tris-HCl, pH 7.5  25 mM 
  NaCl or KCl  50 – 100 mM 
  TCEP  1 – 2 mM 
  DDM or Cymal-5  0.02 – 0.2 % (w/v) 
  Imidazole  200 mM 
 
 
2.3.4.4  Size exclusion chromatography (SEC) 
 
Preparative SEC was used to remove imidazole after eluting the protein from 
the Ni
2+ column on a PD-10 Sephadex G-25M (GE Healthcare) column. The column 
was equilibrated with the appropriate buffer (Table 2-13) before max. 2.5 ml protein 
solution was loaded on the column. Aliquots of 200 – 500 µl were collected and 
fractions with detectable protein content were pooled. 
 
Analytical SEC was carried out using the Ettan LC system (GE Healthcare) 
and  a  Superose
TM  6  (3.2/30)  column  (GE  Healthcare).  The  flow  rate  was  kept 
constant  at  50  µl/min.  All  buffers  (Table  2-13)  used  during  analytical  SEC  were 
filtered (exclusion size 0.2 µm) and degassed. Materials and Methods 
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Table 2-13 | Buffers used for preparative and analytic SEC 
Buffer  Component  Concentration 
SEC  HEPES or Tris-HCl, pH 7.5  25 mM 
  NaCl or KCl  50 – 100 mM 
  TCEP  1 mM 
  DDM or Cymal-5  0.02 – 0.2 % 
 
 
2.3.4.5  Proteolytic cleavage of the fusion tag 
 
The His6-tag was removed using the THROMBIN ClenCleave
TM Kit (Sigma). 
Thrombin  is  a  protease  that  selectively  cleaves  between  the  arginine  and  glycine 
residues of the cleavage site (Leu-Val-Pro-Arg↓Gly-Ser) and can therefore be used 
effectively to remove the purification tag. 
The  washing  and  cleavage  buffers  were  adjusted  to  protein  compatible 
conditions (50 mM HEPES/Tris-HCl, pH 7.5, 50 – 100 mM NaCl/KCl, 1 mM TCEP, 
10 mM CaCl2, 0.02 – 0.2 % DDM/Cymal-5). The cleavage reaction was incubated at 
4 ˚C for 3 – 4 hours with constant stirring. All other steps were performed according 
to the manufacturer’s instructions. 
 
 
2.3.4.6  Protein concentration 
 
Protein was concentrated by centrifugation (4 ˚C, 4,000 g) using the Vivaspin 
4 or Vivaspin 500 concentrators with a molecular weight cut-off of 100,000 kDa 
(Vivascience). To avoid protein aggregation due to high local protein concentration, 
the sample was mixed every 10 minutes. 
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2.3.5   Detergent concentration 
 
The detergent concentration was analyzed after the protein purification was 
completed. The method makes use of the sugar moiety in the detergent which is 
quantified by a colorimetric reaction with phenol and sulfuric acid (Fox and Robyt, 
1991; Urbani and Warne, 2005).  
The reaction was set up in small glass tubes (total volume 750 µl, VWR) that 
were placed on ice. 25 µl of a diluted protein sample (containing 20 – 50 µg protein) 
was mixed with 25 µl 5 % (w/v) phenol before 150 µl of concentrated sulfuric acid 
was added. The reaction was mixed carefully and incubated at 80 ˚C for 30 minutes. 
After cooling to room temperature the samples were pipetted into wells of a 96-well 
plate (Nunc). The absorption was measured at 492 nm using the SpectraMax M2 
(Molecular Devices) microplate reader. Standard curves were calculated using DDM 
or Cymal-5. 
 
 
2.3.6   Protein concentration 
 
2.3.6.1  Bradford assay 
 
The  protein  concentration  of  a  membrane  solution  was  estimated  by  the 
Bradford  assay  (Bradford,  1976).  The  Bradford  Reagent  (Sigma)  contains  the 
Coomassie Brilliant Blue G250 dye that binds to basic amino acids like arginine, 
histidine,  and  lysine  but  also  interacts  with  hydrophobic  amino  acids  like 
phenylalanine,  tryptophan  and  tyrosine.  The  binding  of  the  protein  to  the  dye 
stabilizes  its  anionic  from  which  leads  to  a  bathochromic  shift  of  the  absorption 
maximum from 465 nm (without bound protein) to 595 nm (with bound protein). The 
intensity of the blue colouration is directly proportional to the protein concentration. 
A  standard  curve  was  calculated  using  BSA  and  the  absorption  was  measured  at  
595 nm.  
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2.3.6.2  Protein denaturing method 
 
The protein concentration of purified protein was estimated by measuring the 
absorbance at 280 nm. The extinction coefficient ε and the molar mass Mr of CaiT 
were calculated from the amino acid sequence using the ExPASy ProtParam tool 
(www.expasy.ch/tools/protparam.html). Before measuring the absorption, the purified 
protein  was  denatured  in  6  M  guanidinium  hydrochloride.  Guanidinium 
hydrochloride was also used as the blank reference. The protein concentration was 
calculated using Equation 2-1. 
 
Equation 2-1: 
 
 
! 
c(CaiT =
Abs.("280)•100
#(CaiT)
$ Mr(CaiT) 
 
  ε (EcCaiT) = 153,945    Mr (EcCaiT) = 56,587 Da 
  ε (PmCaiT) = 152,915    Mr (PmCaiT) = 56,318 Da 
  ε (StCaiT) = 150,965    Mr (StCaiT) = 56,748 Da 
 
 
2.3.6.3  Amido Black method 
 
The  concentration  of  protein  reconstituted  into  liposomes  was  determined 
using the Amido Black method (Schaffner and Weissmann, 1973). The Amido Black 
method is a colorimetric assay for measuring total protein concentration in a given 
sample  with  a  concentration  down  to  0.75  µg/ml.  The  protein  is  quantitatively 
precipitated  by  trichloroacetic  acid  (TCA)  and  collected  on  membrane  filters  by 
filtration.  The  protein  collected  on  the  filter  can  be  quantitatively  determined  by 
staining with the dye amido black. 
 
A 2 – 5 µl protein sample was placed in a test tube and water was added to a 
final volume of 225 µl. The solution was first mixed with 30 µl of a buffer containing Materials and Methods 
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1 M Tris-HCl, pH 7.4 and 2 % (w/v) SDS before the protein was precipitated with 50 
µl  90  %  (v/v)  TCA.  The  mixture  was  vortexed  and  kept  2  –  5  minutes  at  room 
temperature. A round filter (MILLIPORE, type HAWP02500, 0.45 µm), which was 
carefully marked with pencil dots, was washed with water and placed on a suction 
device.  The  samples  were  carefully  dropped  on  to  the  respective  pencil  dots  and 
sucked  through  the  filter  with  a  vacuum  pump.  The  protein  spots  were  directly 
washed with 200 µl 6 % (v/v) TCA and the whole filter was again rinsed with 1 – 2 
ml 6 % (v/v) TCA. After completing all the filtrations, the filter was moved to a Petri 
dish  and  immersed  for  2  –  3  minutes  in  Amido  Black  solution  (Table  2-14).  To 
remove excess solution the filter was first rinsed with water before it was washed 
under  agitation  for  2  –  3  minutes  in  destaining  solution  (Table  2-14).  The  spots 
containing protein appeared blue and were cut out and placed in a test tube. 1 ml of 
eluant solution (Table 2-14) was added to the test tubes and the tubes were incubated 
under agitation for 10 minutes at room temperature. The OD of the eluant solution 
was measured at 630 nm. A standard curve was calculated using BSA (concentration 
range: 0 µg to 10 µg). 
 
Table 2-14 | Solutions for the Amido Black Assay 
Solution  Component  Concentration 
Amido Black   Amido Black  0.25 % (w/v) 
  Methanol  45 % (v/v) 
  Glacial acetic acid  10 % (v/v) 
Destaining   Methanol  90 % (v/v) 
  Glacial acetic acid  2 % (v/v) 
Eluant   NaOH  25 mM 
  EDTA  50 µM 
  Ethanol  50 % (v/v) 
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2.3.7   Polyacrylamid gel electrophoresis (PAGE) 
 
2.3.7.1  Blue-Native (BN)-PAGE 
 
The discontinuous BN-PAGE (Schagger and von Jagow, 1991) was used to 
detect  undenatured,  solubilized  proteins  after  purification.  The  method  uses 
Coomassie Blue G250, which induces a charge shift on the proteins and stays tightly 
bound to it even upon high dilution and in the presence of ε-aminocaproic acid, which 
improves the solubility of membrane proteins. 
 
Native gels (4 – 12 % Tris-Glycine gels) used for BN-PAGE were purchased 
from  Invitrogen.  Protein  samples  (3  –  7.5  µg)  were  pre-diluted  with  10×  sample 
buffer (Table 2-15) before loading onto the gel. Electrophoresis was started at 80 V 
until the protein samples were concentrated within the stacking gel. The gels were run 
at a constant voltage (150 V) for 4 – 5 hours. The gels were distained with 10 % (v/v) 
Ethanol and 10 % (v/v) Glacial acetic acid. 
 
Table 2-15 | BN-PAGE buffers 
Buffer  Component  Concentration 
Anode   BisTris, pH 7.0  50 mM 
Cathode  Tricin  50 mM 
  BisTris, pH 7.0  15 mM 
  Comassie-Brilliant-
Blue G250 
0.2% (w/v) 
Sample (10×)  ε-aminocaproic acid  500 mM 
  BisTris, pH 7.0  150 mM 
  Glycerol  10 % (v/v) 
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2.3.7.2  Denaturing SDS-PAGE 
 
To  analyze  the  purity  of  a  protein  sample  a  discontinuous  PAGE  under 
denaturing conditions was performed according to Laemmli (Laemmli, 1970). 15 % 
resolving gels with 5 % stacking gels (Table 2-16) were prepared and stored at 4 ˚C. 
Before electrophoresis the protein samples were diluted with 4× sample buffer (Table 
2-18)  which  contains  the  anionic  detergent  SDS  that  denatures,  linearizes,  and 
charges proteins according to their amino acid length. Electrophoresis was started at 
80  V  until  the  protein  samples  entered  the  stacking  gel  and  afterwards  run  at  a 
constant voltage of 120 V for 45 minutes. Gels were stained with Coomassie (Table 
2-19) according to the protocol by Studier (Studier, 2005).  
 
Table 2-16 | SDS-PAGE gel mixture for two gels 
Gel  Component  Volume  
Resolving (15 %)  H2O  2.3 ml 
  30 % (v/v) acryl-bisacrylamide 
mix 
5.0 ml 
  1.5 M Tris-HCl, pH 6.8  2.5 ml 
  10 % (w/v) SDS  100 µl 
  10 % (w/v) APS (fresh)  100 µl 
  TEMED  5 µl 
Stacking (5 %)  H2O  2.7 ml 
  30 % (v/v) acryl-bisacrylamide 
mix 
670 µl 
  1.5 M Tris-HCl, pH 6.8  500 µl 
  10 % (w/v) SDS  40 µl 
  10 % (w/v) APS (fresh)  40 µl 
  TEMED  5 µl 
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Table 2-17 | SDS-PAGE running buffer 
Component  Concentration 
Tris-HCL (no pH adjustment)  250 mM 
Glycine  1.92 M 
SDS  1 % (w/v) 
 
 
Table 2-18 | 4× sample buffer  
Component  Concentration 
Tris-HCl (no pH adjustment)  250 mM 
SDS  10 % 
Glycerol  50 % 
TCEP   10 mM 
Bromophenol blue  0.02 % (w/v)  
 
 
Table 2-19 | Coomassie staining solutions 
  Component  Concentration 
Solution I:  Ethanol  50 % (v/v) 
  Acetic acid  10 % (v/v) 
Solution II:  Ethanol  5 % (v/v) 
  Acetic acid  7.5 % (v/v) 
Coomassie stock solution:  Ethanol  95 % (v/v) 
  Coomassie brilliant blue R250  0.25 % (w/v) 
 
 
2.3.8   Western blot analysis 
 
Transfer  of  proteins  from  SDS-PAGE  gels  to  methanol-activated  PVDF 
membranes (Immobilon
TM -P Transfer Membrane, pore size 0.45 µm, MILLIPORE) 
was performed using a semi-dry system (Bio-Rad). The PVDF membrane and the gel Materials and Methods 
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were  sandwiched  between  Whatman  3MM  filter  paper  (Schleicher  &  Schüll), 
presoaked  with  transfer  buffer  (Table  2-20).  To  ensure  complete  transfer  of  the 
proteins to the PVDF membrane, blotting was carried out for 45 minutes at 15 V. 
After transfer, the PVDF membrane was incubated at room temperature for 1 hour in 
blocking buffer (Table 2-20) to cover the membrane with protein so the antibodies 
cannot  bind  to  the  membrane  unspecifically.  The  membrane  was  subsequently 
washed 3 – 5 times in TBS buffer (Table 2-20). 
For  immuno-detection,  the  PVDF  membrane  was  incubated  in  primary 
antibody (Monoclonal Anti-polyHISTIDINE clone HIS-1, Sigma; 1 : 1000 dilution) 
for 2 hours at room temperature or overnight at 4 ˚C. The membrane was washed 3 – 
5 times in TBS buffer (Table 2-20) and incubated with the second antibody (Anti-
Mouse  IgG  (whole  molecule)-Alkaline  Phosphatase,  antibody  produced  in  rabbit, 
Sigma; 1 : 5000 dilution) for 2 hours at room temperature or overnight at 4 ˚C. After 
washing 3 – 5 times in TBS (Table 2-20), the membrane was incubated in 10 ml 
developer  buffer  (SigmaFAST
TM  BCIP/NBT,  Sigma;  Table  2-20)  until  bands 
appeared.  To  stop  the  reaction  the  PVDF  membrane  was  washed  with  deionized 
water. 
 
Table 2-20 | Buffers for Western blot analysis 
Buffer  Component  Concentration 
Transfer  Tris-HCl (no pH adjustment)  25 mM 
  Glycine  192 mM 
  SDS  0.1 % (w/v) 
TBS (10×)  Tris-HCl, pH 7.5  500 mM 
  NaCl  1.5 M 
Blocking  TBS buffer  1× 
  Milk powder  5 % (w/v) 
Antibody  TBS  1× 
  Milk powder  0.5 % (w/v) 
Developer  Tris-HCl, pH 7.5  25 mM 
  SigmaFAST
TM BCIP/NBT  1 tablet 
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2.3.9   Thin-layer chromatography (TLC) 
 
TLC  was  performed  to  analyze  the  lipid  content  of  solubilized  membrane 
protein after purification. A small drop of purified protein (10 – 15 µg) in detergent 
solution was applied to a TLC plate (10×10 cm
2, pre-coated, Silica 60, Merck) about 
1 cm from the base. The plate was developed in a closed tank containing a solvent 
mixture (chloroform : methanol : water = 69 % : 27 % : 4 % (v/v/v)). After drying, 
the TLC plate was stained with iodine vapour, which binds to carbon-carbon double 
bonds (C = C) of unsaturated fatty acids and therefore stains lipids non-specifically. 
Phospholipids were detected using the molybdenum blue spray reagent (1.3 % (w/v) 
molybdenum oxide (MoO3) in 4.2 M sulfuric acid, 1 : 1 dilution, Sigma). Under 
acidic condition molybdenum oxide reacts with the phosphate group of phospholipids 
and forms the blue heteropoly-molybdenum anion (PMo
V
4Mo
VI
8 O40
7-). 
 
 
2.3.10   Protein reconstitution into liposomes 
 
For reconstitution of CaiT protein into liposomes, E. coli polar lipids (E. coli 
Polar  Lipid  Extract,  Avanti)  were  used.  An  E.  coli  polar  lipids  (EPL)  aliquot  in 
chloroform : methanol was dried under nitrogen and resuspended in KPi buffer (50 
mM KPi, pH 7.5, 1 mM TCEP) to a final concentration of 20 mg/ml. Aliquots of  
800 µl were frozen in liquid nitrogen and stored at -80 ˚C. 
The  lipid  solution  was  slowly  thawed  at  room  temperature  before  it  was 
extruded 15 – 20 times through a 400 nm membrane filter (Polycarbonate Membrane, 
pore size = 400 nm, Avestin) and diluted to a final concentration of 5 mg/ml. The 
liposomes were titrated with Triton X100 (10 % stock solution (w/v)) to the onset of 
solubilization, which was detected by measuring the absorbance at 540 nm. Protein 
was added at a lipid-to-protein ratio of 20 : 1 (w/w). The protein-liposome solution 
was  incubated  for  20  minutes  at  room  temperature  under  gentle  agitation  before 
detergent was removed by adding Bio-Beads (SM-2 Macroporous Beads, Bio-Rad). 
Proteoliposomes were collected by ultra-centrifugation (20 ˚C, 100,000 g, 35 min), 
washed and resuspended in KPi buffer to a final lipid concentration of 60 mg/ml. Materials and Methods 
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Aliquots of 50 µl were frozen in liquid nitrogen and stored at -80 ˚C. Reconstitution 
was checked by freeze-fracture electron microscopy. 
 
 
2.3.11   Transport measurements 
 
Substrate  exchange  was  measured  by  recording  the  uptake  of  L-[N-Methyl-
14C]-carnitine  hydrochloride  (
14C-L-carnitine,  Perkin  Elmer)  into  CaiT-containing 
liposomes  preloaded  with  a  saturating  concentration  of  non-radioactive  substrate. 
Usually  10  mM  of  potential  substrate  such  as  glycine  (Sigma),  glycine  betaine 
(Sigma),  γ-butyrobetaine  (a  kind  gift  from  the  Lonza  Group  Ltd.)  or  L-carnitine 
(Sigma) was used. Proteoliposomes were loaded by two rounds of freeze-thawing in 
the presence of substrate. After the second freeze-thaw cycle the proteoliposomes 
were extruded first through a 200 nm membrane filter (Polycarbonate Membrane, 
pore diameter 200 nm, Avestin) followed by extrusion through a 400 nm membrane 
filter (Polycarbonate Membrane, pore diameter 400 nm, Avestin). The extraliposomal 
substrate  was  removed  by  washing  the  proteoliposomes  with  KPi  buffer. 
Proteoliposomes were collected by ultra-centrifugation (20˚C, 100,000 g, 35 min). 
Substrate uptake was initiated by aliquots (2 µl) of the proteoliposome suspension 
diluted  into  400  µl  KPi  buffer  with  different  concentration  of 
14C-L-carnitine 
(typically 6 to 620 µM, 2.5 µCi ml
-1). At time points of 5 to 30 sec, 
14C-L-carnitine 
incorporated into the proteoliposomes was determined with a scintillation counter 
TRI-CARB 1500 (Canberra-Packard). All transport assays were repeated three times. 
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2.4   Biophysical methods 
 
2.4.1   Fluorescence 
 
Fluorescence is the spontaneous emitted radiation by a substance that has been 
excited  by  absorption  of  radiation  at  a  different,  usually  shorter,  wavelength. 
Fluorescence  typically  occurs  from  aromatic  molecules,  which  have  rigid  and 
inflexible structures (e.g. flourescein or tryptophan). The Jablonski diagram (Figure 
2-2; (Jablonski, 1935)) illustrates the processes that occur between the absorption and 
emission of light. The initial absorption of a photon transfers the fluorophore to an 
excited electronic state by promoting an electron from a lower to a higher energy 
state. Some of the initially absorbed energy is lost in transitions between vibrational 
energy levels (non-radiative transition). Radiative transition or fluorescence occurs 
when the molecule returns from the excited electronic state (S1) to the ground state 
(S0). 
 
Figure 2-2 | Physical basis of fluorescence 
Simplified Jablonski diagram (Jablonski, 1935). The singlet ground (S0) and the first electronic (S1) 
states are shown. At each of the two different electronic energy levels, the fluorophore can drop to 
different vibrational energy levels (0, 1, 2, 3, …). Absorption of a photon by a fluorophore corresponds 
to a transition from S0 to S1. If the fluorophore has a comparable rigid structure with few vibrational 
energy  levels,  fluorescence  may  occur.  Straight  lines  indicate  radiative  transition  (absorption  or 
emission) of a photon, while dashed lines indicate non-radiative processes. 
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2.4.1.1  Substrate binding assays 
 
Substrate binding assays were performed with 1.5 µM purified CaiT protein 
by  recording  the  tryptophan  fluorescence  emission.  Concentrations  of  potential 
substrates such as glycine betaine (Sigma), γ-butyrobetaine (Lonza Group Ltd.), L-
carnitine (Sigma), or choline (Sigma) were used at concentrations ranging from 0.25 
to 40 mM. The fluorescence emission was recorded using the F-4500 Fluorescence 
Spectrophotometer  (Hitachi).  The  excitation  wavelength  was  set  to  295  nm  and 
emission spectra between 305 nm and 390 nm were recorded. The slit width was set 
to 2.5 nm or 5 nm for measurements of excitation or emission, respectively. Each 
fluorescence emission spectrum represents the mean of 3 to 5 recordings. The mean 
value and standard deviation at maximum emission at 342 nm was plotted for each 
substrate  concentration.  Data  were  fitted  to  the  Michaelis-Menten  equation  as 
previously  described  (Jung  et  al.,  2002)  and  apparent  KM  values  were  calculated 
using  the  program  Origin  7.5.  To  determine  the  sodium  dependency  of  substrate 
binding experiments were carried out at different NaCl concentrations (1 – 50 mM) or 
without added NaCl. 
 
 
2.4.2   Freeze-fracture electron microscopy 
 
A  small  sample  of  proteoliposome  solution  (1.5  –  2  µl,  final  lipid 
concentration 60 mg/ml) was pipetted between two copper plates serving as a sample 
holder. The sample was rapidly frozen in liquid ethane at -180 ˚C. Freeze-fracture of 
proteoliposomes was carried out with a BAF 060 machine (Bal-Tec) at a temperature 
of  -130  ˚C  and  a  pressure  of  2×10
-7  mbar.  The  resulting  fracture  planes  were 
shadowed with platinum / carbon followed by pure carbon shadowing to reinforce the 
replica. The replica was floated with sulfuric acid (40 - 50 % v/v) for 10 hours, 
washed several times with water for cleaning and analyzed in an EM208S electron 
microscope (FEI Company). Images were collected on a 1K × 1K slow-scan CCD 
camera (TVIPS). All freeze-fracturing and imaging steps were performed by F. Joos 
(MPI of Biophysics). Materials and Methods 
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2.4.3   X-ray crystallography 
 
X-ray  crystallography  is  the  prevalent  method  of  determining  the  three-
dimensional (3D) structure of biological macromolecules at atomic resolution. It is 
based on the fact that macromolecules diffract X-rays in a pattern, which is dependent 
on  their  orientation  in  3D  space.  In  crystals,  atoms  or  molecules  are  arranged  in 
regular  repeating  arrays,  which  act  as  diffraction  grating  from  which  X-rays  are 
scattered in particular directions. This scattered radiation can be detected as a two-
dimensional  array  of  spots  of  particular  positions  and  intensities  forming  the 
diffraction pattern. The extent of the diffraction pattern is directly correlated with the 
degree of internal crystal order. The more structurally uniform and precisely arraged 
the molecules are in the crystal, the higher is the resolution to which the pattern 
extends (McPherson, 2004). 
 
 
2.4.3.1  Prediction of 3D crystallization feasibility  
 
The  success-rate  of  forming  highly  ordered,  well  diffracting  crystals  is 
dependent on the internal protein properties, which are defined by the amino acid 
sequence.  The  XtalPred  server  (http://ffas.burnham.org/XtalPred,  (Slabinski  et  al., 
2007b)) estimates, based on the amino acid sequence, the success rate for protein 
production and crystallization by analyzing several predicted protein features such as 
sequence length, isoelectric point, hydrophobicity index or gravy index, which is the 
ration of the sum of the hydrophobicity values for each residue in the protein to the 
actual  protein  length  (Canaves  et  al.,  2004),  length  of  the  longest  disordered 
fragment, instability index, predicted percentage of coil secondary structure, number 
of  residues  in  the  predicted  coil-coiled  regions,  predicted  transmembrane  helices, 
percentage  of  insertions  in  multiple  alignments,  predicted  long  low-complexity 
regions, predicted signal peptide and net protein charge (Slabinski et al., 2007a) . One 
has to keep in mind that the individual protein features are compared to proteins that 
are  available  in  databases  like  the  TargetDB,  (Chen  et  al.,  2004)),  the  Protein Materials and Methods 
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Structure Initiative (PSI, (Norvell and Machalek, 2000)) and the protein data bank 
(PDB). However, there are still only comparatively few membrane protein structures 
(252 unique membrane protein X-ray structures, PDB, June 2010) deposit in the PDB 
compared to the number of soluble protein structures (66 072 soluble protein X-ray 
structures,  PDB,  June  2010),  which  makes  an  unbiased  estimation  for  membrane 
proteins difficult. Nevertheless, the analysis of the results from the crystallization 
feasibility predictions between homologs helps to find the one homolog that might be 
more likely to from well-ordered, high diffracting crystal for structure determination. 
 
 
2.4.3.2  Crystallization of CaiT 
 
Protein crystals can grow from a supersaturated solution (Figure 2-3) after 
nucleation  has  taken  place.  A  stable  nucleus  is  an  ordered  aggregate  of  protein 
molecules that provides a surface at which free molecules can bind via hydrogen 
bonds, electrostatic or hydrophobic interactions. The crystal grows by incorporating 
free protein molecules into its lattice (McPherson, 2004).  Materials and Methods 
63 
 
Figure 2-3 | Phase diagram for protein crystal growth 
The  phase  diagram  shows  three  regions.  In  the  unsaturated  region  (yellow)  crystals  cannot  form 
because a solid phase would immediately dissolve. The supersaturated region (black) is divided into 
two  subregions.  In  the  metastable  region  (green)  crystal  growth  is  possible,  but  protein  crystal 
nucleation occurs spontaneously at higher saturation levels in the labile region (blue). A continuous 
increase in protein or precipitant concentration beyond the labile region leads to protein precipitation 
(red). 
 
The phase diagram (Figure 2-3) shows that reaching supersaturation depends 
on  the  protein  as  well  as  on  the  precipitant  concentration.  Additional  parameters 
which influences protein crystal nucleation and growth are: the type of precipitant 
e.g. salts (NaCl or (NH4)2SO4), organic compounds, e.g. polyethylene glycol (PEG) 
or jeffamine, or non-volatile organic solvents, e.g. 2-methyl-2,4-pentanediol (MPD) 
or  2,5-hexandiol,  the  pH  of  the  solution,  the  temperature  and  the  crystallization 
method itself.  
 
CaiT was crystallized using the hanging drop or sitting drop vapour diffusion 
methods  (Figure  2-4).  The  protein  solution  is  mixed  with  reservoir  solution  and 
placed above the reservoir in a closed chamber. Since the concentration of precipitant 
in the reservoir is initially higher than in the drop, water molecules leave by vapour 
diffusion until the osmolarity of the drop and the reservoir becomes equal. The loss of Materials and Methods 
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water  in  the  drop  leads  to  a  continuous  increase  of  protein  and  precipitant 
concentration.  
 
 
Figure  2-4  |  Schematic  representation  of  the  hanging  drop  and  sitting  drop 
vapour diffusion method  
Since the concentration of precipitant in the reservoir solution is initially higher than in the protein 
drop  mixed  with  reservoir  solution,  water molecules  leave  the  drop  by  vapour  diffusion  until  the 
osmolarity of the drop and the reservoir are equal. 
 
To find initial crystallization conditions for CaiT, commercial crystallization 
screens were used, notably the Index
TM, Crystal Screen
TM and Crystal Screen II
TM 
screens from Hampton, the MbClass
TM and MbClass II
TM screens from Qiagen, the 
MemStart
TM and MemSyst
TM screens
 from Molecular Dimension and the JBScreen 
Basic
TM  and  JBScreen  Membrane
TM  screens  from  Jena  Bioscience.  All  screening 
crystallization  trials  were  performed  in  96-well  sitting  drop  plates  using  the 
Mosquito
TM (TTPLabtech, UK) pipetting robot. The reservoirs of the 96-well sitting 
drop plate were manually filled with 70 µl of crystallization solution. Typically, the 
crystallization drops were prepared using 500 nl of protein solution (5 mg/ml) plus 
250  –  500  nl  of  reservoir  solution.  The  crystallization  plates  were  incubated  at 
different temperatures (4˚C, 6˚C, 8˚C, 10˚C, 12˚C, 16˚C, 18˚C, 22˚C, 25˚C). 
 
Crystallization  conditions  were  optimized  in  24-well  plates  (Hampton 
Research) using the hanging drop vapour diffusion method. For crystallization 500 µl 
of optimized crystallization conditions (Table 2-21) was used as reservoir solution. 
The crystallization drops were set up with 2 µl of CaiT protein solution (2.5 – 7.5 
mg/ml) mixed with 1 µl reservoir solution.  
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Table 2-21 | Optimized crystallization conditions 
Component  Concentration 
MgAc2 or CaAc2, pH 4.4 – 5.5  50 mM 
PEG 400  15 – 26 % (w/v) 
NaCl  0 – 275 mM 
 
 
2.4.3.3  Seeding 
 
Macro-  and  microseeding  experiments  were  performed  to  optimize  CaiT 
crystals. For a macroseeding experiment, small crystals (100 – 150 µm) grown in one 
condition  were  washed  in  stabilizing  condition,  which  usually  contained  a  higher 
PEG  400  concentration.  Then  the  crystals  were  transferred  into  a  non-stabilizing 
solution so that the crystals began to dissolve. The roundish looking crystals were 
then  transferred  to  new  crystallization  drops,  which  had  been  pre-equilibrated  for 
several hours (usually 2 – 12 hours). 
For  a  microseeding  experiment  one  big  crystal  (300  –  400  µm)  was  first 
washed in stabilizing solution and then transferred into a test tube containing 50 µl of 
stabilizing solution. The seed stock solution was vortexed and centrifuged (4 ˚C, 2000 
g, 10 sec). The seed stock was serially diluted (1:5, 1:10, 1:20 and 1:50) and 0.5 µl of 
the  diluted  seed  stocks  were  added  to  pre-equilibrated  crystallization  drops.  The 
crystallization drops contained either different protein or precipitant concentrations or 
were pre-equilibrated for different time spans (usually 2 – 12 hours).  
 
 
2.4.3.4  Detergent screens 
 
Detergent Screening Kits
TM 1 – 3  (Hampton Research) were used to find new 
or additional detergents for optimizing CaiT crystal growth. Each Detergent Screen
TM 
contains 24 unique detergents at 10× of the critical micelle concentration (CMC). For 
detergent screening 5 µl of a double concentrated optimized crystallization condition Materials and Methods 
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was mixed with 1.5 µl of the detergent solution. Water was added to a final volume of 
10 µl (detergent crystallization solution). Crystallization drops were set up using 2 µl 
of CaiT protein solution (2.5 – 7.5 mg/ml) mixed with 1 µl detergent crystallization 
solution.  The  reservoir  solution  contained  500  µl  of  the  optimized  crystallization 
condition without additional detergent.  
Conditions that produced crystals were reproduced several times (usually six 
times)  using  the  same  detergent  crystallization  solution.  X-ray  diffraction  of  the 
crystals  was  tested  and  compared  in  order  to  decide  which  detergents  indeed 
optimized crystal growth. 
 
 
2.4.3.5  Additive screens 
 
Additives  are  small  molecules  that  can  affect  crystallization  by  changing 
protein-protein  or  protein-solvent  interactions.  The  Additive  Screen
TM  (Hampton 
Research)
  contains  96  different  compounds  at  10×  the  recommended  drop 
concentration.  Additives  were  screened  using  the  pipetting  robot  Mosquito
TM 
(TTPLabtech, UK). The reservoirs of the 96-well sitting drop plate were manually 
filled with 70 µl of crystallization solution. Usually, 175 nl of reservoir solution was 
mixed with 75 nl of additive, which was then added to 500 nl of protein solution. 
Conditions  that  yielded  protein  crystals  were  reproduced  in  24-well  plates.  X-ray 
diffraction of the crystals was tested and compared to find the best additives. 
 
 
2.4.3.6  Heavy atom screens 
 
To overcome the phase problem (Section 2.4.7.1) anomalous scatterers are 
used in the multiple or single isomorphous replacement (MIR/SIR) method and the 
multiple  or  single  anomalous  dispersion  (MAD/SAD)  method.  Both  of  these 
approaches require at least one heavy atom derivative of the protein. The search for a Materials and Methods 
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heavy atom that binds without damaging the protein or the crystal is as empirical as 
determining the initial crystallization conditions. 
 
For heavy atom screening, the Heavy Atom Screen Pt
TM, Heavy Atom Screen 
Au
TM,  Heavy  Atom  Screen  Hg
TM,  Heavy  Atom  Screen  M1
TM  and  Heavy  Atom 
Screen M2
TM screen from Hampton and the Tantalum Cluster Derivatization Kit
TM 
from Jena Bioscience were used. All heavy atom screening trials were performed in 
24-well plates (Hampton Research) by hanging drop vapour diffusion at 4 ˚C. 
 
 
2.4.3.7  Cryocrystallography 
 
Cryocrystallography  (Haas,  1968)  is  based  on  the  collection  of  X-ray 
diffraction at liquid nitrogen temperature (100 K). The main advantage of the method 
is the greately reduced rate of radiation damage to the protein crystal during data 
collection at cryogenic temperatures. Since the diffusion of radicals created in the 
crystals by X-ray radiation is limited in the amorphous phase of flash-cooled crystals, 
their lifetime in the beam is increased by about 100-fold (Nave and Garman, 2005; 
Weik and Colletier, 2010). 
To protect the protein crystal from damage caused by ordered ice formation 
during flash freezing, the crystal is transferred into a solution of cryoprotectant agents 
before freezing. Cryoprotectant agents, such as PEG 400 or glycerol, penetrate into 
the solvent-filled channels of protein crystals (Garman and Doublié, 2003; Garman 
and Schneider, 1997) and interact extensively with water molecules. These agents 
thereby prevent the formation of crystalline ice and promote the formation of vitreous 
ice during flash freezing. In contrast to crystalline ice, vitreous ice does not expand 
on formation and therefore does not damage the protein crystals (McPherson, 1999).  
 
CaiT crystals were cryoprotected with MgAc2 or CaAc2 buffered PEG 400 (30 
– 35 % (w/v)). To reduce the osmotic shock, the total volume of 2 µl cryosolution 
was added stepwise (incubation time 1 – 2 min) to the crystallization drop. After an Materials and Methods 
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additional incubation time of 5 – 10 minutes the crystals were fished with cryo-loops 
(Hampton Research; Molecular Dimension) and flash frozen in liquid nitrogen. 
 
 
2.4.4   Principles of X-ray crystallography 
 
A crystal is built up from regularly repeating units. The smallest unit of a 
crystal  is  the  asymmetric  unit  (AU).  It  is  the  minimum  group  of  atoms  whose 
positions, by applying crystallographic symmetry operations, generate the complete 
content  of  the  unit  cell.  The  AU  contains  the  unit  cell  origin  and  the  primary 
generating symmetry element(s). The unit cell is the smallest repeating volume that 
when periodically translated forms the crystal lattice. The unit cell is defined by three 
lattice constants, a, b, c, and by three angles α, β, γ. 
Translation  and  rotation  are  symmetry  operations,  which  define  the  lattice 
symmetry of a crystal. A unit cell and as a consequence also the crystal lattice can 
only have 2-fold, 3-fold, 4-fold and 6-fold rotational symmetry. The multiplicity n of 
the rotation axis and the rotation angle φ are related by φ = (360/n)˚. In a trigonal unit 
cell (P3), a rotation around the 3-fold symmetry axis (·) involves three consecutive 
rotations by 120˚. It is not possible to fill a plane with e.g. regular pentagons, and no 
true crystal lattice with 5-fold symmetry exists.  
By applying all allowed symmetry operations a crystal can be regarded as a 
3D space lattice, an infinite array of points where its neighbours surround each point 
in an identical way. 
 
Protein X-ray crystallography usually uses X-rays with wavelengths in the 
range of 0.6 – 2.5 Å. The electromagnetic radiation can interact with electrons and 
atoms  in  a  crystal  and  diffraction  occurs  when  the  dimensions  of  the  diffracting 
objects (e.g. bond lengths of molecules) are comparable to the wavelength of the 
radiation. The diffraction pattern of a crystal is a list of angles at which reflections are 
observed.  Bragg’s  law  (Figure  2-5)  explains  the  quantitative  relation  between  the 
interplanar lattice spacing of a crystal (dhkl) and the scattering angles (θ) at which 
constructive  interference  (reflection)  occurs  from  a  specific  lattice  point.  The Materials and Methods 
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reciprocal space construction with the Ewald sphere represents the 3D illustration of 
Bragg’s law. The Ewald sphere of radius 1/λ illustrates which reflections will be 
imaged by the detector and explains why the 2-dimensional diffraction pattern shows 
diffraction spots in separate ellipses (Figure 2-5; (Dauter, 1999)).  
 
 
 
Figure 2-5 | Conditions for constructive interference 
Bragg’s  law  (A)  describes  at  which  conditions  diffraction  is  observed.  Constructive  interference, 
which produces strong diffraction, occurs when the difference in path length of reflected rays (R) from 
successive crystal planes is equal to an integral number (n) of wavelengths of the incident X-rays (X). 
Strongly reflected rays emerge from planes of spacing d only at angles θ (Bragg angles) for which 2d × 
sin θ = nλ.  
The reciprocal space construction with the Ewald sphere (B) shows that reflections are observed on the 
detector when a reciprocal lattice point (P) coincides with the Ewald sphere of radius 1/λ. As the 
crystal rotates in the X-ray beam (X), various reciprocal lattice points come in contact with the Ewald 
sphere each producing a reflecting beam (R). This produces a characteristic diffraction pattern with 
diffraction spots in separated ellipses (C). This figure is adapted from (Dauter, 1999). Materials and Methods 
70 
2.4.5   Data collection 
 
Diffraction of CaiT crystals was tested in-house at the MicroMax
TM-007HF 
diffractometer  with  R-AXIS  IV
++  detector  (RIGAKU  Americas)  or  at  the  FR-E
+ 
SuperBright diffractometer with Saturn 944
+ detector (RIGAKU Americas). The first 
device operates at 40 kV and 30 mA, whereas the latter one operates at 45 kV and 55 
mA. 
 
High-resolution  data  sets  of  native  and  derivative  crystals  were  collected 
either  the  Max-Planck  beamline  of  the  Swiss  Light  Source  (SLS,  Villigen, 
Switzerland) or at the European Synchrotron Radiation Facility (ESRF, Grenoble, 
France). 
Before collecting a complete data set, three test images were collected each 60˚ or 90˚ 
apart. These three images were indexed and data collection strategy was optimized. 
High-resolution data were usually collected in two passes of different resolution. First 
a complete low-resolution data set was collected before high-resolution data were 
recorded.  
 
 
2.4.6   Data processing 
 
Indexing and data integration was performed using MOSFLM (Leslie, 1992) 
or XDS (Kabsch, 1993). Data were initially processed in P1 using XDS. The correct 
space  group  was  determined  using  POINTLESS  (Evans,  2006)  and  data  were 
subsequently  scaled  and  merged  using  SCALA  (CCP4,  1994).  Beside  the 
completeness of the data set, the signal-to-noise ratio (I/σI) as well as the Rmerge factor 
(Equation 2-2) were used to judge data quality. Materials and Methods 
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Equation 2-2: 
 
 
! 
Rmerge =
hkl "
i " ||Fhkl |# |Fhkl(i) ||
hkl "
i " |Fhkl(i)
 
 
|Fhkl (i)| is the value of structure factor amplitude of the i-th reflection with Miller 
indices hkl. |Fhkl| is the final value of the structure factor amplitude 
 
 
2.4.7   Phasing 
 
2.4.7.1  The phase problem 
 
In order to calculate the electron density of a protein three parameters are 
refined for each diffraction spot: its index (hkl), intensity (Ihkl) and its phase angles 
(αhkl) of the reflections. From a diffraction pattern only two of these parameters are 
measured.  
 
The complex structure factor from the contents of the unit cell is a function of 
the electron distribution with the unit cell volume V.  
 
Equation 2-3: 
 
 
! 
Fhkl =V •
x " y " z " #xyzexp 2$i(hx + hy + lz) [ ]dxdydz 
 
Fhkl is the Fourier integral of ρxyz. Since ρxyz is the inverse Fourier transform of Fhkl 
and the reciprocal space of a crystal is discrete, the integral can be replaced with a 
discrete triple summation. The electron density can then be calculated as follows: 
 
 Materials and Methods 
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Equation 2-4: 
 
 
! 
"xyz =
1
V
•
x #
y #
z # Fhkl exp[$2%i(hx + ky + lz)] 
 
Since Fhkl = |Fhkl| exp [iαhkl], Equation 2-4 can be written as: 
 
Equation 2-5: 
 
 
! 
"xyz =
1
V
•
x #
y #
z # |Fhkl |exp[$2%i(hx + ky + lz)+ (i&hkl)] 
 
The structure factor amplitude |Fhkl| can be calculated from the intensities I of 
the reflection spots:  Ihkl ∝ |Fhkl|
2. In contrast, the phase angle αhkl cannot be derived 
from the diffraction pattern directly. Several methods have been developed to solve 
this so-called phase problem in X-ray crystallography. 
 
 
2.4.7.2  Methods to solve the phase problem 
 
1. Multiple Anomalous Dispersion (MAD) or Single Anomalous Dispersion (SAD) 
 
The  diffraction  intensities  of  a  native  protein  structure  are  normally 
centrosymmetric. That means two reflections hkl and -h-k-l are related to one another 
by  inversion  through  the  origin  (O)  and  the  measured  intensities,  as  well  as  the 
calculated  structure  factors,  of  the  two  reflections  are  equal  (Figure  2-6).  This 
relationship is called Friedel’s law.  
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Figure 2-6 | Vector diagram for a Friedel pair 
For centrosymmetric structures, two reflections have equal structure factors with equal amplitudes |Fhkl| 
= |F-h-k-l| and opposite phases θhkl = -θhkl. (r = real axis, i = imaginary axis) 
 
The introduction of atoms that absorb X-rays of a particular wavelength into a 
native protein structure can break Friedel’s law. When the wavelength of X-rays is 
chosen to be close to an absorption edge of the atom that was introduced into the 
native protein structure, some of the photons are first absorbed by the electrons of the 
this  atom  before  they  are  re-emitted.  This  leads  to  a  phase  shift  of  the  scattered 
photons (θhkl ≠ -θhkl) and the amplitudes of the reflections hkl and -h-k-l are not equal 
anymore (|Fhkl| ≠ |F-h-k-l) (Figure 2-7). This inequality of symmetry-related reflections 
is  called  anomalous  dispersion  (Blow  and  Rossmann,  1961;  Hendrickson  and 
Lattman, 1970). The symmetry-related reflections (hkl and -h-k-l) are now called 
Bijvoet pair.  Materials and Methods 
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Figure 2-7 | Vector diagram for anomalous scattering conditions 
The atomic scattering factor for an anomalous scatterer (fanom) consists of two parts: a real part f’ and 
the imaginary part if” (A). Introducing an anomalous scatterer into a native protein structure causes the 
break down of Friedel’s law (B). FP and -FP are the structure factors for the Friedel’s pair, whereas FPH 
and -FPH are the structure factors for the Bijvoet pair. Fa’
 and Fa” are the real and imaginary parts of 
structure factors of the anomalous scatterer, respectively (Blow and Rossmann, 1961; Hendrickson and 
Lattman, 1970). 
 
Collection of MAD data at different wavelengths can provide very accurate 
experimental  phases.  The  variation  in  scattering  properties  of  heavy  atoms  as  a 
function of incident X-ray wavelength result both in differences between reflection 
intensities  at  different  wavelengths  (dispersive  differences)  as  well  as  differences 
between  the  intensities  of  the  Bijvoet  pairs  (anomalous  differences)  at  the  same 
wavelength (González, A., 2003). In order to optimize both anomalous differences 
and dispersive differences in a MAD experiment, data collection at three wavelengths 
is necessary. These three wavelengths are the peak wavelength (λp), the wavelength 
at the inflection point (λi) and the remote wavelength (λr) (Figure 2-8).  
Data  collection  at  the  peak  wavelength,  where  the  value  of  the  imaginary 
component of the anomalous scattering factor if” reaches a local maximum, optimizes 
the anomalous differences.  
The  dispersive  differences  are  proportional  to  the  difference  in  the  real 
component Δf’ (Δf’ = frem’ – fmin’). The dispersive differences are ideal when fmin’ 
reaches the minimum value at the inflection point and the value for frem’ is high at a 
wavelength far away from the edge (remote wavelength).  Materials and Methods 
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In  order  to  optimize  the  phasing  power  of  a  three-wavelength  MAD 
experiment, the anomalous scattering factor at the remote wavelength (frem’) should 
be  such  that  it  maximizes  the  quantity  if”  ×  Δf’  (González,  2003).  In  a  two-
wavelength MAD experiment, the best strategy is to optimize the dispersive (Δf’), 
rather  than  the  anomalous  (if”)  differences.  This  means  data  collection  at  the 
inflection  and  remote  wavelength  is  preferred  (González,  2003;  González  et  al., 
1999). For a SAD experiment it is best to optimize the anomalous differences and to 
collect data at the peak wavelength (Dauter et al., 2002). 
 
 
Figure 2-8 | Fluorescence scan of a Lu-containing CaiT crystal 
At peak wavelength (λp), f” reaches a local maximum, the anomalous differences of the Bijvoet pairs 
are maximal. At the inflection point (λi) the value for f’ is minimal. The dispersive differences Δf’ (Δf’ 
= frem’ – fmin’) become optimal when the value for frem’ at the remote wavelength (λr) is high. 
 
The heavy atom positions can be determined from the Harker vectors in the 
Harker sections of the difference Patterson map. After calculation of the structure 
factor amplitudes for FH, FPH and FP (FPH = FP + FH), the phase angles of the heavy 
atoms (αH) and of the protein (αP) can be determined and subsequently an initial 
electron density map of the protein structure can be calculated. 
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For  determination  of  initial  heavy  atom  positions  the  programs  SHELXD 
(Schneider  and  Sheldrick,  2002),  SHARP  (de  La  Fortelle  and  Bricogne,  1997; 
Vonrhein et al., 2007) and SOLVE (Terwilliger and Berendzen, 1999) were used in 
this work. 
 
 
2. Molecular Replacement (MR) 
 
The MR method (Rossmann and Blow, 1962) can be used if a crystal structure 
of a protein with a homologous amino acid sequence is known. The phases of the 
structure faktors of the known protein (search model) can be used to estimate the 
phases of the unknown protein. In the Fourier transform (Equation 2-4, Equation 2-5), 
the amplitudes are obtained from the native intensities of the unknown protein (|Fhkl 
(unknown protein)|) and the phases are taken from the search model (iαhkl (search 
model)).  During  refinement  the  initial  R  values  (R/Rfree)  are  usually  high,  which 
represent the differences between the phases of the search model and the phases of 
the unknown protein. During the refinement process, the phases should change from 
those of the search model to those of the unknown protein and the R values should 
decrease.  
For the MR method, the Patterson function of the search model is used to 
explore  the  Patterson  function  of  the  crystal  structure  to  be  determined.  The 
orientation  and  the  precise  position  of  the  unknown  protein  in  the  unit  cell  are 
determined  by  rotation  and  translation  (Figure  2-9).  In  the  rotational  search,  the 
search model is placed within a P1 unit cell whose dimensions guarantee that the 
volume  contains  only  intramolecular  vectors  (also  called  self  vectors).  The  self 
vectors only depend on the orientation of the molecule and can therefore be used to 
determine  the  spatial  orientation  of  the  known  and  unknown  protein  and  the 
orientation with respect to each other. Once the orientations of the molecules have 
been determined, the translation vector needed to superimpose the correctly oriented 
molecules is calculated (Drenth, 2007; Messerschmidt, 2007). Materials and Methods 
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Figure 2-9 | Schematic description of the MR method 
The Patterson function of two molecules separated by a spatial movement can be formulated as X2 = 
[C]X1 + d, where X1 is the position of molecule 1 and X2 is the positions of molecule 2, [C] is the 
rotation matrix and d is the translation vector (blue arrow). The orientations of the molecules are 
determined by their self vectors (red arrows around the origin O). The rotation matrix [C] of the 
molecules is characterized by three angles α, β, γ (Euler angles). By varying the rotation around these 
angles,  the  molecules  can  be  brought  into  any  desired  angular  orientation.  The  translation  vector 
defines  the  spatial  movement  that  superimposes  the  two  molecules  (Blow,  2005;  Messerschmidt, 
2007). 
 
In this work MR was performed to determine the structure of PmCaiT with a 
poly-alanine model of BetP (PDB accession code 2WIT). The EcCaiT structure was 
determined afterwards by using PmCaiT as search model for MR. In both cases the 
program PHASER (McCoy et al., 2007) was used. Model bias was minimized by 
using the prime-and-switch program (Terwilliger, 2004). The primary density was 
improved by density modification in RESOLVE (Terwilliger, 2000).   
 
 
2.4.8   Phase improvement, model building and refinement 
 
After an initial set of protein phases is obtained, the next step is to interpret 
the map by automatically placing ‘dummy’ atoms and refining their positions. These 
‘dummy’ atoms are used to define bond lengths and the number of neighbouring 
atoms  of  the  initial  model.  A  further  phase  improvement  is  achieved  by  density 
modification  with  solvent  flattening  or  solvent  flipping  combined  with  histogram 
matching. If more than one molecule is found in the asymmetric unit (Section 2.4.4) Materials and Methods 
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and these molecules are related by one or more noncrystallographic symmetry (NCS) 
operators,  NCS  averaging  can  be  used  to  improve  the  protein  phase  angles  by 
averaging the electron density about the different related subunits. 
 
Model building and model refinement is an repetitive alternating process of 
real  space  fitting  the  model  into  the  electron  density  and  global  reciprocal  space 
restrained  refinement  of  the  model’s  positional  parameters.  After  every  cycle  the 
refined phase angles can be used to calculate a new electron density map. The 2Fobs – 
Fcalc  Fourier  coefficient  amplitudes  map  displays  the  atomic  model  with  normal 
weights and indicates errors in the model by its contribution of the difference Fourier 
map  (Messerschmidt,  2007).  Iterative  cycles  of  model  building  and/or  model 
refinement improve the electron density map in such a way that amino acid side 
chains  can  be  correctly  assigned.  The  parameters  of  the  initial  model  (x,  y,  z 
coordinates,  overall  and/or  individual  atomic  displacement  parameter  (B-factor), 
scaling factor) are adjusted to minimize the difference between the calculated and 
observed structure factors. The quality of the crystallographic model can be estimated 
from the crystallographic R-factor (Equation 2-6; (Drenth, 2007)). 
 
Equation 2-6: 
 
 
! 
Rwork =
hkl " ||Fobs |#k |Fcalc ||
hkl " |Fobs |
 
 
During refinement geometric and stereochemical restrains (bond length, bond 
angles and dihedral angles) are applied to the structural model. The conformation of 
the main chain folding is verified by the Ramachandran plot (Ramachandran et al., 
1963) in which the dihedral angles φ and ψ  are plotted against each other for each 
residue. The angles are correct when they lie in the energetically favoured regions of 
secondary  structures  such  as  α-helices,  β-sheets  and  defined  turn  structures 
(Messerschmidt, 2007). 
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Both the EcCaiT and PmCaiT structures were refined with iterative cycles of 
manual rebuilding in COOT (Emsley and Cowtan, 2004) and O (Jones et al., 1991), 
and  simulated  annealing  followed  by  maximum  likelihood-based  energy 
minimization and isotropic B-factor refinement in PHENIX (Adams et al., 2002). The 
validation  of  both  final  models,  PmCaiT  and  EcCaiT,  was  performed  using  the 
program PROCHECK (Laskowski et al., 1993). 
 
 
2.4.9   Figures 
 
Diagrams of the CaiT structure were generated using the programs POVScript+ 
(Fenn et al., 2002) and Povray (http:/www.povray.org), Bobscript (Esnouf, 1999) as 
well  as  PyMol  (DeLano,  2002).  Surface  potentials  were  made  using  PyMol. 
Superpositions  were  carried  out  with  the  SSM  (Krissinel  and  Henrick,  2004) 
superposition routine of COOT (Emsley and Cowtan, 2004). 
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3   Results 
 
In this work, three different homologs of the carnitine transporter CaiT were 
investigated. Proteus mirabilis CaiT (PmCaiT) and Escherichia coli CaiT (EcCaiT) 
share a sequence identity of 87 %, whereas the sequence identity of PmCaiT and 
Salmonella  typhimurium  CaiT  (StCaiT)  is  84  %  (Figure  6-2).  The  twelve 
transmembrane  helices  (TM1  –  TM12)  of  the  CaiT  homologs  share  a  sequence 
identity of 95 %. Non-conserved residues are confined mostly to the loop regions 
connecting the transmembrane helices in the protomer, or to the N- and C-terminal 
ends (Figure 6-2).  
 
The three homologs of CaiT were chosen to enhance the probability of high-
resolution  3D  structure  determination.  This  was  succesfull  with  the  P.  mirabilis 
homolog. The 3D structure of CaiT was then used as a basis for functional analysis 
with the wildtype protein and mutations of functional key residues. The combination 
of  structural  and  functional  analysis  revealed  details  of  the  substrate  transport 
mechanism for CaiT. 
 
Unless  explicitly  mentioned  and  described,  the  CaiT  homologs  were  treated 
equally. Results that are representative for all three CaiT homologs are shown only 
once for one of the three homologs.  
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3.1   Expression and purification 
 
3.1.1   Expression of CaiT in E. coli 
 
3.1.1.1  Native CaiT protein 
 
The  caiT  gene  was  cloned  into  the  pET-15b  vector  using  the  restriction 
enzymes  NdeI  and  XhoI.  Restriction  enzyme  digests  followed  by  sequencing 
determined the success of cloning. Plasmids containing the correctly inserted caiT 
gene were transformed into E. coli BL21(DE3) pLysS cells for expression. Primilary 
expression  tests  in  100  ml  LB  media  showed  an  expression  level  (Figure  3-1) 
sufficient for crystallization and activity studies.  
 
 
Figure 3-1 | SDS-PAGE gel and Western blot of PmCaiT test expression 
The cells of a 100 ml culture were harvested by centrifugation. After diluting the cell pellet to an 
OD600 of 1, the cells were disrupted and an aliquot of 10 µl was loaded onto the SDS gel (A). Western 
blot analysis (B) using an α-His-tag antibody resulted in a single protein band (arrow), which runs 
between 43 kDa and 34 kDa. It was previously shown for EcCaiT (Vinothkumar, 2005) that CaiT 
migrates in the SDS gel at this size.  
 
To  optimize  the  expression  of  native  CaiT,  several  conditions  were  tested 
including growth media, expression strains, growth temperature, IPTG concentration Results 
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for induction and time of induction. The best protein expression was obtained with E. 
coli BL21(DE3) pLysS cell in 2×YT media. Cells were grown at 37 ˚C to an OD600 of 
0.6  to  0.9  before  protein  over-expression  was  induced  with  0.5  mM  ITPG.  After 
induction, the growth temperature was reduced to 30 ˚C and the cells were further 
cultured for 4 hours.  
 
 
3.1.1.2  SeMet-labelled CaiT protein  
 
To produce SeMet-labelled PmCaiT and EcCaiT, E. coli BL21(DE3) RIL-X 
cells were transformed with the pET-15b vector containing PmcaiT or EccaiT.  
 
The  SeMet-labeled  protein  production  in  flasks  was  problematic  since  the 
cells did not grow to a sufficient cell mass. Methionine-auxotrophic cells cultured in 
flasks with SelenoMet medium, selection marker and SeMet only grew to an OD600 of 
0.6 – 0.9. After induction, the cell mass either stagnated or decreased which led to a 
low protein yield even though the expression of SeMet-labeled CaiT was not the 
problem. The fed-batch fermentation strategy was more efficient for uncoupling the 
accumulation  of  cell  mass  from  the  induction  and  expression  of  SeMet-labeled 
protein (Studts and Fox, 1999). 
 
The  production  of  SeMet-CaiT  was  optimized  using  the  fed-batch 
fermentation  (Section  2.3.2.2).  The  best  results  were  obtained  when  the  E.  coli 
BL21(DE3) RIL-X cells were grown in SelenoMet Medium at 37 ˚C to an OD600 of 
1.3 to 1.7. Protein over-expression was induced with 0.5 mM IPTG and cells were 
further grown for 18 – 20 hours at a temperature of 30 ˚C. During the fermentation 
period the cell density of the 3 l culture increased to an OD600 of 2.4 – 2.6. 
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3.1.2   Purification of CaiT 
 
3.1.2.1  Native CaiT protein 
 
The purification of CaiT involved three steps: solubilization of the protein 
(Section  2.3.4.2),  immobilized  metal  affinity  chromatography  (IMAC,  Section 
2.3.4.3)  and  preparative  size  exclusion  chromatography  (SEC,  Section  2.3.4.4). 
Although the procedure of protein purification (Section 2.3.4) was identical for all 
constructs,  two  strategies  were  followed  depending  on  what  the  protein  was 
subsequently  used  for.  When  the  protein  was  used  for  crystallization,  it  was 
solubilized  and  purified  in  Cymal-5  and  HEPES  buffer  in  presence  of  NaCl.  In 
contrast, protein used for binding and transport measurements was solubilized and 
purified in DDM, sodium-free Tris buffer and without any added NaCl as it was one 
aim to test the sodium dependence of substrate binding and transport.  
 
The  best  crystallization  results  were  obtained  when  the  protein  was 
solubilized in 2 % (w/v) Cymal-5, 25 mM HEPES pH 7.5, 100 mM NaCl, 10 % (v/v) 
glycerol and 1 mM TCEP (Figure 3-2). After solubilization, 50 mM imidazole pH 8.0 
was added to the solubilized membrane fraction before it was applied to the Ni
2+ 
column. The imidazole helped to avoid unspecific protein binding to the column. The 
column  was  washed  with  two  different  buffers.  The  first  washing  buffer,  which 
contained 50 mM imidazole pH 8.0 and 10 % (w/v) glycerol, removed impurities 
from the sample (Figure 3-2). The second washing step removed the glycerol, which 
was used during solubilization and in the IMAC binding and the first washing buffer. 
The protein was eluted from the Ni
2+ column with 200 mM imidazole pH 8.0 (Figure 
3-2) and loaded directly onto a PD-10 column to remove the imidazole from the 
protein which tended to induce protein aggregation. The buffer used for eluting the 
protein from the PD-10 column contained 0.12 % (w/v) Cymal-5, 25 mM HEPES pH 
7.5, 100 mM NaCl and 1 mM TCEP. The most concentrated elution fractions (Figure 
3-2)  usually  contained  5  mg/ml  CaiT,  which  was  adequate  for  crystallization. 
Fractions with less protein were pooled and concentrated to 5 mg/ml. The two protein 
samples with a concentration of 5 mg/ml were not pooled but handled separately to Results 
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check whether or not the additional concentration of the protein had an effect on the 
crystallization behaviour. 
 
For activity measurements the protein was solubilized in 2 % (w/v) DDM, 50 
mM sodium-free Tris pH 7.5, 10 % (v/v) glycerol and 1 mM TCEP for 1 – 2 hours at 
4 ˚C. The purification was performed as described above but with buffers containing 
0.05 % DDM, 50 mM sodium-free Tris pH 7.5 and 1 mM TCEP was used. The 
imidazole and glycerol concentrations used for the Ni
2+ column were kept as before. 
For activity studies the protein had either to be reconstituted into liposomes or could 
be used directly in detergent solubilized form. In both cases the protein concentration 
did not need to be as high as for crystallization. To avoid protein aggregation due to 
the  low  ionic  strength  of  the  buffer,  the  protein  concentration  was  kept  at  
2 – 3 mg/ml. 
 
 
Figure 3-2 | SDS-PAGE gel of a PmCaiT purification 
E. coli BL21(DE3) pLysS cells were grown in 2×YT medium. Protein over-expression was induced 
with 0.5 mM IPTG. After expression cells were harvested, broken and membranes (1) were isolated. 
The solubilized membrane fraction (2) was loaded onto a Ni
2+-Sepharose column. The flow-through 
(3) was discarded and the column was washed twice (4, 5) before the protein was eluted (6, 7) with 
200 mM imidazole pH 8.0 in fractions of 500 – 1000 µl. To avoid protein aggregation caused by the 
high imidazole concentration, the protein was directly loaded onto a size exclusion column and eluted 
(8) in fractions of 200 – 500 µl. The purified protein (9) was either used for crystallization or activity 
studies. (M) PageRuler
TM Prestained Protein Ladder (Fermentas). Previous studies showed that CaiT 
froms trimers in detergent solution (Vinothkumar, 2005; Vinothkumar et al., 2006). In the Coomassie 
stained SDS-PAGE gel both the monomeric form (arrow, Mon) and the trimeric form (arrow, Trim) of 
CaiT is detectable.  Results 
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The purification of EcCaiT included an additional step in which the His6-tag 
was cleaved off by incubating the protein 1 – 2 hours at 4 ˚C with the immobilized 
serine protease thrombin. The removal of the His6-tag from EcCaiT is detectable by a 
shift of the protein band on the SDS-PAGE gel (Figure 3-3). 
 
 
Figure 3-3 | SDS-PAGE gel of purified EcCaiT and StCaiT 
The SDS-PAGE gels show the final steps in the purification of EcCaiT (A) and StCaiT (B). The 
protein was eluted from the Ni
2+-Sepharose column (1) and desalted by size exclusion chromatography 
(2).  The  purified  protein  (3)  was  used  for  crystallization  or  activity  measurements.  EcCaiT  was 
additionally incubated with thrombin after the protein was eluted from the Ni
2+ column. The cleavage 
of the His6-tag is detectable in the Coomassie stained SDS-PAGE gel by a shift of the protein band. 
(M) PageRuler
TM Prestained Protein Ladder (Fermentas). 
 
 
3.1.2.2  SeMet-labelled CaiT  
 
SeMet-labelled  protein  was  used  only  for  crystallization.  To  optimize  the 
crystallization  procedure,  several  parameters  were  tested  including  different 
detergents,  detergent  concentrations,  reducing  agents,  concentrations  of  reducing 
agents and different buffers. Although the SeMet-labelled protein was considered as a 
new  protein  and  crystallization  conditions  were  newly  screened,  the  best 
crystallization results were obtained using a purification protocol that was similar to 
that used for native protein. 
 Results 
87 
SeMet-labelled CaiT was solubilized in 1.5 % (w/v) Cymal-5, 25 mM HEPES 
pH 7.5, 100 mM NaCl, 10 % (v/v) glycerol and 2 mM TCEP. After solubilization, 50 
mM imidazole pH 8.0 was added to the solubilized membrane fraction before it was 
applied to a Ni
2+ column. As for the native protein the Ni
2+ column was washed with 
two buffers containing 50 mM imidazole pH 8.0, first with 10 % (w/v) glycerol and 
then without. The protein was eluted from the Ni
2+ column with 200 mM imidazole 
pH 8.0 and loaded directly onto a PD-10 column (Figure 3-4). The buffer used for 
eluting the protein from the PD-10 column contained 0.12 % (w/v) Cymal-5, 25 mM 
HEPES pH 7.5, 100 mM NaCl and 2 mM TCEP (Figure 3-4). Since the protein 
concentration was very low, all protein-containing elution fractions had to be pooled 
and concentrated. The protein was concentrated to 5 mg/ml (Figure 3-4), which was 
the ideal concentration for crystallization.   
 
 
Figure 3-4 | SDS-PAGE gel of purified SeMet-PmCaiT and SeMet-EcCaiT 
The SDS-PAGE gels show the final steps in the purification of SeMet-PmCaiT (A) and SeMet-EcCaiT 
(B). The solubilized membrane fraction containing SeMet-CaiT was loaded onto a Ni
2+ column. After 
washing, the protein was eluted (1) with 200 mM imidazole pH 8.0 and directly loaded onto a size 
exclusion column. The eluted protein (2) was concentrated to 5 mg/ml. The purified and concentrated 
protein (3) was used for crystallization. (M) PageRuler
TM Prestained Protein Ladder (Fermentas). 
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3.1.3   Sample quality of CaiT  
 
After  purification,  the  protein  sample  was  tested  for  stability  and 
monodispersity  by  BN-PAGE  (Section  2.3.7.1)  and  analytical  size  exclusion 
chromatography (SEC) (Section 2.3.4.4). A stable and monodisperse protein sample 
is essential for biochemical measurements such as binding and transport activity and 
for growing highly ordered, well diffracting crystals for structure determination. The 
two different methods that were used are appropriate for membrane proteins. The 
BN-PAGE uses Coomassie G250, which induces a charge shift on the protein and 
stays tightly bound to it, and ε-aminoaproic acid, which improves the solubility of 
membrane proteins during electrophoresis. The analytical SEC was pre-equilibrated 
in detergent to ensure that the protein remains in solution during the run. 
 
 
3.1.3.1  Blue-Native PAGE 
 
4 – 12 % gradient native gels were loaded with 3 – 7.5 µg of purified protein. 
The PAGE was started at 80 V to concentrate the samples within the stacking gel. 
Afterwards the PAGE was run 4 – 5 h at a constant voltage of 150 V. Native EcCaiT 
and  StCaiT  usually  separated  into  two  bands,  PmCaiT  into  three  bands  during 
electrophoresis (Figure 3-5 A). The first protein band migrated to a size between 140 
kDa and 232 kDa, the second protein band ran to a size between 232 kDa and 440 
kDa, while the third band of PmCaiT ran at about 440 kDa according to the native 
protein  marker  (HMW  Native  Marker;  GE  Healthcare).  The  first  protein  band 
indicates the CaiT trimers (169.8 kDa) plus additional bound detergent molecules. 
The second detectable band contains protein that has the appropriate size for CaiT 
hexamers (339.6 kDa) plus bound detergent molecules. This band probably represents 
CaiT  trimer-trimer–interactions  that  are  caused  by  the  high  protein  concentration 
within the gel. The third band of the PmCaiT sample in the BN gradient gel could be 
a CaiT nonamer. 
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On  the  BN-PAGE  of  SeMet-labelled  protein  (Figure  3-5  B,  C)  only  one 
protein band was clearly detectable. This band migrated to a protein size between 140 
kDa and 232 kDa, indicating CaiT trimers. Compared to the native CaiT the SeMet-
labelled protein shifts closer to the 140 kDa band. A reason for the different migration 
behaviour might be the polarizability of the selenium atoms in the protein.  
 
 
Figure 3-5 | BN-PAGE gradient gel of purified native and SeMet-labelled CaiT 
After purification each sample was checked for stability and monodispersity by BN-PAGE. The gel 
was loaded with 3 – 7.5 µg of purified protein. The BN-PAGE gradient gel (4 – 12 %) of native CaiT 
(A) shows two prominent bands for each EcCaiT (Ec), PmCaiT (Pm) or StCaiT (St) sample. The first 
band in the gradient gel indicates a protein size between 140 kDa and 232 kDa, while the second 
protein band runs between 232 kDa and 440 kDa according to the high molecular weight (HMW) 
Native Marker (M; GE Healthcare). In the PmCaiT sample a third band is detectable that migrates at 
about 440 kDa. The protein band between 140 kDa and 232 kDa is also prominent in the gels loaded 
with SeMet-derivatives of PmCaiT (B, SeMet-Pm) or EcCaiT (C, SeMet-Ec).   
The protein band that migrates between 232 kDa and 140 kDa has the appropriate size for CaiT trimers 
surrounded by a detergent micelle. The higher protein band between 232 kDa and 440 kDa is likely to 
be two interacting trimers, as the size is appropriate for a hexameric CaiT plus surrounding detergent 
molecules. The third band in the PmCaiT sample that runs at about 440 kDa might represent a CaiT 
nonamer. The interactions between two or more CaiT trimers is likely an effect of the high protein 
concentration in the gel.  Results 
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3.1.3.2  Analytical size exclusion chromatography (SEC) 
 
Analytical SEC was the second method to check the stability and dispersity of 
the protein sample. For analytical SEC, a Superose
TM 6 (3.2/30) column was used, 
which  had  a  bed  volume  of  2.4  ml  and  an  estimated  void  volume  of  0.72  ml 
(approximately 30 % of the total bed volume, GE Healthcare). After equilibration 
with the appropriate buffer (Table 2-13), the purified protein sample (50 – 100 µg) 
was loaded onto the column. The separation of the sample was performed with a 
constant flow rate of 50 µl/min and fractions of 100 µl were collected using the Ettan 
LC system.  
 
CaiT eluted as a single peak with a retention volume of 1.58 – 1.62 ml (Figure 
3-6).  Occasionally  protein  was  also  detected  in  the  void  volume,  which  was 
considered to be aggregated. Samples, which showed a peak in the void volume, were 
subjected to ultra-centrifugation (4 ˚C, 100,000 g, 20 min) to pellet the aggregates 
before the sample was reanalyzed. Samples that eluted in a single peak were used for 
activity measurements or for 3D crystallization.  
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Figure 3-6 | Analytical size exclusion chromatography of CaiT  
Analytical SEC was performed using a Superose
TM 6 3.2/10 column, which had a total bed volume of 
2.4 ml and an estimated void volume of 0.72 ml. Purified protein samples (0.5 – 1 µg/µl) were loaded 
onto the pre-equilibrated column. Separation was performed using a constant flow rate of 50 µl/min. 
Native protein (blue line) usually eluted in a single peak at an elution volume of 1.58 ml – 1.60 ml. 
SeMet-labelled protein (red line) eluted with the same retention volume as native protein but contained 
an  additional  small  shoulder  beside  the  main  peak.  The  shoulder  was  caused  by  the  higher 
concentration of the reducing agent TCEP used in the SeMet-CaiT buffer as the native EcCaiT (B) also 
showed this peak when it was purified in the same buffer. Analytical SEC elution profile of native 
PmCaiT wildtype (PmCaiT wt, blue line) and SeMet-labelled PmCaiT wildtype (SeMet-PmCaiT wt, 
red line) (A). Native EcCaiT wildtype (EcCaiT wt, blue line) and SeMet-labelled EcCaiT wildtype 
(SeMet-EcCaiT wt, red line) (B). Native StCaiT wildtype (StCaiT wt, blue line) (C). 
 
 
Both methods, BN-PAGE and analytical SEC, demonstrate that both native and 
SeMet-labelled CaiT protein is stable and monodisperse in detergent solution after 
purification. This makes CaiT suitable for activity and structural studies.  
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3.2   3D crystallization 
 
The expression of CaiT in BL21(DE3) pLysS cell was optimized in this work 
to produce sufficient amounts of protein for 3D crystallization. The highly expressed 
protein was folded and did not aggregate. After purification a protein yield of 2 – 3 
mg/(l  culture)  was  obtained.  The  high  expression  level,  the  stability  and  the 
monodispersity of the protein were a prerequisite for high-resolution 3D structural 
studies.   
 
 
3.2.1   3D crystallization feasibility prediction of CaiT 
 
Structural  studies  were  undertaken  on  all  three  CaiT  homologs  of  which 
EcCaiT was the first. The EcCaiT project was taken over from K. R. Vinothkumar, 
who  already  could  show  that  EcCaiT  forms  2D  crystals  in  the  lipid  membrane 
environment which tended to stack (Vinothkumar, 2005; Vinothkumar et al., 2006). 
Since EcCaiT formed 2D crystals, it was promising to analyze its ability to from 3D 
crystals. K. R. Vinothkumar also grew initial 3D crystals of EcCaiT (Vinothkumar, 
2005). 
 
The  XtalPred  server  (Section  2.4.3.1)  calculates  an  individual  protein 
production and crystallization feasibility score and places the result into one of five 
success rate categories: optimal, suboptimal, average, difficult and very difficult. The 
prediction  score  for  the  3D  crystallization  feasibility  of  EcCaiT  (Figure  3-7)  was 
placed into the “very difficult” bin. The server found 388 homologs which all had the 
same  score.  However,  the  XtalPred  predictions  for  EcCaiT,  PmCaiT  (Figure  3-7, 
Figure 3-8) and StCaiT (Figure 3-9) showed differences that might influence their 
crystallization behaviour. The biggest difference between the CaiT homologs was in 
the hydrophobicity index or gravy index (blue arrow) and in the isoelectric point (pI, 
black arrow). The gravy index for both EcCaiT and StCaiT was 0.72 (Figure 3-7, 
Figure 3-9) that for PmCaiT it was 0.68 (Figure 3-8). It has been reported that a gravy Results 
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index  of  0.1  is  the  optimum  for  protein  crystallization  (Slabinski  et  al.,  2007a), 
indicating that PmCaiT, with the lowest gravy index, should crystallize better than the 
other two homologs. The pI for EcCaiT is 8.54, for PmCaiT 8.41 and for StCaiT 8.67. 
The crystallization success rate was shown to be higher for neutral or slightly acidic 
proteins (Slabinski et al., 2007a). All CaiT homologs are basic proteins but the pI of 
PmCaiT (Figure 3-8) seemed slightly more favourable compared to the pI of EcCaiT 
and StCaiT (Figure 3-7, Figure 3-9).  Results 
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Figure 3-7 | Prediction of EcCaiT crystallization probability  
The crystallization probability was estimated from the EcCaiT protein sequence using the XtalPred 
server (http://ffas.burnham.org/XtalPred).   Results 
95 
 
Figure 3-8 | Prediction of PmCaiT crystallization probability  
The crystallization probability was estimated from the PmCaiT protein sequence using the XtalPred 
server (http://ffas.burnham.org/XtalPred).   Results 
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Figure 3-9 | Prediction of StCaiT crystallization probability  
The crystallization probability was estimated from the StCaiT protein sequence using the XtalPred 
server (http://ffas.burnham.org/XtalPred).   Results 
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3.2.2   3D crystallization trials 
 
Initial  crystallization  trials  were  performed  using  commercially  available 
screens  from  Hampton,  Qiagen  and  Jena  Bioscience.  All  three  CaiT  homologs 
yielded initial crystals in several different conditions. The best initial crystals were 
obtained with the condition 0.1 M sodium acetate trihydrate pH 4.5 and 25 % (w/v) 
PEG3350 from the Index
TM screen (Hampton). However, the crystal quality was quite 
different. Initial EcCaiT crystals (Figure 3-10 A) diffracted to a resolution of ~ 9 Å. 
The diffraction limit for initial PmCaiT crystals (Figure 3-10 B) was ~ 5 Å, while 
initial  StCaiT  crystals  (Figure  3-10  C)  did  not  show  any  diffraction  spots 
(MacroMax
TM-007HF diffractometer, R-AXIS IV
++ detector, in-house). The sharp-
edged  crystals  of  EcCaiT  and  PmCaiT  showed  a  rhomboidal  to  rectangular 
morphology. StCaiT crystals had no well-defined edges but formed long triangles.   
Protein samples that were concentrated to 5 mg/ml resulted in many but small 
crystals  whereas  samples  that  eluted  from  the  PD-10  column  with  a  protein 
concentration of 5 mg/ml resulted in few but large crystals. 
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Figure 3-10 | Initial crystallization trials of EcCaiT, PmCaiT and StCaiT 
Initial crystals (green arrow) of EcCaiT (A), PmCaiT (B) and StCaiT (C) were grown in 100 mM 
NaAc  pH  4.5  and  25  %  (w/v)  PEG3350.  The  initial  EcCaiT  protein  buffer  contained  DDM  at  a 
concentration of 0.05 % (w/v), which was too high and resulted in the formation of spherulits (red 
arrow). 
 
The crystals observed were tested to establish that they were indeed of CaiT. 
It was checked if the dissolved protein crystal had the same migration behaviour in 
the SDS-PAGE gel and in the BN-PAGE gel as freshly purified CaiT in solution. 
This was necessary to exclude the possibility that a protein impurity was crystallized 
and to find out if the CaiT protein remained stable during crystallization.   
 
Three initial crystals (50 – 100 nm in the longest direction) were fished in a 
nylon loop and transferred into a drop of stabilizing solution, which had the same 
composition as the protein-free crystallization solution with an additional 5 % (w/v) 
PEG400. The crystals were washed twice before they were transferred into 5 µl of 
protein buffer that contained detergent but no PEG400. After the crystals had been 
dissolved completely in the protein buffer, 2 µl of the solution were analyzed by Results 
99 
SDS-PAGE  (Figure  3-11  A),  while  the  other  3  µl  were  analyzed  by  BN-PAGE 
(Figure 3-11 B).   
 
 
Figure  3-11  |  SDS-PAGE  gel  and  BN-PAGE  gradient  gel  of  dissolved  CaiT 
crystals 
Three of the initial crystals were fished, washed and transferred into a 5 µl drop of protein buffer. It 
was checked with the light microscope that the crystals had dissolved completely. 2 µl of the solution 
were used for SDS-PAGE, the other 3 µl were used for BN-PAGE. The dissolved protein crystal 
solution  (1)  migrated  in  the  SDS-PAGE  gel  (A)  as  two  bands.  Both  protein  bands  have  the 
characteristic  size  for  the  monomeric  (Mon)  and  the  trimeric  (Trim)  form  of  CaiT.  (M)  is  the 
PageRuler
TM Prestained Protein Ladder (Fermentas). The dissolved protein crystal solution (1) and 
freshly purified CaiT (2) migrated to the same position in the BN-PAGE gradient gel (B), but only one 
band was visible in the sample from the CaiT crystals that migrated to a size between 140 kDa and 232 
kDa, which is the appropriate size for CaiT trimers. The size of the CaiT bands was determined in 
relation to the HMW Native Marker (M; GE Healthcare).  
 
SDS-PAGE and BN-PAGE confirmed that the initial crystals contained CaiT 
protein and demonstrated that CaiT was stable in the crystallization solution. 
 
The  initial  crystallization  conditions  were  optimized  by  testing  different 
buffers and varying the pH of the solution, trying different but related salt types in 
various concentrations, altering the concentration and chain length of the precipitant 
PEG, screening different detergents and detergent concentrations and carrying out the 
crystallization in the presence or absence of different concentrations of additives.  
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To improve the crystal quality, different crystallization methods, like sitting 
and  hanging  drop  vapour  diffusion  or  the  under-oil  batch  method  were  tested. 
Additional parameters like the protein concentration (2.5 – 7.5 mg/ml), the protein-to-
reservoir ratio (1:0.5, 1:1, 1:2, 0.5:1 and 2:1), the reservoir volume (250 – 1000 µl) 
and the crystallization temperature (25 ˚C, 22 ˚C, 18 ˚C, 16 ˚C, 12 ˚C, 10 ˚C, 8 ˚C,  
6 ˚C and 4 ˚C) were varied. Crystal seeding (Section 2.4.3.3) was attempted. Various 
parameters were modified in order to optimize seeding. The parameters were: varying 
the  seed  stock  concentration,  protein  concentration,  precipitant  concentration  and 
incubation period.  
 
The best crystals grew at 4 ˚C by the hanging drop vapour diffusion method. 
The crystallization drops were set up with a protein concentration of 5 mg/ml and a 
protein-to-reservoir ratio of 2:1. The total reservoir volume was 500 µl and crystals 
grew in the mother liquor containing: 50 mM MgAc2 or CaAc2 pH 4.5 – 5.5, 0 – 200 
mM NaCl, 19 – 30 % (w/v) PEG400, which were set up in two 96-well fine screens. 
The conditions that yielded the best crystals for the respective CaiT homolog were set 
up in 24 well plates.  
 
PmCaiT crystallized at 4 ˚C in both MgAc2 (Figure 3-12 A) and in CaAc2 
(Figure 3-12 B) at pH 5.0 and grew to a final size of 200 – 500 µm in the longest 
dimension within 3 – 10 days. The change of crystal morphology caused by the two 
ions Mg
2+ and Ca
2+ is striking. PmCaiT crystals that were grown in MgAc2 showed a 
diffraction  limit  of  2.8  Å,  whereas  PmCaiT  crystals  that  were  grown  in  CaAc2 
diffracted  to  2.3  Å.  Both  crystal  forms  diffracted  isotropically.  Although  native 
PmCaiT produced well-ordered crystals, it was not possible to generate crystals that 
diffracted similarly well of SeMet-labelled PmCaiT. 
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Figure 3-12 | Optimized PmCaiT crystals 
Optimized  crystallization  conditions  for  PmCaiT  yielded  crystals  with  different  morphologies  and 
diffraction properties. Triangular pyramidal crystals (A) were grown at 4 ˚C in 50 mM MgAc2 pH 5.0, 
50 – 100 mM NaCl and 21 – 23 % (w/v) PEG400. These crystals diffracted to a resolution of 2.8 Å. 
Rectangular PmCaiT crystals (B) were grown at 4 ˚C in 50 mM CaAc2 pH 5.0, 50 – 100 mM NaCl and 
21 – 23 % (w/v) PEG400 and diffracted to a resolution of 2.3 Å. One of these highly-diffracting 
crystals (black arrow) was used to solve the CaiT structure.  
 
EcCaiT crystallized at 4 ˚C in MgAc2 (Figure 3-13 A) and in CaAc2 (Figure 
3-13 B) at pH 4.8 – 5.2. The crystals grew within 1 – 2 weeks to their final size of 
300 – 600 µm in the longest dimension. In contrast to PmCaiT, the two ions, Mg
2+ 
and Ca
2+, did not have the same striking effect on the crystal morphology for EcCaiT 
as for PmCaiT. In both conditions the crystals had a triangular shape. However, the 
Ca
2+ containing conditions produced more regular shaped crystals. EcCaiT crystals 
that were grown with Mg
2+ diffracted isotropically to a resolution of 3.8 – 4 Å, while 
crystals grown with Ca
2+ diffracted isotropically to a resolution of 3.5 – 3.8 Å. 
The rhomboidal EcCaiT crystals that grew in the initial screen condition were 
reproducible but reached a maximum crystal size of only ~100 µm in the longest 
direction and showed a diffraction limit of ~5.5 Å.   Results 
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SeMet-labelled EcCaiT crystals (Figure 3-13 C) grew only with Ca
2+ at pH 
4.8 – 5.0. The crystals grew within 1 – 2 weeks to a size of 100 – 200 µm, had sharp 
edges and a triangular shape. These crystals diffracted to 5.5 – 6.0 Å.   
 
 
Figure 3-13 | Optimized EcCaiT crystals 
Optimized  crystallization  conditions  for  EcCaiT  produced  crystals  with  different  triangular 
morphologies. EcCaiT crystals with less well-defined triangular shape (A) were grown at 4 ˚C in 50 
mM MgAc2 pH 4.8 – 5.2, 100 mM NaCl and 23 – 25 % (w/v) PEG400. These crystals diffracted to a 
resolution of 3.8 – 4.0 Å. Long triangular pyramidal EcCaiT crystals (B) were grown at 4 ˚C in 50 mM 
CaAc2 pH 4.8 – 5.0, 100 mM NaCl and 23 – 25 % (w/v) PEG400 and diffracted to a resolution of 3.5 – 
3.8 Å. Triangular SeMet-EcCaiT crystals (C) were grown at 4 ˚C in 50 mM CaAc2 pH 4.8 – 5.0, 100 
mM NaCl and 25 – 28 % (w/v) PEG400. These crystals showed a diffraction limit of 5.5 – 6.0 Å. Results 
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StCaiT crystallized at 4 ˚C only in MgAc2 at pH 4.5 – 4.8 (Figure 3-14). 
StCaiT crystals grew within 1 – 2 weeks to their final size of 300 – 400 µm in the 
longest dimension. These crystals had a long triangular morphology and although 
they  appeared  robust,  they  fractured  when  touched  with  the  Micro-Brush
TM 
(Hampton). The best crystals diffracted anisotropically to a resolution of 3.9 – 4.5 Å.  
 
 
Figure 3-14 | Optimized StCaiT crystals 
Optimized crystallization conditions for StCaiT produced crystals with a long triangular morphology. 
StCaiT crystals were grown at 4 ˚C in 50 mM MgAc2 pH 4.5 – 4.8, 100 mM NaCl and 21 – 23 % 
(w/v) PEG400 (A) or in 50 mM MgAc2 pH 4.5 – 4.8, 200 mM NaCl and 25 – 28 % (w/v) PEG400 (B). 
The best StCaiT crystals diffracted anisotropically to a resolution of 3.9 – 4.5 Å. 
 
 
For data collection, crystals were flash-frozen directly in liquid nitrogen. Before 
freezing,  the  crystals  were  cryo-protected  by  a  stepwise  increase  of  the  PEG400 
concentration  in  the  crystallization  drop.  The  cryo-solution  added  to  the 
crystallization drop was identical to the crystallization condition protein-free solution 
from which the crystals grew but contained 40 % (w/v) PEG400.  Results 
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3.3   Structure determination 
 
3.3.1   Data collection and data processing 
 
Diffraction data were collected on the beamlines X10SA at the Swiss Light 
Source  (SLS,  Villigen,  Switzerland)  and  ID  14-eh3  at  the  European  Synchrotron 
Radiation Facility (ESRF, Grenoble, France).  
Diffraction quality was judged from 3 images that were collected 45 ˚ or 60 ˚ 
apart. Crystals showing isotropic diffraction to an appropriate resolution were chosen 
for data collection. The starting angle and optimal collection strategy was determined 
using  the  program  STRATEGY,  which  is  part  of  the  image  processing  program 
MOSFLM (Leslie, 1992).    
 
The diffraction pattern of a PmCaiT crystal is shown in Figure 3-15. The 
crystal diffracted isotropically to a resolution of 2.3 Å and the data set was used for 
the structure determination of PmCaiT.  Results 
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Figure 3-15 | Diffraction pattern of a PmCaiT crystal 
The data set was collected on the beamline X10SA at the SLS (Villigen, Switzerland) from the smaller 
PmCaiT crystal shown in Figure 3-12 B. Data were collected to a resolution of 2.3 Å. The upper right 
quarter of the diffraction pattern was adjusted to a higher contrast level to show the high-resolution 
diffraction spots. 
 
The diffraction pattern of an EcCaiT crystal is shown in Figure 3-16. This 
crystal diffracted isotropically to a resolution of 3.5 Å and this data set was used for 
the EcCaiT structure determination.  
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Figure 3-16 | Diffraction pattern of a EcCaiT crystal 
The  data  set  was  collected  on  the  beamline  X10SA  at  the  SLS  (Villigen,  Switzerland)  from  the 
triangular pyramidal EcCaiT crystal shown in Figure 3-13 B. Data were collected to a resolution of 3.5 
Å. The upper right quarter of the diffraction pattern was adjusted to a higher contrast level to show the 
high-resolution diffraction spots. 
 
The diffraction pattern shown in Figure 3-17 was collected from an StCaiT 
crystal. The crystal diffracted anisotropically to 3.9 Å in one direction and to 4.5 Å in 
the other.  
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Figure 3-17 | Diffraction pattern of an StCaiT crystal 
A data set was collected on the beamline ID 14-eh3 at the ESRF (Grenoble, France) from the long 
triangular StCaiT crystal shown in Figure 3-14 A. The diffraction pattern shows anisotropic diffraction 
to 3.9 Å in one direction but only to 4.5 Å in the other direction. Data were collected to a resolution of 
3.9 Å.  
 
Data were initially processed in P1 using XDS (Kabsch, 1993). The correct 
space group was determined using POINTLESS (Evans, 2006) and the data were 
scaled with SCALA (CCP4, 1994). PmCaiT crystallized in the space group H3 with 
three  molecules  in  the  asymmetric  unit  that  assembled  around  a  three-fold 
crystallographic symmetry axis (Figure 6-3). EcCaiT crystallized in P32 (Figure 6-4) 
and  StCaiT  crystallized  in  the  space  group  P65  (Figure  6-5),  each  with  three 
molecules in the asymmetric unit. The data collection statistics are shown in Table 
3-1. Results 
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Table 3-1 | Data collection statistics 
  PmCaiT  EcCaiT  StCaiT 
Beamline  X10SA SLS  X10SA SLS  ID-eh3 ESRF 
Wavelength (Å)  0.92  0.98  0.98 
Resolution (Å) 
a)  19.7 – 2.3 (2.4 – 2.3)  24.7 – 3.4 (3.5 – 3.4)  24.8 – 4.2 (4.2 – 4.0) 
Space group  H3  P32  P65 
Cell dimensions  a = b = 129.2 Å,  
c = 160.3 Å 
α = β = 90 ˚, γ = 120 ˚ 
a = b = 124.2 Å,  
c = 154.6 Å 
α = β = 90 ˚, γ = 120 ˚ 
a = b = 128.8 Å,  
c = 309.5 Å 
α = β = 90 ˚, γ = 120 ˚ 
Number of measured 
reflections 
246 131  136 423  382 769 
Number of unique 
reflections 
43 243  71 232  45 504 
Completeness (%)  97.7 (91.2)  97.7 (87.1)  98.9 (95.5) 
Redundancy  5.7  1.9  8.4 
I/σI  9.0 (1.4)  12.8 (1.3)  16.8 (1.2) 
Rmerge (%) 
b)  8.4 (55.7)  6.0 (90.0)  9.0 (93.4) 
a) Numbers in parentheses represent statistics for data in the highest resolution shell 
b) 
! 
Rmerge =
hkl "
i " ||Fhkl |# |Fhkl(i) ||
hkl "
i " |Fhkl(i) |
 
 
 
3.3.2   Phase determination, model building and refinement 
 
The  structures  of  all  three  CaiT  homologs  were  solved  by  molecular 
replacement (MR) using a poly-alanine model of BetP (PDB code 2WIT) as a search 
model.  The  success  of  this  approach  was  surprising,  as  CaiT  and  BetP  share  a 
sequence identity of only 27% (Figure 1-8, Figure 6-2), and proved to be in different 
conformations. To minimize model bias during phasing, prime-and-switch phasing 
was performed using the program RESOLVE (Terwilliger, 2001, 2004). The CaiT 
model was build and refined with iterative rounds of manual building and rebuilding 
in  COOT  (Emsley  and  Cowtan,  2004)  and  O  (Jones  et  al.,  1991),  followed  by 
refinement in PHENIX (Adams et al., 2010; Adams et al., 2004; Adams et al., 2002), 
which  modified  the  model  to  satisfy  different  constrains  and  restrains  (e.g.  bond Results 
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angles  or  bond  length).  During  refinement  bulk-solvent  correction,  simulated 
annealing followed by maximum likelihood-based energy minimization and isotropic 
B-factor refinement was applied.  
 
Figure 3-18 shows the initial electron density map of PmCaiT after MR (A), 
the electron density map after applying prime-and-switch phasing to minimize model 
bias (B) and the refined electron density map of PmCaiT (C).   
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Figure 3-18 | Electron density maps and crystal packing of PmCaiT  
The atomic structure of PmCaiT was determined by MR with a poly-Ala model of BetP (2WIT) as a 
search model. The initial electron density map after MR (A) was improved by applying prime-and-
switch phasing that resulted in a model bias minimized electron density map (B). After iterative cycles 
of model building and rebuilding the refined electron density map (C) is represented by the final 
PmCaiT model.  
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The refined atomic model of PmCaiT represents its final electron density map. 
The quality of the model is judged from the Ramachandran plot (Ramachandran et 
al.,  1963)  and  statistical  data  that  compare  the  atomic  model  to  the  measured 
diffraction data (Figure 3-19). The final PmCaiT model was refined to an Rwork of 
21.2  %  and  an  Rfree  of  23.8  %.  The  coordinates  of  the  PmCaiT  model  and  the 
structure factors have been deposited in the PDB with the accession code 2WSW. 
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Figure 3-19 | Ramachandran plot and statistics of the refined PmCaiT model 
The Ramachandran plot shows the phi/psi torsion angles for all residues in the structure. Regions 
marked with a, b, l and p represent the sterically favoured ϕ/ψ–combinations for α–helices, β–sheets, 
left-handed α–helices and epsilons, respectively. The red coloured regions correspond to the most Results 
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favoured  ϕ/ψ  –  combinations  (core  region).  Allowed  and  generously  allowed  ϕ/ψ–combination 
regions are coloured in yellow and beige, respectively. Glycine residues are shown as triangles (·) 
while all other residues are represented as squares (µ). The Ramachandran plot of the PmCaiT model 
was generated using the program PROCHECK (Laskowski et al., 1993).  
 
The structure of EcCaiT was solved by MR with PmCaiT as a poly-alanine 
search model. The initial model and electron density was refined as described for the 
refinement of PmCaiT (see above), in addition, strict non-crystallographic symmetry 
(NCS) restrains were enforced during refinement.   
The initial electron density map of EcCaiT after MR (A), the electron density 
map with minimal model bias after applying prime-and-switch phasing (B) and the 
refined electron density map of EcCaiT (C) is shown in Figure 3-20.   
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Figure 3-20 | Electron density maps and crystal packing of EcCaiT  
The atomic structure of EcCaiT was determined by MR with PmCaiT as poly-Ala as a search model. 
The initial electron density map after MR (A) was improved by applying prime-and-switch phasing 
that resulted in an electron density map with minimal model bias (B). After iterative cycles of model 
building and rebuilding the refined electron density map (C) was used to build the final EcCaiT model.  
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The  quality  of  the  refined  atomic  model  of  EcCaiT  was  judged  from  the 
Ramachandran plot (Ramachandran et al., 1963) and statistical data that compare the 
atomic model to the measured diffraction data (Figure 3-21). The final EcCaiT model 
was refined to an Rwork of 23.7 % and an Rfree of 27.1 %. The coordinates of the 
EcCaiT model and the structure factors have been deposited in the PDB with the 
accession code 2WSX. 
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Figure 3-21 | Ramachandran plot and statistics of the refined EcCaiT model 
The Ramachandran plot shows the phi/psi torsion angles for all residues in the structure. Regions 
marked with a, b, l and p represent the sterically favoured ϕ/ψ–combinations for α–helices, β–sheets, 
left-handed α–helices and epsilons, respectively. The red coloured regions correspond to the most Results 
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favoured ϕ/ψ–combinations (core region). Allowed and generously allowed ϕ/ψ–combination regions 
are coloured in yellow and beige, respectively. Glycine residues are shown as triangles (·) while all 
other residues are represented as squares (µ). Lys165 is marked with a red square (µ), which indicated 
that this residue has an unusual torsion angle and therefore was ranged into the generously allowed 
region. Lys165 is located in loop2 and forms in the EcCaiT crystal hydrogen bonds to the backbone 
carbonyl oxygens of His227 and Tyr388 of the symmetry related molecule, which causes the unusual 
conformation  of  Lys165.  The  Ramachandran  plot  of  the  EcCaiT  model  was  generated  using  the 
program PROCHECK (Laskowski et al., 1993). 
 
The structure of StCaiT was solved by MR with PmCaiT as a poly-alanine 
search model. The initial model and electron density was refined as described for the 
refinement of EcCaiT (see above), except anisotropy correction and TLS refinement 
instead  of  simulated  annealing  was  used  in  the  later  stages  of  refinement.  At  a 
resolution of 4 Å only a few chains are resolved. Therefore, simulated annealing at 
this resolution would introduce serious model bias. Anisotropy correction and TLS 
refinement  was  necessary  to  correct  for  the  diffraction  anisotropy.  As  for  the 
refinement  of  the  EcCaiT  model,  strict  NCS  restrains  were  enforced  during  the 
refinement of the StCaiT model  
 
Figure 3-22 shows the initial electron density map of StCaiT after MR (A), 
the electron density map with minimal model bias after applying prime-and-switch 
phasing (B) and the refined electron density map of StCaiT (C).   
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Figure 3-22 | Electron density maps and crystal packing of StCaiT  
The atomic structure of StCaiT was determined by MR using PmCaiT as a poly-Ala search model. The 
initial electron density map after MR (A) was improved by applying prime-and-switch phasing that 
resulted  in  a  electron  density  map  with  minimal  model  bias  (B).  After  iterative  cycles  of  model 
building and rebuilding the refined electron density map (C) is represented by the final StCaiT model. 
The packing of the protein within the unit cell P65 with the cell parameter a = b = 128.8 Å, c = 309.5 
Å, α = β = 90˚, γ = 120˚ is shown in (D).  
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The  quality  of  the  refined  atomic  model  of  StCaiT  was  judged  from  the 
Ramachandran plot (Ramachandran et al., 1963) and statistical data that compare the 
atomic model to the measured diffraction data (Figure 3-23). The final StCaiT model 
was refined to an Rwork of 24.2 % and an Rfree of 27.5 %. The low R-values of the 
StCaiT model are due to the well-refined starting model used in MR and the use of 
strict three-fold NCS restraints during refinement. The coordinates and the structure 
factors of StCaiT have not yet been deposited in the PDB.  
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Figure 3-23 | Ramachandran plot and statistics of the refined StCaiT model 
The Ramachandran plot shows the phi/psi torsion angles for all residues in the structure. Regions 
marked with a, b, l and p represent the sterically favoured ϕ/ψ–combinations for α–helices, β–sheets, 
left-handed α–helices and epsilons, respectively. The red coloured regions correspond to the most Results 
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favoured ϕ/ψ–combinations (core region). Allowed and generously allowed ϕ/ψ–combination regions 
are coloured in yellow and beige, respectively. Glycine residues are shown as triangles (·) while all 
other residues are represented as squares (µ). Residues marked with a red square (µ) have unusual 
torsion angle and were placed into the generously allowed regions. At a resolution of 4 Å the correct 
assignment  of  residues  is  difficult.  All  these  residues  are  located  in  loop  regions  and  have  less 
conformational restrains to other residues.   Results 
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3.4   The CaiT structure 
 
3.4.1   CaiT topology 
 
The CaiT protomer comprises twelve transmembrane helices (TM1 to TM12), 
with the N- and C-termini on the cytoplasmic side as has been predicted previously 
(Section 1.2; (Jung et al., 2002)). The CaiT topology (Figure 3-24 A) resembles that 
of BetP (Section 1.4.1; (Ressl et al., 2009) and all its structural relatives (Abramson 
and Wright, 2009; Faham et al., 2008; Fang et al., 2009; Gao et al., 2009; Ressl et al., 
2009;  Shaffer  et  al.,  2009;  Weyand  et  al.,  2008;  Yamashita  et  al.,  2005).  CaiT 
containes an inverted repeat motif in which TM3 to TM7 and TM8 to TM12 form the 
two halves of the inverted repeat. The 5 TM helices of repeat 2 can be superimposed 
on the 5 TM helices of repeat 1 by ~180 ˚ rotation around the internal pseudo-twofold 
axis of the protomer, and by ~20 ˚ in the perpendicular direction (Figure 3-24 B). The 
inner core of the protomer is formed by TM3 and TM4 of the first repeat and TM8 
and  TM9  of  the  second  repeat,  which  are  arranged  as  an  antiparallel  four-helix 
bundle. TM5 to TM7 and TM10 to TM12 form a supporting framework around this 
inner  core  that  is  separated  from  the  remainder  of  the  inverted  repeat  by  a 
cytoplasmic loop-helix-loop motif (L4, IH4) and a periplasmic helix-loop-helix motif 
(EH9a, L9, EH9b). The long, curved, amphipathic α-helix 7 (H7) runs along the 
membrane surface on the periplasmic side of the monomer. TM1, together with the 
curved TM2, form a clamp-like scaffold for the repeat helices at the back of the 
protomer, near the threefold axis of the trimer. 
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Figure 3-24 | CaiT topology of the two 5-TM inverted repeats motif 
In the CaiT topology (A), the helices of repeat 1 (TM3 to TM7) in the inverted repeat motif are shown 
in dark colours, whereas the helices of repeat 2 (TM8 to TM12) are shown in lighter colours. Protein 
segments that do not belong to the inverted repeat motif are coloured in grey. Bound substrate is 
represented by yellow diamonds and is labelled with γ-B1 and γ-B2.  
The 5 TM helices of the two inverted repeats (B) are superimposable by rotating repeat 2 (right) 
relative to repeat 1 (centre) by ~180 ˚ around the internal pseudo-twofold axis of the protomer (black 
line), and by ~20 ˚ in the perpendicular direction. Results 
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3.4.2   The CaiT trimer 
 
As  expected  from  the  high  sequence  identity  between  the  three  CaiT 
homologs  (Figure  6-2),  the  overall  structures  of  PmCaiT,  EcCaiT  and  StCaiT 
resemble  one  another  closely.  CaiT  crystallized  as  a  symmetric  trimer  with  three 
identical protomers (Figure 3-25).  
 
 
Figure 3-25 | CaiT homotrimer viewed from the periplasmic side and parallel to 
the membrane 
Cytoplasmic (left) view and view parallel to the membrane (right) of CaiT. CaiT forms a symmetric 
trimer with three identical protomers. The tight interaction of the CaiT monomers (A – C) in the 
homotrimer are mediated by the long, curved, amphipathic helix 7 (H7), the loop connecting H7 to 
TM8 (L7b) and TM4. The colour code is equivalent to that of the CaiT topology.  
 
Interactions between the protomers are mediated by the curved helix H7, by 
the  loop  connecting  H7  to  TM8  (L7b)  and  by  TM4  (Figure  3-25,  Figure  3-26). 
Arg299 in H7 forms a salt bridge to Asp288 in H7 of the neighbouring protomer. A 
second  polar  contact  is  the  hydrogen  bond  that  connects  the  hydroxyl  group  of 
Thr304 in L7b to the backbone carbonyl oxygen of Asn284 in H7 of the adjacent 
protomer. A water molecule forms hydrogen bonds between the carboxyl group of 
Asp305 and the backbone amide nitrogen of Gly308 in L7b and to the carboxyl group 
of Glu132 in TM4 of the next protomer (Figure 3-26). In the cavity between the three 
protomers detergent molecules – one per protomer – were bound (Figure 3-26). In the Results 
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native lipid environment this cavity would be filled with lipid molecules, which might 
additionally stabilize the CaiT homotrimer.  
 
 
Figure  3-26  |  CaiT  protomer–protomer  interaction  and  protomer–detergent 
interaction  
Polar interactions between the CaiT protomers stabilize the homotrimer. Arg299 in H7 forms a salt 
bridge to Asp288 in H7 of the neighbouring protomer. A tight hydrogen bond is found between the 
carboxyl group of Asp305 in L7b and the backbone carbonyl oxygen of Asn284 in H7 of the next 
protomer.  A  third  interaction  is  mediated  by  a  water  molecule  (red  sphere),  which  connects  the 
carboxyl group of Glu132 in TM4 to the carboxyl group of Asp305 and the backbone carbonyl oxygen 
of Gly308 in L7b. The hydroxyl group of the maltoside in Cymal-5, which was found in the cavity 
between  the  protomers,  forms  a  hydrogen  bond  to  the  carbonyl  oxygen  of  Arg73  in  TM2.  An 
additional van der Waals contact between the cyclohexyl of Cymal-5 and Phe67 in TM2 holds the 
detergent in position.   Results 
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3.4.3   Cytoplasmic  substrate  pathway,  central  transport  site  and 
periplasmic substrate-binding site 
  
In the protomer, the four-helix bundle (Figure 3-24), together with TM5, TM6 
and TM11, line a ~25 Å deep funnel from the cytoplasmic membrane surface to the 
transport  site  in  the  centre  of  the  protomer.  The  funnel  is  wide  open  on  the 
cytoplasmic  side,  with  a  diameter  of  ~15  Å,  and  narrows  to  ~7  Å  at  the  central 
transport site (Figure 3-27). Its entire length is unobstructed by sidechains, providing 
unhindered access to the central transport site. All three CaiT structures therefore 
clearly show the open, inward-facing conformation of the antiporter.   
 
 
Figure 3-27 | Unobstructed cytoplasmic substrate pathway of CaiT 
Cytoplasmic  view  down  the  substrate  pathway  to  the  central  transport  site  of  EcCaiT,  which  is 
occupied  by  γ-butyrobetaine  (arrow,  yellow  sticks).  The  four-helix  bundle  (TM3,  TM4,  TM8  and 
TM9) together with TM5, TM6 and TM11 form a funnel that is wide open on the cytoplasmic side, 
with a diameter of ~15 Å, and narrows to ~7 Å at the central transport site. The entire length of the 
substrate pathway is unobstructed by sidechains.  Results 
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In the EcCaiT structure two prominent non-protein densities were found that 
both fitted the shape and the size of γ-butyrobetaine. One of the substrate molecules is 
located in the central transport site of the protomer. The second substrate molecule is 
bound on the extracellular surface of the protomer, at a distance of ~16 Å from the 
central  transport  site  (Figure  3-28).  As  there  was  no  substrate  added  during 
purification or in the crystallization trials, the molecules must have been carried over 
from the host cell used to express the protein.   
 
 
Figure  3-28  |  Slice  through  the  EcCaiT  protomer,  viewed  parallel  to  the 
membrane   
Two  γ-butyrobetaine  molecules  are  bound  to  the  EcCaiT  protomer  (arrows).  One  of  the  substrate 
molecules is bound in the central transport site that is freely accessible from cytoplasmic side and the 
second is bound in a shallow cavity on the extracellular surface of the protomer.  Results 
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3.4.3.1  The central transport site of CaiT 
 
The central transport site in CaiT is a tryptophan box (Figure 3-29, Figure 
3-30), as in BetP (Ressl et al., 2009). One half of the tryptophan box is defined by 
Trp142 and Trp147 from the partly unwound TM4. The other half consists of Trp323 
and Trp324, which are found in the continuous but highly tilted TM8. In EcCaiT, the 
indole  ring  of  Trp323  in  TM8  is  well  placed  for  cation-π  interaction  with  the 
positively charged ammonium group of γ-butyrobetaine (Figure 3-29).   
 
An additional attractive interaction in the central transport site is formed by 
the  carboxyl  group  of  γ-butyrobetaine  and  the  sulfur  of  Met331.  Although  the 
methionine side chain is usually thought of as hydrophobic, it can in fact participate 
in polar interactions because the large, uncharged sulfur atom is more easily polarized 
than smaller atoms and can therefore interact with the negatively charged carboxyl 
group of γ-butyrobetaine.  
 
 
Figure 3-29 | Stereo view of the central transport site of EcCaiT with bound 
substrate 
The central transport site is a tryptophan box that is defined by Trp142, Trp147 (TM4), Trp323 and 
Trp324 (TM8). The indole ring of Trp323 (light blue circle) is well placed for a cation-π interaction to 
the γ-butyrobetaine (γ-BB). The sulfur of Met331 coordinates the carboxyl group (dashed line) of the 
bound substrate by polar interaction and replaces Na1 in the Na
+-dependent transporters, accounting 
for  Na
+  independent  transport  in  CaiT.  The  2Fo  –  Fc  electron  density  map  (blue)  around  the  γ-
butyrobetaine is contoured at 1.0 σ.  Results 
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The  transport  site  of  PmCaiT  does  not  contain  a  bound  substrate.  The 
sidechain of Trp323 is rotated by 43˚ each in χ1 and χ2 relative to EcCaiT to a 
position that leaves no room for a substrate to bind (Figure 3-30 A). Instead the Trp 
box of PmCaiT contains a small solvent molecule, most likely a glycerol from the 
solubilizaiton buffer, which seems to form a hydrogen bond to the indole nitrogen of 
Trp323 (Figure 3-30 B). The orientation of Trp323 is the most prominent difference 
between the EcCaiT and PmCaiT structures.   
 
 
Figure 3-30 | Stereo views of the central transport site of PmCaiT   
In the transport site of PmCaiT, the indole side chain of Trp323 (A; light blue circle) is rotated by 43˚ 
small molecule, most likely glycerol (B), carried over from the purification, which forms a hydrogen 
bond (dashed line) to the indole nitrogen of Trp323. The 2Fo – Fc electron density map (blue) around 
the glycerol molecule is contoured at 1.0 σ. The orientation of the helices in (A) is the same as these of 
EcCaiT in Figure 3-29. To show the interaction between the glycerol molecule and the indole nitrogen 
of Trp323, the helices in (B) are rotated by -17˚ around the y-axis.  Results 
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The resolution of the StCaiT structure was too low to correctly assign the 
orientations of the residues unambiguously. The side chains of the residues in the 
central transport site resemble those of PmCaiT, which is most likely due to model 
bias. In addition, at the resolution of 4 Å, no extra non-protein density indicating 
bound substrate was discernible.  
 
 
3.4.3.2  The second substrate binding site of CaiT 
 
The second substrate molecule in the extracellular cavity of EcCaiT is bound 
by cation-π interaction with Tyr114 in TM3 and Trp316 in TM8 and an additional 
hydrogen  bond  that  is  formed  by  the  carboxyl  group  of  γ-butyrobetaine  to  the 
backbone nitrogen of Gly315 (Figure 3-31). 
 
 
Figure 3-31 | Stereo view of the external substrate-binding site of EcCaiT 
In the extracellular substrate-binding site of EcCaiT, the γ-butyrobetaine (γ-BB) is bound by cation-π 
interaction with Tyr114 (TM3) and Trp316 (TM8). A hydrogen bond is formed by the γ-butyrobetaine 
carboxyl and the backbone amide nitrogen of Gly315. The 2Fo – Fc electron density map (blue) around 
the γ-butyrobetaine is contoured at 1.0 σ. 
 
 
In PmCaiT, the place of γ-butyrobetaine in the external substrate-binding site 
was taken by two ordered water molecules, which link Lys470 and Gln473 (TM12) to 
the  main-chain  carbonyl  of  Ala315  (TM8;  Figure  3-31).  A  third  resolved  water Results 
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molecule  connects  the  indole  nitrogen  of  Trp316  to  the  main-chain  carbonyl  of 
Tyr114 in TM3, thus establishing a hydrogen bond between the two halves of the 
central four-helix bundle. The same water molecule forms a hydrogen bond to the 
Arg(-2) sidechain of a symmetry-related protomer (Figure 3-32, Figure 3-33). Arg(-2) 
is  part  of  a  short  linker  peptide  between  the  N-terminus  and  a  His6-affinity  tag 
introduced  for  purification.  This  tag  had  been  removed  in  EcCaiT  prior  to 
crystallization. The crystal contact blocks access to the second binding site, which 
might explain why the site is empty in PmCaiT. 
 
 
Figure 3-32 | Stereo view of the external substrate-binding site of PmCaiT 
In the substrate-free external binding site of PmCaiT, two water molecules (blue spheres) mediate the 
interaction between TM8 to TM12. Lys470 (TM12) is connected to the backbone amide group of 
Ala315 (TM8) and to Gln473 (TM12) via two water molecules in series. Gln473 (TM12) stabilizes the 
interaction  between  TM8  and  TM12  with  an  additional  hydrogen  bond.  A  third  water  molecule 
mediates a connection between TM3 and TM8 by forming hydrogen bonds to the carbonyl oxygen of 
Tyr114  (TM3)  and  to  the  indole  nitrogen  of  Trp316  (TM8).  The  same  water  molecule  forms  a 
hydrogen bond to Arg(-2) (grey) in the linker peptide between the N-terminus and the His6-affinity tag 
of a symmetry-related protomer. This crystal contact blocks substrate access to the external binding 
site. 
 
 
3.4.3.3  The extracellular substrate pathway to the central binding site 
 
Access to the central transport site from the extracellular site is blocked by 
bulky hydrophobic residues (Figure 3-33). On this side, Trp316 (TM8) that forms Results 
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part  of  the  external  substrate-binding  site,  and  Trp107  (TM3)  protrude  into  the 
substrate pathway together with Tyr320 (TM8), which is held in a position directly 
above the central transport site by a hydrogen bond to the carboxyl group of Glu111 
(Figure 3-33). Additional hydrophobic contacts between TM3 and TM5 of the first 
repeat, and TM8 and TM12 of the second repeat help to seal the pathway towards the 
outside. 
 
 
Figure 3-33 | Stereo view of the residues and hydrogen bond network blocking 
the substrate pathway on the periplasmic side   
In  the  inward-facing  open  conformation,  the  extracellular  substrate  pathway  is  blocked  by  bulky 
hydrophobic residues that are held in position by forming an extensive hydrogen bond network around 
Glu111 (arrow). The extracellular block lines helices of the two repeats (TM3, TM4 of repeat 1 and 
TM8 of repeat 2). These helices must move apart when the extracellular pathway opens. The external 
substrate-binding  site  near  the  exit  of  the  closed  substrate  pathway  and  the  central  transport  site 
(yellow ovals) are separated by a distance of 16 Å.  
 
 
3.4.3.4  Replacement of Na
+ ions in the Na
+-independent CaiT 
 
Unlike  its  relative  BetP,  CaiT  is  Na
+-independent.  A  comparison  of  the 
structures reveals the reason for this striking difference. Although bound Na
+ ions 
were not resolved in the 3.35 Å BetP structure, their positions were modelled by 
homology to LeuT. By this model, a critical Na
+ (Na1) is coordinated by the carboxyl Results 
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group of the glycine betaine substrate and the backbone carbonyl oxygens of Ala148 
and Met150 in TM3 (Ressl et al., 2009). Although this interaction would be equally 
possible in CaiT, neither the EcCaiT nor the PmCaiT structure shows an apparent Na
+ 
density  in  this  region.  Instead,  inspection  of  the  residues  surrounding  the  central 
transport site indicates an attractive non-bonding interaction between the carboxyl 
group of γ-butyrobetaine and the sulfur of Met331 (Figure 3-29).  
 
Met331 is conserved in prokaryotic CaiT and mammalian OCTN2, but not in 
BetP or BetT, which both require Na
+ (Figure 6-2). In BetP, the position of Met331 is 
taken by Val381 (Figure 1-8, Figure 6-2). Remarkably, the interaction with the Met 
sulfur in CaiT thus replaces the Na
+ ion coordination of the substrate in BetP. 
 
A second well-resolved Na
+ ion (Na2) in LeuT is positioned between helices 
1 and 8 (Yamashita et al., 2005). This Na2 site was modelled between TM3 and 
TM10 in BetP (Figure 1-13; (Ressl et al., 2009)). Na2 stabilizes the unwound stretch 
of helix 1, which in LeuT participates in substrate coordination. In CaiT, the position 
corresponding  to  Na2  is  occupied  by  Arg262  in  TM7  (Figure  3-34),  which  is 
accessible to solvent in the cytoplasmic funnel. The positive charge of Arg262 links 
TM3  to  TM10,  and  stabilizes  the  unwound  region  of  TM3,  which  contributes  to 
substrate binding in the external binding site through Tyr114 (Figure 3-31). Results 
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Figure 3-34 | Stereo view of the hydrogen bond network around Arg262 
Arg262 (TM7) is located between TM3 and TM10 and stabilizes the unwound region of TM3 by 
hydrogen bonds. Thus the positive charge of Arg262 takes over the role of Na2 inLeuT and related 
Na
+-dependent transporters.  Results 
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3.5  Lipid analysis and reconstitution of CaiT 
 
3.5.1  Lipid analysis  
 
Detergent  solubilization  and  purification  of  membrane  proteins  destroys  the 
lipid environment that surrounds the protein in the cell. Despite this harsh treatment, 
some lipids remain attached to the purified protein. These bound lipids often play an 
important role in the stabilization or functionality of the protein. Knowing the lipids 
that remain attached to the protein after solubilization and purification helps to define 
the  conditions  for  reconstituting  the  active  protein  into  liposomes  which  is  often 
essential  for  functional  studies.  In  addition,  it  is  interesting  to  see  if  there  is  a 
difference in the composition of bound lipid composition between the heterologously 
expressed proteins PmCaiT and StCaiT and the homologoulsy expressed EcCaiT. 
 
The  lipid  composition  of  the  purified  protein  was  evaluated  by  thin-layer 
chromatography (TLC). Silica gel TLC plates were loaded with E. coli lipid standards 
(EPL, PE and PG), a detergent (Cymal-5) standard and the purified protein sample.  
 
In all three cases the lipid PE was observed in the protein sample (Figure 3-35) 
indicating that PE remained attached to CaiT after solubilization and purification. 
There is no obvious difference in the lipid composition between the homologously 
and heterologously expressed CaiT proteins. 
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Figure 3-35 | Silica gel TLC plate of E. coli lipids, Cymal-5, PmCaiT, EcCaiT 
and StCaiT 
The samples were loaded on a TLC plate and the lipids were separated using a chloroform : methanol : 
water (69 % : 27 % : 4 % v/v) mixture. The dried plate was first stained with iodine vapour to visualize 
electron rich molecule moieties like carbon-carbon double bonds of unsaturated fatty acids or the 
maltoside  of  detergent  molecules  like  Cymal-5  or  DDM.  Afterwards  the  plate  was  stained  with 
molybdenum spray reagent to detect phospholipids. The commercially available E. coli lipids E. coli 
polar lipids (EPL), Phosphatidylethanolamine (PE) and Phosphatidylglycerol (PG) were used as lipid 
standards  and  Cymal-5  (C-5)  as  detergent  standard.  50  –  100  µg  of  the  purified  protein  samples 
(PmCaiT, EcCaiT and StCaiT) were loaded onto the TLC plate.  
 
 
3.5.2  Reconstitution of CaiT into liposomes 
 
Activity  studies  were  performed  using  CaiT  reconstituted  into  E.  coli  polar 
lipids (EPL). The reconstitution was first tested with EcCaiT and a lipid-to-protein 
ratio  (LPR)  of  20:1.  The  resulting  proteoliposomes  as  assessed  by  freeze  facture 
(Figure 3-36) showed evenly distributed proteins in liposomes that measured between 
400  –  600  nm  in  diameter.  These  proteoliposomes  were  suitable  for  binding  and 
transport studies.  
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Figure  3-36  |  Freeze-fracture  image  of  EcCaiT  wt  reconstituted  into  EPL 
liposomes  
Reconstitution was achieved with EPL liposomes and purified EcCaiT wt at an LPR of 20:1. The 
proteoliposomes were extruded first through a 200 nm membrane filter followed by extrusion through 
a 400 nm membrane filter. 
 
Initial binding and transport measurements on proteoliposomes with an LPR 
of 20:1 showed promising results but the signal was to weak for detailed analysis, an 
LPR of 10:1 was required. All binding and transport measurements with reconstituted 
EcCaiT wt, PmCaiT wt and PmCaiT mutants (Figure 3-37), and StCaiT wt (Figure 
3-38) were performed with proteoliposomes of an LPR of 10:1.   
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Figure  3-37  |  Freeze-fracture  images  of  PmCaiT  wt  and  PmCaiT  mutants 
reconstituted into EPL liposomes  
Proteoliposomes used for binding and transport studies were checked by freeze-fracture (performed by 
F. Joos, MPI of Biophysics). Reconstitution of PmCaiT wt was first tested with an LPR of 20:1 (A). 
PmCaiT wt proteoliposomes at  an LPR of 10:1 (B) were more suitable for binding and transport 
studies. In (C) – (F) the mutants PmCaiT W316A, PmCaiT M331V, PmCaiT E111A and PmCaiT 
R262E were reconstituted with an LPR of 10:1. Results 
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Figure  3-38  |  Freeze-fracture  image  of  StCaiT  wt  reconstituted  into  EPL–
liposomes  
StCaiT wt was reconstituted into EPL–liposomes at an LPR of 10:1. Results 
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3.6   Substrate transport and binding studies 
 
3.6.1   Substrate transport studies 
 
3.6.1.1  Wildtype CaiT  
 
To  study  substrate  transport  by  the  three  homologs  PmCaiT,  EcCaiT  and 
StCaiT,  the  protein  had  to  be  reconstituted  into  liposomes.  The  proteoliposomes 
(Figure  3-36,  Figure  3-37,  Figure  3-38)  were  preloaded  with  a  saturating 
concentration  (10  mM)  of  non-radioactive  potential  substrates  such  as  glycine, 
glycine  betaine,  L-carnitine  and  γ-butyrobetaine.  The  impermeability  of  the 
proteoliposomes was controlled with unloaded proteoliposomes. Substrate exchange 
was measured by recording the uptake of 
14C-labelled L-carnitine. Plotting the initial 
rates  of  L-carnitine  uptake  against  the  external  concentration  of 
14C-labelled  L-
carnitine resulted in a saturation curve for proteoliposomes that were preloaded either 
with  non-radioactive  L-carnitine  or  γ-butyrobetaine  (Figure  3-39).  CaiT  clearly 
discriminates  between  its  natural  substrates,  L-carnitine  and  γ-butyrobetaine,  and 
other potential substrates like glycine or glycine betaine. The data were fitted to the 
Michaelis-Menten equation as previously described (Jung et al., 2002) and values for 
the binding constant (KM) and the maximum substrate uptake (vmax) were calculated 
using the program Origin 7.5. The kinetic analysis of CaiT protoliposomes preloaded 
with L-carnitine gave a KM for L-carnitine of 40 – 90 µM and a vmax of 3000 – 5200 
nmol L-carnitine/(min•mg protein) (Table 3-2) for all three homologs. Analysis of 
CaiT proteoliposomes preloaded with γ-butyrobetaine gave a KM for L-carnitine of 45 
– 100 µM and a vmax of 4600 – 5800 nmol L-carnitine/(min•mg protein) (Table 3-2) 
for the three homologs.  
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Figure  3-39  |  L-carnitine  uptake  into  proteoliposomes  with  reconstituted 
PmCaiT, EcCaiT or StCaiT  
CaiT was reconstituted into liposomes at an LPR of 10 and buffered in sodium-free Tris buffer. The 
resulting proteoliposomes were preloaded with non-radioactive potential substrates such as glycine 
( ),  glycine  betaine  (§),  L-carnitine  (©)  and  γ-butyrobetaine  (Ú).  The  impermeability  of  the 
proteoliposomes was tested with unloaded proteoliposomes as a control (¥). Substrate uptake was 
performed in sodium-free buffer and all measurments were repeated 3 – 5 times.   Results 
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The  sodium  dependence  of  PmCaiT  and  EcCaiT  uptake  was  tested  with 
protein  reconstituted  into  liposomes  buffered  in  Tris  with  100  mM  NaCl.  The 
proteoliposomes  were  preloaded  with  γ-butyrobetaine  and 
14C-labelled  L-carnitine 
uptake was recorded (Figure 3-40). Data analysis indicated a KM of 100 – 120 µM 
and a vmax of 4800 – 5000 nmol L-carnitine/(min•mg protein) (Table 3-2) for PmCaiT 
and  EcCaiT  with  NaCl  present.  Comparison  of  the  parameters  with  the  kinetic 
parameters calculated from measurements under sodium-free conditions show that the 
KM increases slightly in the presence of NaCl. The maximum substrate uptake (vmax) 
does not change when NaCl is added.    
 
 
Figure  3-40  |  L-carnitine  uptake  into  proteoliposomes  with  reconstituted 
PmCaiT or EcCaiT in the presence of Na
+  
CaiT was reconstituted into liposomes at an LPR of 10 and buffered in Tris with 100 mM NaCl. The 
proteoliposomes  were  preloaded  with  γ-butyrobetaine  and 
14C-labelled  L-carnitine  uptake  was 
measured for PmCaiT (¥) and EcCaiT (£) in the presence of 100 mM NaCl.  
 
 
Table 3-2 gives an overview of the substrate transport parameters for wildtype 
PmCaiT, EcCaiT and StCaiT. Results 
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Table 3-2 | Kinetic analysis of PmCaiT wt, EcCaiT wt and StCaiT wt 
  PmCaiT wt  EcCaiT wt  StCaiT wt 
proteoliposomes preloaded 
with L-carnitine  
     
KM (µM)   43 ± 2  89 ± 10  79 ± 6 
vmax (nmol L-carnitine/ 
(min•mg protein)) 
3081 ± 98  4932 ± 186  5158 ± 132 
kcat (L-carnitine/min)  173 ± 6  280 ± 11  292 ± 7 
proteoliposomes preloaded 
with γ-butyrobetaine  
     
KM (µM)  46 ± 6 
119.7 ± 20 
a) 
82 ± 12 
100 ± 14
 a) 
103 ± 9 
vmax (nmol L-carnitine/ 
(min•mg protein)) 
4672 ± 205 
4824 ± 301
 a) 
4921 ± 243 
4975 ± 243
 a) 
5735 ± 368 
kcat (L-carnitine/min)  263 ± 12 
272 ± 17
 a) 
279 ± 14 
282 ± 14
 a) 
325 ± 21 
a) Measurements were performed in buffers containing 100 mM NaCl 
 
 
3.6.1.2  PmCaiT mutants 
 
Based  on  the  CaiT  structure,  different  mutants  were  designed  and  their 
influence  on  substrate  uptake  was  tested.  The  following  mutants  were  of  special 
interest:  Met331  which  mimics  the  Na1  in  the  central  transport  site,  Trp316  that 
contributes to the coordination of the external substrate, Glu111 which is the central 
residue in the external substrate pathway that holds the bulky residues in position to 
close the pathway in the inward-facing open conformation, and Arg262 that mimics 
the Na2 and stabilizes the unwound region of TM3.   
 
The mutation of Met331 to valine shows a drastical reduced transport activity 
compared  to  wildtype  PmCaiT  (Figure  3-41).  The  kinetic  analysis  of  PmCaiT 
Met331Val  proteoliposomes  preloaded  with  γ-butyrobetaine  gave  a  KM  for  L-
carnitine of 120 µM and a vmax of 480 nmol L-carnitine/(min•mg protein) (Table 3-3). 
The binding affinity of the mutant is reduced by a factor of 2 while the substrate Results 
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uptake is reduced by a factor of 10 compared to PmCaiT wt (Figure 3-41, Table 3-2, 
Table 3-3). Met331 in CaiT mimicks Na1 of LeuT (Figure 1-12) and BetP (Figure 
1-13)  and  therefore  has  a  crucial  role  during  substrate  transport  while  substrate 
binding is less affected by the mutation as it is mainly enabled by the tryptophans of 
the tryptophan box.   
 
The mutation of Trp316 to alanine reduces the transport activity by a factor of 
3 compared to PmCaiT wt (Figure 3-41). The KM of Trp316Ala for L-carnitine was 
calculated as 160 µM and vmax as 1800 nmol L-carnitine/(min•mg protein) (Table 
3-3).  The  L-carnitine  uptake  of  PmCaiT  Trp316Ala  was  measured  with 
proteoliposomes that were preloaded with γ-butyrobetaine.    
 
The mutation of Glu111 to alanine renders the protein inactive (Figure 3-41). 
Replacing Glu111 by Ala not only effects the proteins transport activity but also de-
stabilizes the trimer (Figure 3-42), highlighting the crucial role of this residue for 
CaiT assembly and function. 
 
 
Figure 3-41 | Substrate transport activity of PmCaiT mutants 
The PmCaiT mutants were reconstituted into liposomes with an LPR of 10 and buffered in sodium-free 
Tris buffer. The proteoliposomes were preloaded with γ-butyrobetaine and 
14C-labelled L-carnitine 
uptake was measured for PmCaiT wt (¥), PmCaiT Met331Val (©), PmCaiT Trp316Ala ( ) and 
PmCaiT Glu111Ala (§). Results 
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Figure 3-42 | BN-PAGE gradient gel of PmCaiT E111A and PmCaiT wt  
Wildtype PmCaiT (wt) forms stable trimers that run at about 232 kDa in the BN-PAGE gradient gel. 
Replacing Glu111 by alanine (E111A) destabilizes the trimer and results in the appearance of dimers 
and monomers. 
 
The  mutant  in  which  Arg262  is  changed  to  glutamate  shows  a  striking 
substrate  transport  behaviour.  The  mutant  renders  the  protein  inactive  when  no 
sodium is present but transport activity is partially rescued by Na
+ (Figure 3-43). The 
kinetic  analysis  of  PmCaiT  Arg262Glu  proteoliposomes  preloaded  with  γ-
butyrobetaine  gave  a  KM  for  L-carnitine  of  20  µM  and  a  vmax  of  1300  nmol  L-
carnitine/(min•mg protein) (Table 3-3) in the presence of 100 mM NaCl. Compared 
to PmCaiT wt the binding constant of PmCaiT Arg262Glu is reduced by a factor of 
2.5 while the maximum substrate uptake is reduced by a factor of 3.6.   Results 
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Figure 3-43 | Na
+-dependent substrate transport of PmCaiT Arg262Glu 
L-carnitine uptake by PmCaiT wt (¥) and PmCaiT Arg262Glu with (§) and without ( ) 100 mM 
NaCl. Na
+ can partially rescue the transport activity of Arg262Glu mutant.  
 
 
Table  3-3  summarizes  the  transport  activity  parameters  of  the  PmCaiT 
mutants Glu111Ala, Arg262Glu, Trp316Ala and Met331Val.  
 
Table 3-3 | Substrate transport activity constants of PmCaiT mutants 
  PmCaiT 
E111A 
PmCaiT 
R262E 
without NaCl 
PmCaiT 
R262E 
with NaCl 
PmCaiT 
W316A 
PmCaiT 
M331V 
proteoliposomes preloaded 
with γ-butyrobetaine 
         
KM (µM)  inactive  inactive
  21 ± 2
 a)  159.2 ± 
11 
123 ± 12 
vmax (nmol L-carnitine/ 
(min•mg protein)) 
inactive  inactive
  1272 ± 32
 
a) 
1816 ± 
353 
478 ± 53 
kcat (L-carnitine/min)  inactive  inactive
  72 ± 2
 a)  69 ± 4  26 ± 3 
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3.6.2   Binding studies 
 
Substrate binding to CaiT is readily monitored by tryptophan fluorescence, 
which senses the chemical environment of tryptophan sidechains. Comparisons of the 
PmCaiT and EcCaiT structures show that the main difference between the two is the 
orientation and the chemical environment of Trp323. These changes are induced upon 
substrate binding that can be monitored by tryptophan fluorescence measurements.  
 
 
3.6.2.1  Binding studies of CaiT in detergent solution 
 
3.6.2.1.1   Wildtype CaiT  
 
To  determine  the  substrate  binding  parameters  of  PmCaiT,  EcCaiT  and 
StCaiT,  the  intrinsic  fluorescence  changes  of  the  homologs  were  first  tested  with 
different  potential  substrates  such  as  glycine,  glycine  betaine,  L-carnitine,  γ-
butyrobetaine and choline (Figure 3-44). The intrinsic fluorescence of the protein 
without substrate was recorded for reference.  
 
The potential substrates glycine and choline had no effect on the intrinsic 
fluorescence of CaiT. The addition of glycine betaine at saturation concentration (25 
mM) influences the intrinsic fluorescence of CaiT. This is reflected by an increase in 
the fluorescence intensity in all three homologs. The increase in fluorescence was 
more prominent for EcCaiT and StCaiT (~25 %) than for PmCaiT (~15 %) (Figure 
3-44).  
 
The addition of the CaiT substrates L-carnitine or γ-butyrobetaine shows a 
clear effect on tryptophan fluorescence. The substrates induce changes in both the 
fluorescence intensity and the emission maximum (red shift; Figure 3-44) reflecting 
substrate binding. At saturating concentrations of L-carnitine or γ-butyrobetaine the Results 
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fluorescence intensity increases by 30 – 40 % and the emission maximum shifts from 
338 nm to 342 nm (Figure 3-44). 
 
 
Figure 3-44 | Influence of potential substrates on the intrinsic fluorescence of 
PmCaiT wt, EcCaiT wt and StCaiT wt 
Fluorescence spectra of PmCaiT wt (top left), EcCaiT wt (top right) and StCaiT wt (lower left) show 
the effect of different potential substrates on tryptophan fluorescence. The protein was excited at 295 
nm (slit width 2.5 nm) and fluorescence emission was recorded from 305 nm to 370 nm (slit width 5.0 
nm). All binding measurements were repeated 3 – 5 times.  
 
 
To  calculate  binding  parameters  for  all  three  CaiT  homologs  the 
concentration-dependent fluorescence change was tested for γ-butyrobetaine (Figure 
3-45) and L-carnitine (Figure 3-46) in the concentration range from 0.5 mM to 100 
mM.  The  fluorescence  spectra  show  that  the  protein  is  saturated  at  a  substrate 
concentration of ~25 mM. At a substrate concentration of 0.5 mM, the fluorescence 
intensity increase is not obvious but the red shift is detectable. For all subsequent 
binding assays the fluorescence change was recorded in the substrate concentration Results 
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range of 0.25 mM to 40 mM. The intrinsic fluorescence of protein without substrate 
was recorded for reference.  
 
 
Figure  3-45  |  γ-butyrobetaine  induced  fluorescence  change  of  PmCaiT  wt, 
EcCaiT wt and StCaiT wt 
Fluorescence spectra of PmCaiT wt (top left), EcCaiT wt (top right) and StCaiT wt (lower left) show 
the concentration-dependent effect of the natural substrate γ-butyrobetaine on the CaiT tryptophan 
fluorescence.  
 Results 
150 
 
Figure 3-46 | L-carnitine induced fluorescence change of PmCaiT wt, EcCaiT wt 
and StCaiT wt 
Fluorescence spectra of PmCaiT wt (top left), EcCaiT wt (top right) and StCaiT wt (lower left) show 
the  concentration-dependent  effect  of  the  natural  substrate  L-carnitine  on  the  CaiT  tryptophan 
fluorescence.  
 
 
Plotting the fluorescence change (ΔF/F) at a wavelength of 342 nm against the 
concentration of titrated substrate resulted in a saturation curve (Figure 3-47). The 
data were fitted to the Michaelis-Menten equation as previously described (Jung et 
al.,  2002)  and  values  for  the  dissociation  constant  (KD),  the  maximum  substrate 
binding concentration (Bmax) and the Hill coefficient (h) were calculated using the 
program Origin 7.5. The substrate binding analysis of CaiT solubilized in Cymal-5 
gave a KD for γ-butyrobetaine of 2.9 – 3.9 mM, a Bmax of 40 – 43 mM and a Hill 
coefficient  of  1.0  –  1.2  for  the  three  CaiT  homologs  (Table  3-4).  The  respective 
analysis for PmCaiT wt, EcCaiT wt or StCaiT wt with L-carnitine gave a KD of 1.8 – 
1.9 mM, a Bmax of 39 – 43 mM and a Hill coefficient of 1.0 – 1.2 (Table 3-4). 
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Figure 3-47 | Binding of γ-butyrobetaine or L-carnitine to PmCaiT wt, EcCaiT 
wt or StCaiT wt, monitored by tryptophan fluorescence 
Binding of γ-butyrobetaine (top diagram) or L-carnitine (lower diagram) to PmCaiT (¥), EcCaiT (£) 
or StCaiT ( ) solubilized in Cymal-5 resulted in a saturation curve from which the binding constants 
for each substrate can be calculated. The measurements were performed with sodium-free Tris buffer 
and the proteins were purified without NaCl in sodium-free Tris buffer.   
 
For PmCaiT wt the influence of Na
+ or H
+ on substrate binding was tested 
(Figure  3-48).  The  binding  assays  were  performed  in  the  presence  of  different 
concentrations of Na
+ or at pH 7.0 and pH 9.0. At pH 5.0 the protein aggregated and 
binding studies were not possible.  
 
The substrate binding analysis for L-carnitine with 50 mM NaCl gave a KD of 
2.4 ± 0.4 mM, a Bmax of 39 ± 2.3 mM and a Hill coefficient of 1.0 ± 0.1. The Results 
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respective analysis for PmCaiT wt with L-carnitine at pH 9.0 gave a KD of 3.1 ± 0.3 
mM, a Bmax of 40.4 ± 2.6 mM and a Hill coefficient of 1.2 ± 0.1 (Table 3-4). 
 
 
Figure 3-48 | Na
+- or pH-independent L-carnitine binding of PmCaiT wt 
Influence  of  the  L-carnitine  binding  to  PmCaiT  wt  solubilized  in  Cymal-5  under  different  Na
+ 
concentrations  (top  diagram)  or  at  different  pH  (lower  diagram).  In  the  left  diagram  L-carnitine 
binding to PmCaiT wt was tested in the presence of no NaCl (¥), 1 mM NaCl ( ), 10 mM NaCl (§) 
or 50 mM NaCl (©). The right diagram shows L-carnitine binding to PmCaiT wt at pH 7.0 (¥) or pH 
9.0 ( ). None of the tested parameters had an influence on the substrate binding to CaiT. 
 
 
Table 3-4 summarizes the substrate binding parameters for the wildtype CaiT 
homologs PmCaiT, EcCaiT and StCaiT. Results 
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Table 3-4 | Substrate binding constants for PmCaiT wt, EcCaiT wt and StCaiT 
wt 
  PmCaiT wt 
without NaCl 
PmCaiT wt 
with NaCl 
EcCaiT wt  StCaiT wt 
KD (γ-butyrobetaine) (mM)  3.1 ± 0.6  3.4 ± 0.2  3.9 ± 0.7  2.9 ± 0.2 
Bmax (γ-butyrobetaine) (mM)  42.0 ± 1.0
 a)  42.0 ± 1.0
  43.3 ± 3.2  40.8 ± 2.0 
Hill coefficient  
(γ-butyrobetaine) 
1.0 ± 0.1  1.1 ± 0.1  1.0 ± 0.1  1.2 ± 0.1 
         
KD (L-carnitine) (mM)  1.8 ± 0.3 
3.1 ± 0.3
 a) 
2.4 ± 0.4
   1.9 ± 0.2  1.9 ± 0.1 
Bmax (L-carnitine) (mM)  40.3 ± 2.5 
40.4 ± 2.6
 a) 
39.1 ± 2.3  39.1 ± 3.1  43.2 ± 3.6 
Hill coefficient (L-carnitine)  1.1 ± 0.1 
1.2 ± 0.2
 a) 
1.0 ± 0.1  1.2 ± 0.1  1.1 ± 0.1 
a) Measurements were performed at pH 9.0 
 
 
3.6.2.1.2   PmCaiT mutants 
 
For a deeper understanding of the CaiT exchange mechanism, the binding 
behaviour of two PmCaiT mutants were studied. The question was how mutations of 
Met331 that coordinates the substrate in the central transport site, or of Trp316 that 
contributes to the coordination of the external substrate, would affect CaiT function.  
 
The binding of γ-butyrobetaine or L-carnitine to Met331Val was measured in 
the absence or presence of NaCl (Figure 3-49). The substrate binding analysis gave a 
KD for γ-butyrobetaine of ~12 mM in the absence or presence of NaCl (Table 3-5). 
Compared  to  PmCaiT  wt  (Table  3-4)  the  binding  constant  of  the  mutant  to  γ-
butyrobetaine is reduced by a factor of 4. The KD for L-carnitine of the PmCaiT 
Met331Val was ~7 mM without or with NaCl (Table 3-5). This is again a reduction 
of the binding affinity by a factor of 4 compared to PmCaiT wt (Table 3-4). The 
analysis gave a Bmax of 42 – 51 mM and a Hill coefficient of 1.0 – 1.2 for both Results 
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substrates γ-butyrobetaine and L-carnitine and in absence or presence of NaCl (Table 
3-5). 
 
The binding analysis for the mutant Trp316Ala gave a KD of 17.5 ± 6.0 mM 
for  γ-butyrobetaine  and  9.0  ±  1.3  mM  for  L-carnitine,  which  when  compared  to 
PmCaiT wt (Table 3-4) equals a reduction in the binding affinity for γ-butyrobetaine 
or L-carnitine by a factor of 6 or 5, respectively. The analysis gave a Bmax of 58.6 ± 
7.8 mM for γ-butyrobetaine and 33.7 ± 1.3 mM for L-carnitine and a Hill coefficient 
of 1.0 for both substrates (Table 3-5).  
 
 
 
Figure 3-49 | Substrate binding activity of PmCaiT M331V and PmCaiT W316A  
Binding of γ-butyobetaine and L-carnitine to PmCaiT wt (¥), PmCaiT Met331Val (£,©) and PmCaiT 
W316 ( ) solubilized in Cymal-5 in sodium-free Tris buffer (top) or in Tris buffer containing 50 mM 
NaCl.  
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Table 3-5 gives an overview of the substrate binding parameters of PmCaiT 
Met331Val and PmCaiT Trp316Ala. 
 
Table 3-5 | Substrate binding constants of PmCaiT M331V and PmCaiT W316A 
  PmCaiT M331V 
without NaCl 
PmCaiT M331V 
with NaCl 
PmCaiT W316A 
KD (γ-butyrobetaine) (mM)  11.7 ± 1.2
  11.8 ± 1.7
  17.5 ± 6.0 
Bmax (γ-butyrobetaine) (mM)  51.1 ± 3.0
)  50.2 ± 2.8
  58.6 ± 7.8 
Hill coefficient 
(γ-butyrobetaine) 
1.1 ± 0.1
  1.2 ± 0.1
  0.9 ± 0.1 
       
KD (L-carnitine) (mM)  7.1 ± 1.1 
7.0 ± 0.8
 a) 
7.0 ± 0.8
  9.0 ± 1.3 
Bmax (L-carnitine) (mM)  41.7 ± 2.7
  45.1 ± 1.5
  33.7 ± 1.3 
Hill coefficient (L-carnitine)  1.1 ± 0.1
  1.0 ± 0.1
  1.0 ± 0.1 
 
 
3.6.2.2  Binding studies of reconstituted CaiT   
 
In addition to the substrate binding studies with CaiT solubilized in Cymal-5, 
measurements with reconstituted PmCaiT and EcCaiT were performed. The binding 
characteristics of the protein might be different in the natural lipid environment. The 
mutant  PmCaiT  Trp316Ala  was  considered  in  these  measurements  because  the 
question was if the mutation of the external substrate-binding site has an effect on the 
transport mechanism which might be more pronounced under natural conditions.   
 
The  substrate  binding  curves  for  CaiT  reconstituted  into  liposomes  are 
sigmoidal  (Figure  3-50),  indicating  positive  cooperative  substrate  binding.  The 
cooperativity is not apparent with detergent-solubilized CaiT (Figure 3-47, Figure 
3-48, Figure 3-49).   
 
The binding analysis gave a KD for γ-butyrobetaine of 5.6 ± 0.8 mM or 5.3 ± 
0.8 mM and a Bmax of 34.3 ± 2.9 mM and 21.8 ± 1.8 mM for PmCaiT wt and EcCaiT Results 
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wt, respectively (Table 3-6). The Hill coefficient for the PmCaiT wt and EcCaiT wt is 
1.5 ± 0.1 and 1.4 ± 0.1, respectively.  
The analysis for L-carnitine as substrate gave a KD of 4.5 ± 0.8 mM and 5.8 ± 
1.0 mM and a Bmax of 28.3 ± 1.9 mM or 30.5 ± 1.5 mM for PmCaiT wt or EcCaiT wt 
(Table 3-6). The calculated Hill coefficients for PmCaiT wt and EcCaiT wt are 1.4 ± 
0.1 and 1.5 ± 0.1, respectively.   
Both the binding affinity and the maximal substrate binding concentration for 
the two substrates are reduced when the protein is reconstituted into liposomes (Table 
3-4) compared to the detergent-solubilized wildtype CaiT (Table 3-4). 
 
Binding analysis for the reconstituted Trp316Ala mutant resulted in KD values 
for γ-butyrobetaine or L-carnitine of 11.2 ± 1.7 mM or 7.5 ± 1.2 mM (Table 3-6). 
These  values  are  comparable  with  the  substrate  affinity  constants  for  PmCaiT 
Trp316Ala solubilized in Cymal-5 (Table 3-5). The Bmax values 21.8 ± 1.8 mM or 
24.4  ±  0.8  mM  for  γ-butyrobetaine  or  L-carnitine  are  reduced  compared  to  the 
detergent-solubilized PmCaiT Trp316Ala (Table 3-5). This result is similar to that 
seen  for  the  wildtype  CaiTs  that  was  reconstituted  into  liposomes.  The  Hill 
coefficient for reconstituted PmCaiT Trp316Ala is 1.7 ± 0.1 for γ-butyrobetaine and 
1.6  ±  0.1  for  L-carnitine  (Table  3-6),  indicating  the  presence  of  pronounced 
cooperativity for the binding of γ-butyrobetaine and L-carnitine in proteoliposomes.  
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Figure 3-50 | Binding studies of reconstituted PmCaiT wt, PmCaiT Trp316Ala 
and EcCaiT wt  
PmCaiT wt, PmCaiT Trp316Ala or EcCaiT was reconstituted into liposomes at an LPR of 10, buffered 
in  sodium-free  Tris.  The  proteoliposomes  were  titrated  with  γ-butyrobetaine  (top  diagram)  or  L-
carnitine (lower diagram). Substrate binding for PmCaiT wt (¥), PmCaiT Trp316A ( ) and EcCaiT 
(£) was monitored by tryptophan fluorescence. The protein was excited at 295 nm (slit width 2.5 nm) 
and fluorescence emission was monitored at 342 nm (slit width 5.0 nm).  
 
 
The  calculated  substrate  binding  parameters  for  CaiT  reconstituted  into 
liposomes are summarized in Table 3-6. Results 
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Table 3-6 | Substrate binding constants of PmCaiT wt, PmCaiT W316A and 
EcCaiT wt reconstituted into liposomes 
  PmCaiT wt  PmCaiT W316A  EcCaiT wt 
KD (γ-butyrobetaine) (mM)  5.6 ± 0.8  11.2 ± 1.7  5.3 ± 0.8 
Bmax (γ-butyrobetaine) (mM)  34.3 ± 2.9  21.8 ± 1.8  22.8 ± 0.8 
Hill coefficient 
(γ-butyrobetaine) 
1.5 ± 0.1  1.7 ± 0.2  1.4 ± 0.1 
       
KD (L-carnitine) (mM)  4.5 ± 0.8  7.5 ± 1.2  5.8 ± 1.0 
Bmax (L-carnitine) (mM)  28.3 ± 1.9  24.4 ± 0.8  30.5 ± 1.5 
Hill coefficient (L-carnitine)  1.4 ± 0.1  1.6 ± 0.1  1.5 ± 0.2 
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4   Discussion 
 
In this work the 3D X-ray structures of the secondary substrate/product antiporter 
CaiT from three different species were solved. To obtain more information about the 
substrate  transport  mechanism  of  CaiT,  binding  and  transport  analyses  were 
performed on the wildtype protein and on mutants that were designed on the basis of 
the crystal structure. 
 
 
4.1   Crystallization behaviour of the three CaiT homologs 
 
The EcCaiT project was taken over from K. R. Vinothkumar, who had obtained 
EcCaiT  2D  crystals  (Figure  1-6)  that  grew  in  the  presence  of  DPPC 
(dipalmitoylphosphatidylcholine) and POPC (palmitoyl-oleyl-sn-phophatidylcholine). 
The  projection  map  (Figure  1-6)  obtained  from  negatively  stained  vesicular  two-
dimensional crystals of EcCaiT had a resolution of 25 Å and showed P3 symmetry 
with a unit cell dimension of a = b = 93 Å and γ = 120 ˚ (Figure 1-6; (Vinothkumar et 
al., 2006)). K. R. Vinothkumar also started 3D crystallization of CaiT which yielded 
crystals that diffracted to ~6 Å (Vinothkumar, 2005).  
 
The CaiT homologs of P. mirabilis and S. typhimurium were chosen out of 388 
homologs after analyzing the results of the crystallization feasibility calculated by the 
XtalPred  server  (http://ffas.burnham.org/XtalPred).  All  388  CaiT  homologs  were 
categorized as “very difficult”. The selection of the two CaiT homologs used for 
crystallization was therefore based on two criteria: the isoelectric point (pI) and the 
hydrophobicity index or gravy index. Since EcCaiT has a pI of 8.54 (Figure 3-7) one 
homolog was chosen with a lower and the other with a higher pI value. PmCaiT has a 
pI of 8.41 and StCaiT has a pI of 8.67 (Figure 3-8, Figure 3-9). Comparisons of pI 
values from crystallized proteins that were deposited in data bases (Section 2.4.3.1) 
showed  that  the  pI  of  8.41  from  PmCaiT  lies  in  a  pI  value  region  of  “observed Discussion 
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successes” (Figure 3-8). The pI value of 8.67 from StCaiT lies in a pI value region of 
“observed failure” (Figure 3-9). 
The gravy index gives an indication of the hydrophobicity of a protein and thus 
how likely the protein is able to establish crystal contacts between molecules. The 
optimal gravy index lies in the region of -0.4 – 0.2. Membrane proteins tend to have a 
high gravy index since a considerable part of the protein has to interact with the 
hydrophobic acyl chains of the lipids in the membrane. The hydrophobicity index of 
most CaiT homologs is 0.72 as it is for EcCaiT (Figure 3-7) and StCaiT (Figure 3-9). 
One of the few exceptions is PmCaiT, which has a gravy index of 0.68 (Figure 3-8). 
The lower gravy index for PmCaiT suggests that it may crystallize more easily.  
 
The crystallization behaviour of the three CaiT homologs was quite different 
from the initial crystallization trials. Both EcCaiT and PmCaiT formed sharp edged 
rhomboidal or rectangular crystals whereas StCaiT crystallized in small needles. The 
crystallization prediction calculated by the XtalPred server correlates well with the 
real  crystallization  behaviour  of  the  CaiT  homologs.  PmCaiT  had  the  best 
crystallization criteria in the prediction with the pI value in the “observed success” 
range  and  the  lowest  gravy  index.  The  diffraction  data  collected  from  PmCaiT 
crystals was used to solve the structure of CaiT.  
The  gravy  indices  of  EcCaiT  and  StCaiT  are  identical  but  the  pI  value  of 
EcCaiT is 0.13 units lower than that of StCaiT and was categorized in the “observed 
success” region (Figure 3-7). EcCaiT crystallized better than StCaiT but not as well 
as  PmCaiT.  Although  diffraction  data  was  collected  for  phasing  from  EcCaiT 
cyrstals, the structure could not be solved without the well-refined PmCaiT model.  
StCaiT has a pI of 8.67 and thus was categorized in the “observed failure” 
region (Figure 3-9). Compared to the other two CaiT homologs, StCaiT crystals were 
difficult to optimize and even the optimized crystals were fragile. Due to the low 
resolution, the StCaiT structure is biased by the PmCaiT model.  
 
The crystal contact observed in PmCaiT is mainly formed by Arg(-2) that is 
located  in  the  thrombin  cleavage  site  between  the  protein  and  the  His6-tag  and 
residues forming in the external substrate binding site of CaiT (Figure 3-32). When 
the linker peptide is included in the calculation for the crystallization feasibility the Discussion 
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gravy index for PmCaiT decreases to 0.67 (Figure 6-6), while the pI increases to 8.56 
(Figure 6-6), which is still categorized in the “observed success” region. All three 
homologs were crystallized with and without His6-tag and therefore with and without 
the linker peptide. PmCaiT only crystallized well with the His6-tag left at the protein 
while EcCaiT and StCaiT crystallized better with the His6-tag cleaved off. EcCaiT 
formed crystal contacts between residues in loop L9b and residues in the loops L2 
and  L10  of  the  symmetry  related  protomer.  StCaiT  formed  crystal  contacts  by 
residues  in  the  loops  L2  and  L10  with  residues  in  the  loops  L3  and  L9b  of  the 
symmetry related protomer.  
 
Although  PmCaiT  is  clearly  an  unexpected  positive  exception,  the 
crystallization tendency of the three CaiT homologs followed the XtalPred server 
predictions.  However,  all  parameters  analyzed  in  these  predictions  are  based  on 
soluble proteins. A similar prediction server for membrane proteins is needed which 
estimates, apart from the stability and tertiary structure of the protein of interest, the 
charge distribution of the extracellular and intracellular surface at certain pH values, 
determines  the  hydrophobic  region  and  possible  hydrophobic  interactions  and 
estimates  the  length  and  charge  distribution  of  loop  regions  also  at  different  pH 
values.  
 
 
4.2  Oligomeric state of CaiT 
 
The oligomeric state of CaiT has been analyzed by K. R. Vinothkumar, who 
showed using different methods that CaiT forms stable trimers in detergent solution 
and  in  the  lipid  membrane  of  2D  cyrstals  (Vinothkumar  et  al.,  2006).  In  single 
particle analysis of CaiT it was shown that in detergent solution two CaiT trimers 
tend to stack together and form hexamers (Figure 4-1; (Vinothkumar et al., 2006)). 
The hexamer formation was also observed during BN gradient gel electrophoresis 
(Figure 3-5). When equal concentrations of the three homologs were loaded onto a 
BN gradient gel, EcCaiT and StCaiT usually separated into two bands corresponding 
to a CaiT trimer and hexamer (Figure 3-5). PmCaiT separated into three (Figure 3-5) Discussion 
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or four bands, which shows that PmCaiT has a high tendency to associate into higher 
oligomers without forming unordered aggregates – a behaviour that is advantageous 
for 3D crystallization.  
 
When the structure of the CaiT trimer is modeled into the side view oriented 2D 
average of single particles (Figure 4-1 B), an interaction between the α-helical loop 
L9b and loop L2 of the next protomer is possible. A similar contact is observed in the 
crystal structures of EcCaiT and StCaiT. It is likely that this interaction is the reason 
for the formation of CaiT hexamers in detergent solution. The tendency of PmCaiT to 
form higher oligomers can be explained by the strong interaction of the N-terminus 
and residues in L9b, TM8 and TM3.   
 
 
Figure 4-1 | 3D CaiT structure modeled into 2D averages of single particles  
The 3D CaiT structure is modeled into the face-on view (A) and side view (B) of 2D averaged of CaiT 
single particles (Vinothkumar et al., 2006). In the side view two CaiT trimers interact. The distance 
between the two trimers is about 6 Å (yellow arrow), side chains not included. This distance allows 
interactions between residues in the helical formed loop L9b and loop L2 of the next protomer.   
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4.3   The CaiT structure  
 
4.3.1   CaiT trimer architecture 
 
CaiT forms compact trimers of three identical protomers (Figure 4-2). The 
three protomers are arranged in a closely packed triangle with a length of about 100 Å 
in the longest dimension. The surface potential of each protomer of CaiT (Figure 4-2) 
shows a predominantly negatively charged periplasmic surface and a predominantly 
positively charged cytoplasmic surface. This electrostatic destribution is in agreement 
with the positive-inside rule (von Heijne and Gavel, 1988). In addition, both the N- 
and  C-terminus,  which  are  located  in  the  cytoplasm,  are  positively  charged.  The 
distance between the two surfaces measures ~45 Å and consists of non-polar residues 
that are engaged in protein-lipid interactions. The width of the hydropobic part is in 
good  agreement  with  the  experimentally  determined  thickness  of  pure 
phophatidylcholine (PC) bilayers with 18:1 acyl chains, where the phosphodiester 
groups are 38 Å apart and the hydrophobic core is 27 Å thick (Lewis and Engelman, 
1983; Palsdottir and Hunte, 2004). Although PC is not a naturally compound of the E. 
coli  membrane,  the  experimentally  determined  thickness  of  the  PC  bilayer  is 
comparable to the native membrane in E. coli (Lewis and Engelman, 1983; Palsdottir 
and Hunte, 2004). The three protomers within the CaiT trimer form a hydrophobic 
cavity (Figure 4-2) on the cytoplasmic side that measures about 24 Å in height and 
about  15  –  20  Å  in  diameter.  In  the  cavity  of  PmCaiT,  three  Cymal-5  detergent 
molecules were found, each biniding to one protomer (Figure 3-26). These detergent 
molecules are likely to be replaced by lipids in the native membrane, which would 
additionally stabilize the trimer. Lipid analysis of the purified protein show that PE 
remains bound to the protein after purification (Figure 3-35), but no density could be 
assigned to a lipid molecule without ambiguity.  
 
Strong  ionic  and  polar  interactions  between  the  protomers  (Section  3.4.1; 
Figure 3-26) ensure trimer formation and make the trimer more rigid than that of 
BetP, where interactions mediated by residues in H7 are mainly hydrophobic (Ressl Discussion 
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et al., 2009) and comparatively weak. In BetP the flexibility within the trimer is 
thought  to  enable  the  protomers  to  activate  their  neighbours  (Ressl  et  al.,  2009) 
whereas the rigid trimer architecture of CaiT suggests that each protomer functions 
independently similar as the glutamate transporter from Pyrococcus horikoshii GltPh 
(Reyes et al., 2009; Yernool et al., 2004), which also crystallized as rigid trimers 
(Yernool  et  al.,  2004).  However,  the  transport  domains  are  expected  to  move 
stochastically and independently within each trimer (Reyes et al., 2009; Yernool et 
al., 2004) and crosslinking studies lead to the conclusion that the crystal structure 
represents  the  rare  case  when  all  three  protomers  are  trapped  in  the  same 
conformation (Reyes et al., 2009).  
 
 
Figure  4-2  |  PmCaiT  trimer  with  surface  potential  shown  for  one  of  the 
protomers 
The symmetrical CaiT trimer is shown from the periplasmic side (A), the cytoplasmic side (B) and 
parallel to the membrane (C). One protomer is shown with surface potential that was calculated at pH 
6.8 with the APBS (Adaptive Poison-Boltzmann Solver), an implemented tool in PyMOL (DeLano, 
2002). The longest dimension of the trimer measures ~100 Å, the distance between the periplasmatic Discussion 
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surface and the cytoplasmatic surface is ~45 Å and the hydrophobic part of the protein measures about 
27 Å in height. On the cytoplasmic side between the three protomers a hydrophobic cavity is formed 
(red arrow) with a height of ~24 Å and a diameter of about 10 – 15 Å, which is likely to contain lipids 
in the native membrane environment.   
 
 
4.3.2   The CaiT protomer 
 
The CaiT protomer consists of twelve transmembrane helices (TM1 to TM12) 
(Figure 4-3). Ten of these helices (TM3 – TM7 and TM8 – TM12) form two inverted 
repeats  of  five  TM  helices  (Figure  3-24)  that  make  up  the  transporter  core.  The 
helices TM1 and TM2 together with the long, curved H7 are not part of the two 5-TM 
inverted repeats and form the supporting scaffold for the CaiT transporter core.  
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Figure 4-3 | Stereo view of the EcCaiT protomer 
Periplasmic (A) and side (B) view on the EcCaiT protomer with two substrate molecules bound. The 
first substrate molecule is bound in the center of the protomer (black arrow), the second molecule is 
held in an extracellular cavity (blue arrow) near the exit of the closed substrate pathway.   
 
 
The 5-TM inverted repeat motif was first reported for the sodium-coupled 
secondary transporter LeuT (Yamashita et al., 2005). Including CaiT, there are now 
seven unique structures of five different transporter families all of which contain this 
core  motif  (LeuT,  Neurotransmitter  Sodium  Symporter  NSS  family  (Singh  et  al., 
2008; Yamashita et al., 2005); vSGLT, Sodium Solute Symporter SSS family (Faham 
et al., 2008); Mhp1, Nucleobase Cation Symporter-1 NCS-1 family (Shimamura et 
al., 2010; Weyand et al., 2008); BetP/CaiT Betaine/Carnitine/Choline Transporter Discussion 
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BCCT  family  (Ressl  et  al.,  2009;  Tang  et  al.,  2010);  AdiC/ApcT,  Amino  acid, 
Polyamine and Organocation APC family (Fang et al., 2009; Gao et al., 2009; Gao et 
al., 2010). The inner core of these transporters consists of an antiparallel four-helix 
bundle, which is formed by the first two helices of the two inverted repeats. In CaiT, 
the four-helix bundle provides residues for the substrate-binding site that is located in 
the center of the protein (Figure 3-24, Figure 3-28, Figure 4-3).  
 
In CaiT, the two substrate-binding sites both occur on the four-helix bundle. 
The central transport site is located in the centre of the protein halfway across the 
membrane and consists of a tryptophan box (Figure 3-29, Figure 3-30), resembling 
that of BetP (Ressl et al., 2009). A second substrate-binding site is located in an 
extracellular cavity near the exit of the closed substrate pathway (Figure 3-28, Figure 
3-31). In the antiporter CaiT the two substrate-binding sites found in the EcCaiT 
structure (Figure 3-28, Figure 3-29, Figure 3-31) and the sigmoidal substrate binding 
behaviour  (Figure  3-50)  suggest  that  the  two  sites  are  necessary  to  perform  the 
exchange of the substrate L-carnitine against the metabolic product γ-btyrobetaine. 
Both binding sites must be occupied, as seen in the EcCaiT structure, before substrate 
transport is possible.  
The chemical environment of the external substrate-binding site in CaiT is 
conserved  in  BetP,  suggesting  a  similar  site  could  also  be  present  in  BetP.  An 
external  second  substrate-binding  site  at  a  similar  position  was  also  proposed  for 
LeuT  ((Shi  et  al.,  2008);  Section  4.4.2.2).  In  symporters  like  BetP  and  LeuT  an 
external  substrate-binding  site  might  be  necessary  to  deliver  substrate  to  the 
transporter by binding first to its external surface. Binding of substrate to a proposed 
external binding site in LeuT might trigger the intracellular release of Na
+ from the 
Na1 binding site and substrate bound in the central substrate-binding site (Quick et 
al., 2009; Shi et al., 2008). Discussion 
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4.3.2.1 Comparison of a recently published E. coli CaiT structure 
 
Recently, an X-ray structure of CaiT from E. coli (PDB accession code 3HFX) 
at a resolution of 3.15 Å has been reported (Tang et al., 2010). It is largely identical 
to  the  EcCaiT  structure  presented  in  this  work  (Figure  4-4),  except  from  small 
changes in loop regions that are involved in crystal contacts. 
 
 
Figure 4-4 | EcCaiT protomers 
The EcCaiT (A) structure and the E. coli CaiT from Tang et al. (B) are largely identical, except from 
changes in loop regions that are involved in crystal contacts (black arrows).  
 
 
Tang  et  al.  co-crystallized  CaiT  with  5  mM  L-carnitine,  which  is  
approximately 2.5 times KD. Each CaiT protomer binds four L-carnitine molecules, 
two  of  the  binding  sites  confirm  those  that  bind  γ-butyrobetaine  in  the  EcCaiT 
structure (Figure 4-5) presented in this work. The other two binding sites are most 
likely transiently occupied when the substrate moves from the cytoplasm into the 
central transport site.  
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Figure 4-5 | Substrate molecules in the substrate pathway of EcCaiT 
The EcCaiT substrate pathway (A) contains two γ-butyrobetaine molecules. The first molecule (γ-
BB1) is bound in the central transport site while the second molecule (γ-BB2) is held in the regulatory 
binding site of the protomer. In the CaiT structure of Tang et al. (B), four L-carnitine molecules were 
found. The first molecule (LC-I) is localized in the central transport site, the second (LC-II) is bound  
~6  Å  below  the  first  substrate  molecule.  The  third  L-carnitine  molecule  (LC-III)  is  held  in  the 
extracellular  substrate-binding  site  and  the  fourth  molecule  (LC-IV)  is  bound  at  the  entry  of  the 
cytoplasmically open substrate pathway. 
 
The residues in the central transport site of the two CaiT structures are almost 
identical (Figure 4-6). Both the γ-butyrobetaine in EcCaiT and the first L-carnitine in 
the CaiT structure of Tang et al. are strongly interacting with Trp323. In both E. coli 
CaiT structures, Trp323 takes on the same rotamer orientation that allows substrate 
binding. This rotamer orientation is different to the one seen for Trp323 in PmCaiT at 
higher  resolution,  which  has  no  substrate  bound  (Figure  3-30).  The  second  L-
carnitine froms a cation-π interaction with Tyr327 (Tang et al., 2010). Tyr327 rotates 
by  only  ~2˚  upon  L-carnitne  binding,  suggesting  that  in  the  inward-facing  open 
conformation most of the residues in the pathway involved in substrate interaction 
have a default orientation that requires minimal rotational energy in order to transfer 
substrate to the central binding site.  
 
In the external substrate-binding site (Figure 4-6), the substrate is bound by 
cation-π interaction to Tyr114 and Trp316 in both CaiT structures. In EcCaiT, γ-
butyrobetaine forms an additional hydrogen bond to the backbone amid nitrogen of Discussion 
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Gly315  while  in  the  other  E.  coli  CaiT  structure  an  additional  hydrogen  bond  is 
formed by L-carnitine to Gly310 (Tang et al., 2010).  
 
 
Figure 4-6 | Central transport site and regulatory binding site 
The residues in the central transport site of EcCaiT (A) and in the E. coli CaiT reported by Tang et al. 
(B) are almost identical. The substrate γ-butyrobetaine (γ-BB1) or L-carnitine (LC-I) interacts mainly 
by cation-π interaction with Trp323, which takes on the same rotamer orientation in both structures. 
The second L-carnitine molecule (LC-II) bound in CaiT (Tang et al., 2010) interacts with Tyr327 that 
only reorients by ~2˚ upon substrate binding. In the regulatory substrate-binding site of EcCaiT (C) the 
γ-butyrobetaine interacts by cation-π interaction with Tyr114 and Trp316. The same residues interact 
with L-carnitine (LC-III) in the external substrate-binding site of CaiT reported by Tang et al. (D). 
 
In both E. coli CaiT structures, the substrates L-carnitne and γ-butyrobetaine 
are bound in the same way mainly by cation-π interactions in both substrate-binding 
sites. This is the reason why both substrates can be transported in both directions. 
Additional hydrogen bonds between the carboxyl group of the substrate and residues Discussion 
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in  the  protein  stabilize  the  orientation  of  the  substrate  in  the  binding  site.  The 
formation of specific hydrogen bonds is dependent on the substrate flexibility.  
 
 
4.3.3   Transporter conformation 
 
In  the  alternating  access  mechanism  the  central  transport  site  must  be 
accessible from one side of the membrane to bind substrate. To transport the substrate 
across the membrane, the protein must undergo conformational changes in which the 
transporter closes the central transport site from the one site of the membrane before 
it subsequently opens to the other site allowing substrate transport without opening a 
continuous transmembrane pore (Jardetzky, 1966; Krishnamurthy et al., 2009). The 
four conformations (Figure 1-10) that were previously described are the outward-
facing  open,  represented  by  Mhp1  (PDB  accession  code  2JLN;  (Weyand  et  al., 
2008)), the outward-facing occluded, represented by LeuT-Leu (PDB accession code 
2A65;  (Yamashita  et  al.,  2005)),  the  occluded,  represented  by  BetP-Bet  (PDB 
accession  code  2WIT;  (Ressl  et  al.,  2009))  and  the  inward-facing  occluded, 
represented by vSGLT-Gal (PDB accession code 3DH4; (Faham et al., 2008)). CaiT 
crystallized in an inward-facing, open conformation. Access to the central transport 
site  from  the  cytoplasm  is  unhindered  by  sidechains.  The  inward-facing,  open 
conformation  was  the  last  major  conformation  missing  in  the  alternating  access 
transport  mechanism  of  LeuT-type  transporters.  Superpositions  of  the  different 
transporters with PmCaiT or EcCaiT show the major conformational changes in the 
helices lining the substrate transport pathway (TM3, TM7, TM8, TM10 and TM12, 
CaiT numbering) of the transporters. The root means square deviation (rmsd) values 
of the different transporter conformations are listed in Table 4-1.     Discussion 
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Table 4-1 | Structure comparisons of PmCaiT and EcCaiT to each other and to 
the structurally related transporters BetP, vSGLT, LeuT and Mhp1 
Mol A  Mol B  Z-Score  Aligned 
Residues 
rmsd 
(Å) 
Sequence 
Identity (%) 
PmCaiT 
(Trimer) 
EcCaiT 
(Trimer) 
53.6  972  0.9  87 
PmCaiT 
(Protomer) 
EcCaiT 
(Protomer) 
60.5  496  0.7  87 
           
PmCaiT 
(Trimer) 
BetP 
(Trimer) 
43.1  1348  2.2  25 
PmCaiT 
(Monomer) 
BetP 
(Monomer) 
43.7  478  2.2  25 
           
EcCaiT 
(Trimer) 
BetP 
(Trimer) 
37.2  895  2.3  25 
EcCaiT 
(Monomer) 
BetP 
(Monomer) 
44.0  481  2.2  25 
           
PmCaiT 
(Monomer) 
vSGLT 
(Monomer) 
13.7  334  4.2  13 
EcCaiT 
(Monomer) 
vSGLT 
(Monomer) 
13.6  333  4.0  12 
           
PmCaiT 
(Monomer) 
LeuT 
(Monomer) 
14.8  342  4.1  10 
EcCaiT 
(Monomer) 
LeuT 
(Monomer) 
14.7  335  4.3  10 
           
PmCaiT 
(Monomer) 
Mhp1 
(Monomer) 
17.2  320  4.2  8 
EcCaiT 
(Monomer) 
Mhp1 
(Monomer) 
16.8  317  4.4  7 
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In  the  different  transporters  the  two  inverted  repeats  start  with  different 
helices. In CaiT and BetP, the first two TM helices (TM1 and TM2) form a protecting 
scaffold for the protein core and the inverted repeats start with TM3. In LeuT, the 
supporting  helices  are  located  at  the  C-terminal  end  (TM11  and  TM12)  and  the 
inverted repeats start with TM1. vSGLT has 14 TM helices in which the first (TM1) 
and the last three helices (TM12-TM14) form the protein scaffold and the inverted 
repeats start with TM2. Table 4-2 provides a list of residues that correspond to the 10 
TM helices of the two inverted repeats.   
 
Table 4-2 | Lookup table of residues for the 10 TM helices of the two inverted 
repeats in LeuT-type transporters 
  CaiT  BetP  vSGLT  LeuT  Mhp1  AdiC  ApcT 
  Residues  Residues  Residues  Residues  Residues  Residues  Residues 
Repeat 1               
Helix 1  87 – 118 
TM3 
137 – 169 
TM3 
52 – 80 
TM2 
10 – 38 
TM1 
28 – 55 
TM1 
11 – 37 
TM1 
9 – 37 
TM1 
Helix 2  127 – 163 
TM4 
177 – 212 
TM4 
83 – 109 
TM3 
40 – 72 
TM2 
57 – 86 
TM2 
43 – 67 
TM2 
40 – 66 
TM2 
Helix 3  186 – 224 
TM5 
234 – 268 
TM5 
123 – 158 
TM4 
87 – 125 
TM3 
99 – 137 
TM3 
81 – 112 
TM3 
83 – 117 
TM3 
Helix 4  228 – 249 
TM6 
275 – 296 
TM6 
161 – 178 
TM5 
165 – 185 
TM4 
142 – 159 
TM4 
122 – 143 
TM4 
122 – 141 
TM4 
Helix 5  251 – 277 
TM7 
300 – 325 
TM7 
185 – 213 
TM6 
189 – 214 
TM5 
161 – 191 
TM5 
146 – 172 
TM5 
145 – 172 
TM5 
Repeat 2               
Helix 6  311 – 340 
TM8 
358 – 390 
TM8 
249 – 277 
TM7 
240 – 269 
TM6 
208 – 234 
TM6 
195 – 217 
TM6 
183 – 214 
TM6 
Helix 7  343 – 377 
TM9 
393 – 427 
TM9 
279 – 314 
TM8 
275 – 306 
TM7 
241 – 278 
TM7 
226 – 248 
TM7 
218 – 247 
TM7 
Helix 8  403 – 435 
TM10 
448 – 482 
TM10 
348 – 385 
TM9 
336 – 371 
TM8 
295 – 331 
TM8 
277 – 310 
TM8 
269 – 305 
TM8 
Helix 9  445 – 467 
TM11 
488 – 511 
TM11 
391 – 418 
TM10 
374 – 396 
TM9 
335 – 351 
TM9 
323 – 342 
TM9 
320 – 337 
TM9 
Helix 10  469 – 502 
TM12 
513 – 546 
TM12 
422 – 448 
TM11 
398 – 425 
TM10 
359 – 383 
TM10 
351 – 376 
TM10 
339 – 364 
TM10 
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4.3.3.1  Alternating access models 
 
For the alternating access mechanism of LeuT-type transporters two models 
have been proposed. Gouaux and coworkers (Krishnamurthy et al., 2009; Singh et al., 
2008)  propose  a  mechanism  for  LeuT  based  on  the  outward-facing  open 
conformation  of  LeuT-Trp  (Singh  et  al.,  2008),  the  outward  facing  occluded 
conformation of LeuT-LeuT (Yamashita et al., 2005) and the inward facing occluded 
conformation of vSGLT (Faham et al., 2008) in which the unwound regions of TM1 
and TM6 provide a hinge around which rotational and translational conformational 
changes  can  occur.  The  continuous  helices  TM2  and  TM7  would  constrain  large 
movements of TM1 and TM6 but would move and bend in the transition from the 
outward-facing to the inward-facing conformation. In addition, a bending of TM3 and 
TM8 may also contribute to the opening and closing of the transporter (Figure 4-7 
black  circles;  (Krishnamurthy  et  al.,  2009)).  The  helices  which  form  a  scaffold 
around the four-helix bundle stabilizes the transporter within the lipid membrane and 
mediate conformational changes of the transporter on one site of the membrane to 
movements on the other side (Krishnamurthy et al., 2009).  
 
 
Figure 4-7 | Proposed mechanism of the transition from the outward-facing to 
the inward-facing conformation in LeuT-type transporters 
The  helices  TM1,  TM3,  TM6  and  TM8  line  the  central  transport  pathway.  The  extracellular  and 
intracellular loops EL4 and IL1, respectively, act as lids that seal the extracellular and intracellular 
pathway in their closed conformation. In the transition from the outward-facing conformation (LeuT, 
A) to the inward-facing conformation (vSGLT, B) TM1 and TM6 rotate relative to TM3 and TM8. 
The rotation axis is shown in A in black. The figure is adapted from (Krishnamurthy et al., 2009). 
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In this proposed mechanism, the helices of the four-helix bundle would move 
independently from one another and not as a rigid body (Krishnamurthy et al., 2009) 
as it is proposed in a second transport mechanism. 
 
The second mechanism is described as rocking bundle mechanism, which is 
based on the LeuT structure, LeuT modeled in the inward-facing conformation as 
well as mutagenisis and accessibility studies of the mammalian serotonin transporter 
SERT,  which  is  a  member  of  the  same  transporter  family  as  LeuT  (Forrest  and 
Rudnick, 2009; Forrest et al., 2008). The four-helix bundle of LeuT (Table 4-2) is 
seen as a rigid body (Figure 4-8) and the transporter transforms from the outward-
facing  to  the  inward-facing  conformation  by  a  rotation  of  the  four-helix  bundle 
relative to the scaffold of the protein around an axis that is close to the substrate and 
ion binding site (Forrest et al., 2008). During the substrate transport, the rotation of 
the four-helix bundle can be regarded as an alternate rocking of the bundle (Forrest et 
al., 2008) from one conformation to the other.  Discussion 
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Figure 4-8 | Conformational changes of LeuT predicted by the rocking bundle 
model   
LeuT  is  shown  in  the  outward-facing  conformation  (A)  in  which  it  was  crystallized  and  in  the 
modelled inward-facing conformation (B). The scaffold of the protein is shown in blue, and the four-
helix  bundle  in  red  for  the  outward-facing  conformation  and  in  gold  for  the  inward-facing 
conformation.  In  the  transition  from  the  outward-facing  conformation  to  the  inward-facing 
conformation, the four-helix bundle rotates around an axis that lies perpendicular to the paper plane 
and close to the substrate and ion binding site. The substrates leucine (yellow and dark blue) and 
sodium (green) are shown in space-filling representation. The figure is adapted from (Forrest et al., 
2008). 
 
Recently, Mhp1 has been crystallized in three different conformations, the 
outward-facing  open,  the  outward-facing  occluded  and  the  inward-facing  open 
conformation (Shimamura et al., 2010; Weyand et al., 2008). Based on the analysis 
of the three structures and MD simulations with the protein in a nativelike bilayer the 
authors propose a mechanism similar to the rocking bundle mechanism in which the 
scaffold and the four-helix bundle move relative to each other as approximately rigid 
bodies (Shimamura et al., 2010). However, two of the three Mhp1 structures, the 
outward-facing  occluded  conformation  (4.0  Å)  and  the  inward-facing  open 
conformation  (3.8  Å),  were  solved  at  low  resolution  at  which  precise  helix 
positioning and detailed analysis of helix movements are not possible.  Discussion 
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The  rocking  bundle  model  combines  the  LeuT-type  transporter  architecture 
with the internal symmetry of the two 5-TM inverted repeats and the arrangement of 
the four-helix bundle relative to the transporter scaffold with symmetric movements 
resulting  in  conformational  changes  that  expose  the  central  substrate-binging  site 
alternately to the two sites of the membrane. By definition, models describe complex 
mechanisms in a very simplified manner.  
 
Comparisons of the two CaiT structures and BetP show that the transition from 
the inward-facing open conformation to the occluded conformation involves iris-like 
movements of the helices TM3 and TM8 in the four-helix bundle as well as TM7 and 
TM10, which are located in the scaffold. These helix rotations are similar to the 
movements proposed by Gouaux and coworkers (Krishnamurthy et al., 2009; Singh 
et al., 2008). The transition from the occluded conformation to the outward-facing 
open  conformation,  represented  by  LeuT-Trp  (Singh  et  al.,  2008),  requires  an 
additional independent shift of the periplasmatic part of TM12. These movements are 
inconsistent with the rocking bundle model. 
 
The substrate transport mechanism seems to vary among the different LeuT-
type transporters and can only be described in detail for a single transporter when the 
structures of the three major conformations are available at high resolution.  Discussion 
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4.4   The CaiT transport mechanism 
 
 
4.4.1   Cation-π interaction 
 
In CaiT the specific binding of the substrates appears to be mainly established 
by cation-π interactions between the positively charged quaternary ammonium group 
of the substrate and aromatic residues like tryptophans or tyrosines of CaiT (Figure 
4-11, Figure 4-12). 
 
The origin of the cation-π interaction is the negative electrostatic potential of 
the quadrupole moment in sp
2 carbon systems such as benzene or tryptophan. This 
negative electrostatic potential is highest in the center of the aromatic ring (Figure 
4-9) and arises from the separation of the six local C
δ--H
δ+ bond dipoles (Dougherty, 
2007). Cations are attracted to the negative electrostatic potential over the face and 
not the edge, of the aromatic system (Dougherty, 1996).  
 
 
Figure 4-9 | Cation-π interaction 
The  cation-π  interaction  is  due  to  an  electrostatic  attraction  between  a  positive  charge  and  the 
quadrupole  moment  of  an  aromatic  system.  The  quadrupole  moment  of  the  three  sp
2  orbitals  of 
benzene, viewed on edge, with regions of positive (blue) and negative (red) partial charge, is shown 
schematically in (A). The quadrupole moment arises from the separation of the six local C
δ--H
δ+ bond 
dipoles. High-level quantum mechanical calculations (B) show the negative electrostatic potential (red) 
in the center of the trytophan indole ring to which the cations bind. Cations are attracted to the negative 
electrostatic potential over the face, not the edge, of the indole ring (C). (Dougherty, 1996, 2007) Discussion 
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One  important  role  of  the  cation-π  interaction  is  stabilizing  the  secondary 
structure of proteins by establishing a specific binding force between the amino acids 
Phe/Typ/Trp and Lys/Arg. Another role of the cation-π interaction is protein-ligand 
recognition.  Strong  cation-π  interactions  often  involve  ligands  that  contain  a 
quaternary ammonium ion, such as RNMe3
+ (Dougherty, 2007). The orientation of 
the ligand relative to the aromatic ring influences the binding strength. The strongest 
cation-π  interaction  involves  a  T-shape  geometry  of  the  ligand  relative  to  the 
aromatic system (Figure 4-10; (Gallivan and Dougherty, 1999)). 
 
 
Figure 4-10 | Geometry of cation-π interactions 
The preferred geometry of cation-π interactions in protein structures is the orientation of the cation 
parallel to the quadrupole moment of the tryptophan indole ring, although some of the strongest cation-
π interactions involve the T-shape geometries (Gallivan and Dougherty, 1999). 
 
 
4.4.1.1  Cation-π interaction in CaiT 
 
In EcCaiT, the γ-butyrobetaine bound in the central transport site is oriented 
in  the  T-shape  geometry  to  Trp323  (Figure  4-11),  forming  a  strong  cation-π 
interaction  with  the  tryptophan.  In  PmCaiT,  Trp323  is  rotated  by  ~60˚  to  an 
orientation that prohibits a cation-π interaction to the substrate but allows hydrogen 
bond formation to small solvent molecules. The indole ring of Trp323 only reorients 
into the substrate-binding position when a substrate molecule binds in the external 
binding site. The positively charged quaternary ammonium group of the substrate 
replaces the water molecules in the central transport site and interacts strongly with Discussion 
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the indole ring of Trp323 since the sp
2 carbon is more electronegative than hydrogen 
(Dougherty, 2007).  
 
 
Figure 4-11 | Geometry of the cation-π interaction in the central transport site of 
EcCaiT 
The positively charged quaternary ammonium group of γ-butyrobetaine in the central transport site of 
EcCaiT is oriented in a T-shape geometry to Trp323, which allows a strong cation-π interaction.  
 
In the external regulatory binding site of EcCaiT, the γ-butyrobetaine is bound 
in  parallel  geometry  to  Tyr114  and  W316  (Figure  4-12).  The  parallel  cation-π 
interaction  is  weaker  than  the  interaction  in  the  T-shape  geometry  (Gallivan  and 
Dougherty, 1999). 
 
 
Figure 4-12 | Geometry of the cation-π interaction in the regulatory binding site 
of EcCaiT 
The cation-π interaction of the positively charged quaternary ammonium group of γ-butyrobetaine to 
Tyr114 and Trp316 in the regulatory binding site of EcCaiT is in parallel geometry. 
 
The chemical environment and the binding characteristics of the substrates in 
the two substrate-binding sites are different. The binding environment in the central Discussion 
181 
transport site is provided by four tryptophans and one polar interaction to Met331. In 
the regulatory binding site, two aromatic residues provide the binding environment. 
An  additional  hydrogen  bond  is  also  formed  between  the  carboxyl  group  of  the 
substrate and the backbone amide nitrogen of G315 to hold the substrate in position 
in the external binding site.  
 
Based  on  the  chemical  environment  and  the  binding  characteristic  of  the 
substrate in the CaiT structure, the central transport site should have a significantly 
higher  affinity  for  the  substrate  than  the  external  binding  site.  However,  in  CaiT 
substrate  binding  is  cooperative  (Sections  3.6.2.2  and  4.4.2.2)  and  the  substrate 
binding affinity in the central transport site is probably determined by the substrate 
affinity of the external binding site. The positive cooperative binding of substrate in 
CaiT (Figure 3-50) shows a heterotropic effect, i.e., after binding of one substrate to 
the external site the substrate binding affinity of the central binding site is strongly 
increased and as long as substrate is bound in the external binding site, the central 
transport site has a strong affinity for the substrate. The increased substrate-binding 
affinity of the central binding site after binding of substrate in the external binding 
site can be explained by small conformational changes in the protein – a mechanism 
known  as  Koshland’s  induced  fit  model  (Koshland,  1958,  1973;  Koshland  et  al., 
1966).  According  to  this  mechanism,  the  protein  is  assumed  to  exist  in  two 
conformations.  In  a  heterotropic  positive  cooperative  induced  fit  mechanism  the 
absence of substrate causes the protein to stay in an inactive conformation. However, 
when  substrate  is  available  it  binds  to  the  regulatory  binding  site  and  induces  a 
conformational  change  which  favours  binding  of  a  second  substrate  at  a  second 
binding site (Koshland, 1973).  
 
The positive cooperative substrate binding suggests an allosterically regulated 
transport mechanism of CaiT, which is likely to be the reason why the calculated KD 
in the binding studies (Table 3-4, Table 3-5, Table 3-6) and the determined KM in the 
kinetic analyses (Table 3-2, Table 3-3) show a difference of a factor of ~50.  Discussion 
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4.4.2   Na
+-independent  and  cooperative  substrate/product  antiport 
in CaiT  
 
The structure of CaiT gives the first example of a secondary transporter that is 
independent of an electrochemical gradient. All other structurally related LeuT-type 
transporters  are  either  Na
+-  or  H
+-dependent.  Structural  analysis  combined  with 
binding and transport studies reveal how the antiporter CaiT transports its substrates 
without the help of a cation.  
 
 
4.4.2.1  Sodium-independent substrate transport mechanism 
 
In  the  high-resolution  X-ray  structure  of  LeuT,  two  well-resolved  sodium 
binding sites (Na1 and Na2) have been determined (Yamashita et al., 2005). The two 
sodium ions have key roles in binding the substrate and in stabilizing the architecture 
of the central transport site. None of the three CaiT structures shows density for a Na
+ 
ion  in  the  vicinity  of  either  of  the  two  corresponding  Na  sites  of  LeuT.  Instead, 
inspection of side chain residues in these two regions provides an explanation for the 
Na
+-independence of CaiT. 
 
The binding of γ-butyrobetaine in the central binding site of EcCaiT reveals 
an attractive interaction between the carboxyl group of the γ-butyrobetaine, and the 
sulfur  of  Met331  (Figure  4-11).  Although  the  methionine  side  chain  is  usually 
thought of as hydrophobic, it can in fact participate in polar interactions because the 
large uncharged sulfur is more easily polarized than smaller atoms. Two different 
types of interactions with neighbouring charges are possible (Rosenfield et al., 1977). 
The methionine sulfur is either negatively polarized and behaves as a nucleophile 
towards positively charged binding partners (e.g. Na
+, Ni
2+, H
δ+, C
δ+). Alternatively, 
the  methionine  sulfur  can  be  positively  polarized  and  behave  as  an  electrophile 
towards anions or atoms with a partial negative charge (e.g. Cl
-, O
δ-). In CaiT, the 
sulfur of Met331 interacts specifically with the carboxyl group of γ-butyrobetaine. Discussion 
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This  provides  an  elegant  solution  to  the  problem  of  recognizing  and  binding  a 
hydrophilic compound in the hydrophobic interior of a protein without the need for an 
ion as a second non-protein binding partner. It is known from the structures of small 
organic  compounds  like  3-(methylthio)  propanoic  acid  or  norbornane  endo-acid 
(Mahling et al., 1987) that an sulfur atom in a covalent bond, as in methionine, can 
interact with carboxylates (Burling and Goldstein, 1993; Mahling et al., 1987; Pal and 
Chakrabarti, 2001). 
 
Met331 is conserved in the prokaryotic CaiT and in the mammalian organic 
cation/carnitine transporters (OCTN) (Figure 6-2). In BetP, however, the position of 
the methionine is taken by Val381, which cannot coordinate the negatively charged 
carboxyl group of the substrate. Mutating Met331 to valine in PmCaiT reduces KD 
for substrate binding by a factor of ~4, but vmax in transport measurements by a factor 
of 10 (Figure 3-49, Table 3-5, Figure 3-41, Table 3-3). This highlights the pivotal role 
of  this  residue  for  transport.  However,  the  mutation  does  not  make  CaiT  Na
+-
dependent. 
 
Interestingly, ApcT, which is H
+-dependent, but, like CaiT Na
+-independent, 
also has a methionine (Met202) in the Na1 position (Figure 4-13; (Shaffer et al., 
2009). The putative central transport site of ApcT was not occupied by substrate so 
that  an  interaction  between  this  methionine  and  the  substrate  was  not  observed. 
Instead, the volume of the putative substrate-binding site was occupied by ordered 
water molecules (Figure 4-13; (Shaffer et al., 2009)).  Discussion 
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Figure 4-13 | Putative central transport site in ApcT 
In the putative central transport site of the H
+-dependent Apc transporter, Met202 (red circle) might 
coordinate the substrate as in CaiT. In this way, the transporter would avoid the need for an additional 
binding partner. This picture is adapted from (Shaffer et al., 2009). 
 
 
The Na2 position in LeuT is occupied by Arg262 (TM7) in CaiT (Figure 
4-14).  This  residue  is  accessible  to  solvent  in  the  open  cytoplasmic  funnel.  The 
positively charged arginine sidechain evidently has the same role as Na2 in LeuT, 
linking TM3 to TM10 and stabilizing the unwound region of TM3, which contributes 
to substrate binding in the external binding pocket through Tyr114 (Figure 4-12). In 
the H
+-dependent ApcT, a lysine (K158) is located in a position equivalent to the Na2 
ion in LeuT (Figure 4-14; (Shaffer et al., 2009)). This residue undergoes reversible 
protonation  and  deprotonation  during  the  substrate  transport  cycle  (Shaffer  et  al., 
2009).  
 
Replacing Arg262 by glutamate in PmCaiT renders the protein inactive but 
with addition of Na
+ the mutant regains a partial transport activity that is four-fold 
reduced compared to wildtype PmCaiT (Figure 3-43, Table 3-3). The insertion of a 
negative  charge  at  a  position  that  was  held  by  a  positive  charge  in  the  wildtype 
protein has to make the protein inactive, as the chemical environment is adjusted to Discussion 
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compensate  a  positive  charge.  However,  it  is  striking  that  the  inactive  PmCaiT 
Arg262Glu mutant can be partially rescued by addition of Na
+. Thus, a single point 
mutation confers Na
+-dependence in CaiT. However, it is unlikely that the mutant 
cotransports Na
+ with the substrate. It is more likely that the Na
+ remains bound the 
to Glu262 in the mutant. Detailed Na
+ stoichiometry analyses of the Na
+-dependent 
PmCaiT  Arg262Glu  mutant  and  control  experiments  with  a  non-charged  residue 
introduced at this position still need to be done. These experiments will clarify if a 
positive  charge  is  essential  or  if  a  neutral  environment,  with  only  one  Na
+ 
compensating  for  the  negative  charge  of  the  glutamate,  is  sufficient  for  protein 
activity.   
 Discussion 
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Figure 4-14 | Position of Na2 in LeuT and the equivalent position in the Na
+-
independent transporters CaiT and ApcT 
Na2 (green sphere) in LeuT (A) links TM1 to TM8. These helices correspond to helices TM3 and 
TM10 in CaiT. The sodium ion stabilizes the unwound region of TM1. TM1 in LeuT provides residues 
for substrate binding in the central transport site. The position equivalent to Na2 in LeuT is taken by 
Arg262 in CaiT (B)  and  Lys158  in  ApcT  (C).  In  both  Na
+-independent  transporters,  a  positively 
charged side chain takes over the function of Na
+. The protonated side chain of Arg262 avoids the 
need of an additional binding partner in CaiT, whereas the Lys158 in the H
+-dependent ApcT needs to 
undergo reversible protonation and deprotonation during the transport cycle.  Discussion 
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4.4.2.2  Cooperative activation of CaiT 
 
The EcCaiT crystal structure revealed two substrate-binding sites. Substrate-
binding  curves  for  CaiT  reconstituted  into  proteoliposomes  are  sigmoidal  (Figure 
3-50),  indicating  positive  cooperativity  (Ricard  and  Cornish-Bowden,  1987).  This 
means that transport activity is allosterically regulated, such that a substrate molecule 
bound to one site increases the binding affinity of the other. The cooperativity is not 
apparent  with  detergent-solubilized  CaiT  (Figure  3-47,  Figure  3-48,  Figure  3-49), 
presumably because the transporter is more relaxed and flexible in detergent solution 
than  in  the  membrane.  Delipidation  upon  detergent  solubilization  during  protein 
preparation  decreases  the  lateral  pressure  that  impacts  on  the  protein  in  the  lipid 
bilayer  (Palsdottir  and  Hunte,  2004).  Thus  a  lipid  environment  that  may  include 
ordered lipid in the hydrophobic cavity of the trimer (Figure 3-25, Figure 3-26, Figure 
4-2) seems to be required for cooperativity.  
 
It  is  reasonable  to  assume  that  the  external  substrate-binding  site  is  the 
regulatory site. This assumption is strongly supported by the finding that the PmCaiT 
structure does not contain bound substrate, whereas that of EcCaiT does. In PmCaiT, 
access to the second site is blocked by a crystal contact (Figure 3-32), which cannot 
form when substrate is bound. An empty regulatory site would reduce the affinity of 
the central transport site, which indeed is also empty in PmCaiT. 
 
The  affinity  of  CaiT  for  γ-butyrobetaine  is  significantly  lower  than  for  L-
carnitine (Table 3-6) and this must reflect the binding properties of the regulatory 
site.  With  its  extra  hydroxyl  group,  a  L-carnitine  molecule  can  establish  another 
hydrogen bond to the ε-amino group of Lys470 in the regulatory binding site (Figure 
4-12), whereas there are no such polar interactions in the central transport site. The 
finding that the W316 mutant is strongly impaired in transport but only moderately in 
substrate binding (Table 3-3, Table 3-5, Table 3-6) supports the conclusion that the 
external binding site is the regulatory site, as the structure of the transport site, and 
therefore its binding affinity for either substrate, will be largely unaffected by the Discussion 
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W316A mutation. If the external site were not the regulatory site, no strong effect on 
transport would be expected, contrary to what is observed (Figure 3-49, Figure 3-50). 
 
The  Hill  coefficients  derived  from  the  binding  curves  (Figure  3-50)  range 
from 1.4 or 1.5 for wt PmCaiT or EcCaiT and L-carnitine, to 1.7 for the W316 mutant 
and  γ-butyrobetaine  (Table  3-6),  indicative  of  pronounced  cooperativity.  Many 
allosteric proteins are oligomers with only one binding site per protomer. CaiT has 
two  binding  sites  and  it  is  therefore  interesting  to  ask  whether  the  cooperativity 
applies to the two binding sites in the protomer, or to all six in the trimer. Comparison 
of the EcCaiT and PmCaiT trimers shows that in addition to structural changes in the 
protomer each protomer tilts 3˚ toward the three-fold axis of the trimer (Figure 4-15) 
when substrate is bound. 
 
The overall rms deviation between the substrate-bound and the apo protomer 
is 0.7 Å and 0.9 Å for the trimers (Table 4-1) with and without bound substrate. This 
difference indicates that these changes are significant as the rmsd between spinach 
and pea LHC-II, two similarly homologous, trimeric membrane proteins that do not 
undergo a conformational change, is 0.35Å (Barros et al., 2009). A Hill coefficient 
>1 signifies an interaction of at least 2 binding sites, which are likely to be those 
observed in the protomer, as cooperativity between all six sites in the trimer should 
result  in  a  higher  Hill  coefficient.  However,  the  exact  role  of  the  CaiT  trimer  in 
allosteric regulation remains to be determined. Discussion 
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Figure 4-15 | Superposition of the PmCaiT trimer on the EcCaiT trimer 
Cytoplasmice (left) and extracellular (right) view of the PmCaiT trimer (yellow) superimposed on the 
EcCaiT trimer (blue). The superposition indicates a 3˚ tilt of the substrate-bound EcCaiT protomer 
relative to PmCaiT towards the threefold axis. 
 
 
A second substrate-binding site has also been proposed for LeuT. The location 
of this site in LeuT was deduced from stirred molecular dynamic (SMD) simulations 
(30 ns) in which the substrate leucine was pulled from the occluded position along the 
possible substrate pathway towards the extracellular region. This site is located in an 
extracellular vestibule around 11 Å above the central transport site (Quick et al., 
2009; Shi et al., 2008). SMD simulations of LeuT together with kinetic substrate 
trapping  studies  suggest  that  binding  of  substrate  at  the  extracellular  binding  site 
allosterically triggers intracellular Na
+ and substrate release from the central binding 
site (Shi et al., 2008). Three different tricyclic antidepressants (TCAs) or an n-octyl-
β-D-glucopyranoside  (OG)  molecule  bound  at  this  position  renders  the  protein 
inactive (Quick et al., 2009; Singh et al., 2008; Zhou et al., 2007).  Discussion 
190 
4.4.2.3  Substrate translocation model 
 
Analysis of the two structures, EcCaiT and PmCaiT, combined with transport 
and  binding  studies,  allows  to  propose  a  mechanism  of  allosterically  regulated 
substrate uptake by CaiT that encompasses all the findings reported in this thesis 
(Figure 4-16). This model should be regarded as speculative, until structures of all 
intermediate stages have been determined. According to this proposed mechanism, a 
substrate molecule first binds to the regulatory extracellular site. This substrate would 
normally be L-carnitine, which is more abundant outside the cell than its metabolic 
product γ-butyrobetaine. Through the network of hydrogen bonds and hydrophobic 
sidechain contacts, substrate binding to the regulatory site triggers the reorientation of 
Trp323,  which  would  result  in  an  increased  affinity  for  substrate  in  the  central 
transport site. The wide open cytoplasmic substrate funnel in the default low-energy 
state of CaiT ensures free access from the cell interior, so that substrate can bind as 
soon as Trp323 reorients. The substrate molecule binding from the inside would be γ-
butyrobetaine, which is more abundant in the cell. Discussion 
191 
 
Figure 4-16 | Proposed substrate antiport mechanism 
The empty transporter, represented by the structure of PmCaiT, binds a L-carnitine molecule (yellow 
diamond) in its regulatory site. This triggers the reorientation of Trp323, so that a γ-butyrobetaine 
molecule  (red  diamond)  can  bind  in  the  central  transport  site.  In  the  outside-open  state,  the  γ-
butyrobetaine diffuses out of the central binding site, and L-carnitine binds instead. The transporter 
then changes conformation back to the inside-open state, releasing the L-carnitine into the cell interior, 
where it is consumed. When the L-carnitine concentration outside the cell drops below a critical level, 
the substrate diffuses out of the regulatory site, and the transporter switches off. 
 
The subsequent steps in the CaiT transport cycle can be gleaned from the 
structure of BetP and the LeuT-type transporters, which have different default low-
energy states shown by their crystal structures. Transition from the inside-open to the 
occluded state, represented by BetP, involves an iris-like movement of the helices 
TM3 and TM8 in the central bundle and TM7 and TM10 of the protein scaffold 
(Figure 4-17), along with the reorientation of bulky hydrophobic sidechains that lock 
the substrate into the transport site.  Discussion 
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Figure 4-17 | Iris-like helix movement in the transition from the inward-facing, 
open conformation to the occluded conformation  
Stereo drawing of superposed protomers of PmCaiT and BetP, showing an iris-like movement of the 
cytoplasmatic part of the helices TM3, TM7, TM8 and TM10 (yellow for PmCaiT, red for BetP) in the 
transition from the inward-facing, open conformation of CaiT to the occluded state of BetP. 
 
The outside-open conformation is exemplified by LeuT and its relatives that 
crystallized in the same state (Faham et al., 2008; Fang et al., 2009; Gao et al., 2009; 
Ressl et al., 2009; Shaffer et al., 2009; Shimamura et al., 2010; Singh et al., 2008; 
Tang et al., 2010; Weyand et al., 2008; Yamashita et al., 2005). Although sequence 
similarity  between  the  LeuT-type  transporters  is  low  (Table  4-1),  the  overall 
structures of the protomers are surprisingly well conserved, and a superposition of ten 
TM helices of the transporter core (Table 4-2) allows describing the helix movements 
in the transition from the occluded to the outside-open conformation. When modelled 
on the outside-open conformation of LeuT (Figure 4-18), the extracellular ends of 
helices TM3 and TM4 in repeat 1 of CaiT move by 3.2 Å and 5 Å, while TM8 and 
TM12 in repeat 2 move by 6.2 Å and 5 Å, in each case out of the extracellular 
substrate pathway to open it. It follows that the hydrogen bonds between Glu111 and 
Tyr320, and between Tyr137 and Thr317 (Figure 3-33) must break for the outside 
funnel to open. Several of the hydrogen bonds around Glu111 are longer by up to 1.0 
Å in EcCaiT than in PmCaiT, suggesting that substrate binding to the external site 
weakens  the  central  hydrogen  bonding  network  in  the  protomer.  Therefore  the Discussion 
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transition  to  the  outside-open  conformation  would  require  less  energy  in  EcCaiT, 
which contains bound substrate, than in PmCaiT, which does not. 
 
In the outside-open state, γ-butyrobetaine would diffuse out of the transport 
site, and the more abundant L-carnitine would bind instead. The process would then 
go into reverse. The extracellular pathway would close, and the cytoplasmic funnel 
would open, releasing L-carnitine to the cell interior where its concentration is low. 
The constant consumption of L-carnitine in the cell would maintain a concentration 
gradient that drives uptake. In the CaiT structure modelled on the outward-open state 
of LeuT, the second site remains intact (Figure 4-18) suggesting that the substrate 
remains  bound  throughout  the  transport  cycle  (Figure  4-16)  as  long  as  there  is 
sufficient substrate in the environment. When the external L-carnitine concentration 
drops below a critical level, the substrate would diffuse out of the regulatory site and 
transporter would switch off. 
 Discussion 
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Figure 4-18 | Conformational changes in the transition from the inward-facing, 
open to the outward-facing, open conformation in CaiT  
Stereo drawings comparing EcCaiT helices TM3, TM8 and TM12 with key residues in the inward-
facing, open conformation (A, blue) to a model of EcCaiT in the outward-facing, open conformation 
(B, pink), based on the LeuT-Trp structure. In the model (B), the second, regulatory substrate-binding 
site on the extracellular side defined by residues Tyr114, Trp316 and the carbonyl oxygen of Gly315 
remains  intact,  so  that  substrate  is  likely  to  remain  bound  throughout  the  transport  cycle.  (C) 
Superposition of A and B, indicating the helix movements that accompany the transition from the 
inside-open to the outside-open conformation on the extracellular side of CaiT. Discussion 
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4.5   Concluding remarks and outlook 
 
At  the  beginning  of  this  project  little  was  known  about  the  structure  and 
mechanism of CaiT. K. R. Vinothkumar investigated in his PhD thesis the oligomeric 
state of EcCaiT and established the expression and a purification protocol that was 
refined for a successful 2D and initial 3D crystallization (Vinothkumar, 2005). The 
high  caiT  expression  rate  and  the  high  protein  yield  was  a  prerequisite  to  start 
working on the 3D crystallization of CaiT. A crucial step during this work was to 
investigate CaiT homologs from different species in order to find one homolog that 
crystallized  well  and  diffracted  to  high  resolution.  PmCaiT  was  the  successful 
homolog with which the structure determination of CaiT was possible. The EcCaiT 
and StCaiT structures were subsequently solved with the well-refined PmCaiT model.   
 
The  3D  X-ray  structure  of  the  trimeric  CaiT  revealed  interesting  protein 
features. In the CaiT protomer two substrate-binding sites have been found. Binding 
studies with reconstituted protein showed that substrate binding in the antiporter CaiT 
is  regulated  in  a  heterotropic  positive  cooperated  mechanism.  Substrate/product 
antiport  in  CaiT  is  thus  allosterically  regulated.  The  two  structures,  PmCaiT  and 
EcCaiT,  also  provide  insights  on  how  Na
+-independent  substrate  transport  is 
achieved. In the EcCaiT structure an interesting and important interaction was found 
between the negatively charged carboxyl group of the substrate and the sulfur atom of 
a  methionine  in  the  central  binding  site.  Although  such  an  interaction  has  been 
postulated to occur in proteins (Pal and Chakrabarti, 2001), this does not seem to 
have  been  described  before.  This  interaction  allows  the  protein  to  coordinate  the 
substrate without the need for additional binding partners. The same strategy is used 
at the equivalient position where H
+-dependent or Na
+-dependent transporter bind H
+ 
or Na
+ ions. In CaiT this position is taken by a positively charged arginine.  
 
After  analyzing  the  CaiT  structure,  point  mutations  were  inserted  into  the 
protein and functional studies were performed to explain the mechanism of CaiT and 
to prove hypotheses that were made based on the structural information. All results Discussion 
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taken together allowed us to propose a substrate/product exchange mechanism for 
CaiT. 
 
The investigations of CaiT now need to focus on more detailed mechanistic 
problems. Many questions are open and need to be answered. One of those questions 
is the function of the CaiT trimer and if a protomer on its own would be functionally 
active. The complex substrate binding process needs to be resolved, i.e., the binding 
affinity  of  the  regulatory  binding  site  and  the  central  binding  site  needs  to  be 
determined separately.  
Regarding the L-carnitine production, it would be interesting to improve the 
substrate affinity and the tranport efficiency of CaiT. 
 
It would also be very interesting to solve the CaiT structure in the outward-facing 
conformation and in the occluded state. Additional bioinformatic investigations with 
the structures of the three CaiT states would give further details of conformational 
changes that occur upon substrate binding and during the substrate/product exchange 
mechanism. 
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6  Appendix 
 
 
6.1   Protein constructs 
 
PmCaiT   
UniProtKB entry name: CaiT_PROSL  UniProtKB accession no.: P59334 
>sp|P59334|CAIT_PROSL  L-carnitine/gamma-butyrobetaine  antiporter 
OS=Proteus sp. (strain LE138) GN=caiT PE=3 SV=1 
MSKDNKKAGIEPKVFFPPLIIVGILCWLTVRDLDASNEVINAVFSYVTNVWGWAFEWYMV 
IMFGGWFWLVFGRYAKKRLGDEKPEFSTASWIFMMFASCTSAAVLFWGSIEIYYYISSPP 
FGMEGYSAPAKEIGLAYSLFHWGPLPWATYSFLSVAFAYFFFVRKMEVIRPSSTLTPLVG 
EKHVNGLFGTVVDNFYLVALILAMGTSLGLATPLVTECIQYLFGIPHTLQLDAIIISCWI 
LLNAICVAFGLQKGVKIASDVRTYLSFLMLGWVFIVGGASFIVNYFTDSVGTLLMYMPRM 
LFYTDPIGKGGFPQAWTVFYWAWWVIYAIQMSIFLARISKGRTVRELCLGMVSGLTAGTW 
LIWTYSGGNTLQLIDQNILNIPQLIDQYGVPRAIIETWAALPLSTATMWGFFILCFIATV 
TLINACSYTLAMSTCRSMKEGAEPPLLVRIGWSVLVGIIGIILLALGGLKPIQTAIIAGG 
CPLFFVNIMVTLSFIKDAKVHWKD 
 
 
EcCaiT   
UniProtKB entry name: CaiT_ECOLI   UniProtKB accession no.: P31553 
>sp|P31553|CAIT_ECOLI  L-carnitine/gamma-butyrobetaine  antiporter 
OS=Escherichia coli (strain K12) GN=caiT PE=1 SV=2 
MKNEKRKTGIEPKVFFPPLIIVGILCWLTVRDLDAANVVINAVFSYVTNVWGWAFEWYMV 
VMLFGWFWLVFGPYAKKRLGNEPPEFSTASWIFMMFASCTSAAVLFWGSIEIYYYISTPP 
FGLEPNSTGAKELGLAYSLFHWGPLPWATYSFLSVAFAYFFFVRKMEVIRPSSTLVPLVG 
EKHAKGLFGTIVDNFYLVALIFAMGTSLGLATPLVTECMQWLFGIPHTLQLDAIIITCWI 
ILNAICVACGLQKGVRIASDVRSYLSFLMLGWVFIVSGASFIMNYFTDSVGMLLMYLPRM 
LFYTDPIAKGGFPQGWTVFYWAWWVIYAIQMSIFLARISRGRTVRELCFGMVLGLTASTW 
ILWTVLGSNTLLLIDKNIINIPNLIEQYGVARAIIETWAALPLSTATMWGFFILCFIATV 
TLVNACSYTLAMSTCREVRDGEEPPLLVRIGWSILVGIIGIVLLALGGLKPIQTAIIAGG 
CPLFFVNIMVTLSFIKDAKQNWKD 
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StCaiT   
UniProtKB entry name: CaiT_SALTI  UniProtKB accession no.: Q8Z9L1 
>sp|Q8Z9L1|CAIT_SALTI  L-carnitine/gamma-butyrobetaine  antiporter 
OS=Salmonella typhi GN=caiT PE=3 SV=1 
MKNEKRKSGIEPKVFFPLLIIVGILCWLTVRDLDAANVVINAVFSYVTNVWGWAFEWYMV 
VMLFSWFWLVFGPYAKKRLGDEKPEFSTASWIFMMFASCTSAAVLFWGSIEIYYYISTPP 
FGLEPNSTGAKEIGLAYSLFHWGPLPWATYSFLSVAFAYFFFVRKMDVIRPSSTLVPLVG 
EKHAKGLFSTIVDNFYLVALIFAMGTSLGLATPLVTECMQWLFGIPHTLQLDAIIITCWI 
ILNAICVACGLQKGVRIASDVRSYLSFLMLGWVFIVSGASFIMNYFTDSVGMLLMHLPRM 
LFYTDAIGKGGFPQGWTVFYWAWWVIYAIQMSIFLARISRGRTVRELCFGMVMGLTASTW 
ILWTVLGSNTLLLMDKNILNIPQLIEQHGVARAIIETWAALPLSTATMWGFFILCFIATV 
TLINACSYTLAMSTCREVRDGEEPPLLVRIGWSVLVGIIGIVLLALGGLKPIQTAIIAGG 
CPLFFVNIMVTLSFIKDAKVHWKDK 
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6.2   Vector System 
 
 
Figure 6-1 | pET-15b vector map 
The  EccaiT,  PmcaiT  or  StcaiT  gene  was  cloned  into  the  pET-15b  (Novagen)  vector,  using  the 
restriction enzymes NdeI and XhoI (red box). 
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6.3   Sequence Alignment 
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Figure 6-2 | Sequence Alingment 
Amino  acid  sequence  alignment  of  CaiT  from  Proteus  mirabilis  (PmCaiT),  E.  coli  (EcCaiT), 
Salmonella  typhimorium  (StCaiT),  Shewanella  loihica  (SlCaiT),  BetP  from  Corynebacterium 
glutamicum (CgBetP), E.coli BetT (EcBetT), and organic cation transporters from mouse (mOCTN3) 
and  human  (hOCTN2).  Red  triangle:  Met331  which  coordinates  the  carboxyl  group  of  the  bound 
substrate in the transport site of CaiT. Orange triangles: fully or partly conserved hydrophobic residues 
in the central transport site. Blue triangle: Trp316 in the regulatory site of CaiT. Red asterisk: Glu111, 
which coordinates the network of hydrogen bonds linking the two inverted repeats in the inside-open 
conformation of CaiT. Residues 588 – 677 of EcBetT were omitted.  Appendix 
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6.4  Crystal packing 
 
 
Figure 6-3 | Unit cell packing of PmCaiT  
Packing of PmCaiT within the unit cell H3 with the cell parameters a = b = 129.2 Å, c = 160.3 Å, α = 
β = 90˚, γ = 120˚. 
 
 
 
Figure 6-4 | Unit cell packing of EcCaiT 
Packing of EcCaiT within the unit cell P32 with the cell parameters a = b = 124.2 Å, c = 154.6 Å, α = 
β = 90˚, γ = 120˚. 
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Figure 6-5 | Unit cell packing of StCaiT 
Packing of StCaiT within the unit cell P65 with the cell parameters a = b = 128.8 Å, c = 309.5 Å, α = β 
= 90˚, γ = 120˚. 
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Figure 6-6 | Prediction of the crystallization probability for PmCaiT with linker 
peptide 
When the small linker peptide connecting the amino terminus to the His6 tag in PmCaiT is included in 
the calculations for the crystallization feasibility prediction the hydrophobicity index decreases to 0.67 
and the pI value increases to 8.56, which is still located in the “observed success” region.   
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